	id	term_id	term	parents	ancestors	children	descendants
0	0	R-HSA-162582	Signal Transduction R-HSA-162582	2629	2629	21,23,32,47,49,53,59,74,142,147,197,577,712,966,1000,1142,1528	21,22,23,28,32,36,38,47,48,49,50,51,53,59,63,65,70,74,79,83,88,103,115,136,141,142,147,149,151,152,163,164,176,197,208,225,227,229,254,257,269,294,296,315,317,319,323,324,327,331,333,347,349,357,361,371,373,385,389,407,410,413,418,419,421,443,449,455,468,474,479,495,497,501,507,510,512,519,524,533,537,538,544,546,558,565,572,573,575,577,578,580,581,586,588,600,602,608,615,621,625,630,631,632,635,646,649,661,664,678,681,683,695,699,700,701,704,706,712,719,724,725,727,728,730,733,740,759,763,764,770,788,790,793,795,803,814,820,825,828,833,842,843,854,862,863,868,876,877,879,880,888,890,896,903,906,908,911,915,921,922,957,958,961,964,966,976,992,994,998,999,1000,1003,1007,1013,1018,1026,1027,1029,1040,1042,1043,1046,1055,1064,1065,1066,1071,1075,1079,1082,1083,1087,1101,1103,1106,1121,1123,1129,1130,1137,1142,1143,1144,1145,1151,1153,1160,1171,1182,1183,1194,1202,1204,1205,1208,1209,1216,1217,1224,1237,1239,1251,1255,1262,1268,1273,1281,1283,1289,1294,1300,1301,1310,1315,1323,1324,1332,1333,1342,1353,1358,1360,1362,1367,1373,1377,1388,1390,1392,1398,1404,1408,1409,1417,1419,1422,1427,1443,1444,1446,1450,1452,1453,1455,1471,1481,1484,1500,1501,1509,1519,1528,1532,1537,1549,1563,1569,1572,1579,1586,1594,1599,1600,1602,1603,1606,1611,1616,1635,1642,1646,1648,1653,1654,1656,1659,1660,1675,1679,1681,1688,1689,1691,1696,1700,1701,1704,1712,1713,1714,1723,1725,1732,1735,1740,1743,1746,1751,1759,1769,1774,1791,1796,1805,1816,1817,1823,1827,1828,1831,1834,1855,1861,1879,1886,1887,1891,1901,1902,1905,1906,1910,1913,1914,1917,1920,1927,1934,1936,1939,1945,1950,1951,1954,1959,1961,1963,1965,1967,1973,1974,1978,1984,1989,1993,2000,2007,2023,2028,2030,2033,2050,2052,2053,2062,2066,2072,2079,2085,2088,2093,2126,2127,2134,2138,2146,2152,2159,2169,2177,2201,2211,2214,2226,2234,2259,2263,2276,2279,2283,2293,2302,2331,2336
1	1	R-HSA-1430728	Metabolism R-HSA-1430728	2629	2629	17,44,58,82,107,120,248,293,634,955,1396,1441,1457,1470,2132	17,44,58,82,91,107,120,122,140,185,187,188,192,209,212,218,243,248,251,263,270,293,308,314,367,398,420,476,514,525,539,540,547,566,567,584,604,619,628,634,656,662,708,710,732,744,745,751,758,767,778,780,791,807,808,822,832,856,865,869,872,873,918,919,930,936,941,949,950,955,968,971,982,984,993,1012,1020,1023,1024,1025,1031,1044,1068,1069,1078,1084,1092,1108,1112,1119,1134,1135,1164,1166,1170,1176,1184,1196,1200,1203,1210,1211,1218,1227,1240,1241,1250,1258,1259,1272,1276,1314,1319,1321,1325,1331,1338,1344,1350,1351,1354,1359,1361,1363,1371,1372,1375,1393,1396,1401,1405,1418,1425,1434,1441,1445,1457,1460,1462,1470,1473,1474,1475,1480,1482,1496,1504,1511,1512,1516,1520,1530,1531,1543,1546,1558,1559,1565,1566,1568,1575,1576,1581,1587,1588,1589,1591,1609,1615,1619,1625,1640,1645,1651,1670,1673,1686,1697,1702,1707,1711,1716,1718,1719,1722,1724,1731,1757,1762,1771,1776,1782,1784,1792,1794,1797,1801,1807,1819,1822,1833,1840,1845,1856,1859,1860,1864,1865,1870,1871,1877,1883,1884,1888,1889,1892,1896,1898,1899,1900,1908,1909,1916,1919,1926,1928,1933,1935,1938,1941,1958,1964,1966,1970,1971,1972,1976,1990,1991,1992,1996,2003,2014,2031,2032,2035,2037,2039,2041,2042,2043,2058,2071,2080,2082,2083,2089,2101,2102,2103,2107,2110,2125,2130,2131,2132,2137,2142,2147,2150,2160,2165,2180,2187,2188,2191,2200,2202,2212,2218,2222,2239,2246,2255,2257,2260,2269,2272,2274,2282,2303,2304,2305,2311,2314,2323,2324,2325,2337,2338,2347,2378,2380,2456,2468,2486,2491,2551,2555,2559,2561,2586,2588,2613
2	2	R-HSA-168256	Immune System R-HSA-168256	2629	2629	10,14,16	10,14,16,33,34,43,52,66,109,113,127,128,144,145,154,155,162,171,190,196,210,222,223,224,226,233,234,239,247,249,253,258,264,265,268,272,277,278,280,281,286,287,299,302,303,342,352,358,360,370,374,380,384,394,406,414,417,435,436,438,446,461,480,484,489,494,502,522,541,551,585,613,633,648,659,672,673,674,690,735,753,756,777,781,785,806,829,866,883,901,904,914,929,933,948,952,972,974,980,983,1005,1010,1021,1034,1035,1037,1050,1056,1075,1086,1088,1091,1098,1105,1109,1115,1124,1125,1188,1221,1228,1247,1252,1254,1264,1265,1266,1269,1275,1307,1317,1326,1328,1340,1370,1397,1402,1406,1414,1431,1436,1447,1452,1459,1476,1494,1499,1502,1503,1522,1526,1555,1557,1567,1570,1582,1584,1618,1637,1644,1663,1666,1667,1674,1683,1760,1763,1777,1778,1779,1781,1817,1836,1838,1842,1868,1872,1881,1911,1929,1937,1955,1982,2011,2015,2048,2168,2174,2194,2210,2227,2277,2281,2384
3	3	R-HSA-392499	Metabolism of proteins R-HSA-392499	2629	2629	6,60,198,241,288,290,345,893,1918	6,54,57,60,75,81,110,114,117,139,198,204,206,228,230,231,237,241,250,273,275,276,288,290,300,309,310,321,329,332,335,338,341,345,388,390,399,434,456,472,487,491,503,511,515,516,518,599,647,651,653,665,698,734,737,741,742,746,760,792,802,827,834,840,893,898,907,942,981,985,987,1011,1032,1038,1047,1062,1096,1118,1127,1136,1148,1180,1199,1201,1231,1277,1303,1366,1415,1424,1478,1483,1492,1539,1595,1601,1620,1623,1627,1649,1708,1728,1741,1811,1837,1869,1878,1882,1918,1922,1931,1956,2087,2161,2184,2207,2298,2622
4	4	R-HSA-1643685	Disease R-HSA-1643685	2629	2629	11,37,72,121,266,611,752,892,1162,1429,1433,2204	11,12,35,37,56,72,80,84,85,95,121,131,134,143,150,156,157,167,169,172,174,175,180,193,205,216,219,220,221,261,266,284,285,289,305,320,325,337,375,391,393,430,433,441,444,454,470,488,500,520,527,530,532,535,536,545,550,574,592,611,612,637,638,654,655,657,658,660,669,685,687,689,691,693,716,717,718,721,722,723,748,752,754,762,771,772,774,775,782,784,798,801,804,805,811,812,817,818,821,826,830,839,841,846,847,859,861,870,882,884,891,892,909,934,937,938,946,962,967,986,989,990,991,995,997,1001,1006,1009,1014,1019,1036,1049,1054,1059,1073,1077,1080,1090,1093,1116,1128,1138,1141,1147,1155,1156,1157,1158,1159,1162,1177,1179,1181,1191,1193,1214,1220,1225,1233,1236,1243,1257,1263,1267,1274,1279,1286,1293,1296,1297,1299,1304,1305,1306,1308,1311,1316,1318,1322,1327,1334,1335,1336,1341,1347,1348,1357,1368,1369,1374,1376,1379,1382,1386,1387,1400,1407,1412,1416,1428,1429,1430,1432,1433,1437,1439,1449,1451,1463,1466,1468,1477,1479,1489,1490,1498,1517,1525,1533,1538,1540,1561,1564,1598,1610,1612,1631,1641,1643,1662,1664,1665,1672,1677,1680,1695,1706,1709,1715,1730,1742,1744,1745,1747,1749,1753,1756,1761,1764,1765,1767,1775,1785,1786,1790,1795,1798,1799,1800,1810,1814,1815,1818,1824,1825,1829,1835,1839,1841,1843,1846,1847,1853,1858,1867,1885,1903,1907,1944,1946,1949,1952,1962,1968,1969,1986,1994,2008,2010,2016,2017,2020,2021,2024,2026,2027,2034,2036,2040,2044,2045,2046,2047,2054,2055,2057,2059,2060,2061,2067,2068,2069,2073,2074,2076,2099,2100,2104,2109,2111,2113,2114,2116,2118,2119,2120,2121,2123,2124,2128,2129,2133,2136,2139,2143,2145,2148,2149,2151,2153,2156,2163,2166,2167,2171,2172,2175,2176,2179,2181,2183,2185,2186,2189,2190,2192,2193,2195,2196,2199,2204,2206,2209,2213,2216,2217,2219,2220,2223,2228,2231,2235,2236,2237,2238,2240,2241,2245,2249,2250,2251,2252,2253,2254,2256,2258,2261,2264,2266,2270,2271,2273,2275,2278,2280,2284,2285,2286,2287,2288,2289,2291,2292,2294,2295,2296,2297,2299,2300,2301,2306,2307,2308,2309,2313,2315,2316,2317,2318,2319,2320,2322,2327,2328,2329,2330,2332,2333,2334,2335,2339,2340,2341,2342,2343,2344,2345,2346,2349,2350,2351,2352,2353,2354,2355,2356,2357,2358,2359,2360,2361,2362,2363,2364,2365,2367,2368,2369,2370,2371,2372,2373,2374,2375,2376,2377,2379,2381,2382,2383,2387,2388,2389,2390,2391,2392,2393,2394,2395,2396,2397,2398,2399,2400,2401,2402,2403,2404,2405,2406,2407,2408,2409,2410,2411,2412,2413,2414,2415,2416,2417,2418,2419,2420,2421,2422,2423,2424,2425,2426,2427,2428,2429,2430,2431,2432,2433,2434,2435,2436,2437,2438,2439,2440,2441,2442,2443,2444,2445,2446,2447,2448,2449,2450,2452,2453,2455,2457,2458,2459,2460,2461,2462,2463,2464,2465,2466,2467,2469,2470,2471,2472,2473,2474,2475,2476,2477,2478,2479,2480,2481,2482,2483,2484,2485,2487,2488,2489,2490,2492,2493,2494,2495,2496,2497,2498,2499,2500,2501,2502,2503,2504,2505,2506,2507,2508,2509,2510,2511,2512,2513,2514,2515,2516,2517,2518,2519,2520,2521,2522,2523,2524,2525,2526,2527,2528,2529,2530,2531,2532,2533,2534,2535,2536,2537,2538,2539,2540,2541,2542,2543,2544,2545,2546,2547,2548,2549,2550,2552,2553,2554,2556,2557,2558,2560,2562,2563,2564,2565,2566,2567,2568,2569,2570,2571,2572,2573,2574,2575,2576,2577,2578,2579,2580,2581,2582,2583,2584,2585,2587,2589,2590,2591,2592,2593,2594,2595,2596,2597,2598,2599,2600,2601,2602,2603,2604,2605,2606,2607,2608,2609,2610,2611,2612,2614,2616,2617,2618,2619,2621,2623,2624,2625,2626,2627,2628
5	5	R-HSA-74160	Gene expression (Transcription) R-HSA-74160	2629	2629	7,111,165,242,713,2091	7,9,45,76,111,132,165,184,207,242,245,246,256,259,262,298,304,330,339,344,351,377,382,408,423,426,462,463,469,475,490,492,496,528,534,563,582,608,624,639,641,642,643,645,675,703,713,714,715,757,766,776,779,789,790,815,824,836,853,868,871,875,897,900,932,943,944,945,960,970,1017,1033,1063,1085,1114,1146,1189,1195,1197,1223,1229,1246,1292,1302,1346,1349,1394,1395,1399,1410,1505,1506,1510,1514,1608,1613,1626,1636,1652,1671,1676,1703,1705,1729,1733,1754,1789,1809,1830,1863,1880,1893,1904,1930,1942,1960,1979,1987,1999,2006,2009,2049,2063,2064,2091,2112,2162,2173,2208,2290,2366
6	6	R-HSA-597592	Post-translational protein modification R-HSA-597592	3	3,2629	54,57,75,110,237,250,321,388,472,503,653,1231	54,57,75,81,110,114,117,139,237,250,273,275,321,388,390,399,434,456,472,487,491,503,515,647,651,653,665,734,741,742,760,792,802,827,840,898,907,981,985,1047,1118,1136,1148,1199,1231,1277,1303,1424,1478,1492,1539,1601,1620,1623,1627,1649,1708,1741,1811,1837,1869,1878,1882,1922,1931,1956,2087,2161,2184,2207,2298,2622
7	7	R-HSA-73857	RNA Polymerase II Transcription R-HSA-73857	5	5,2629	9,377,382,463,528,641,643,970	9,45,76,132,184,207,298,304,330,351,377,382,423,463,469,490,496,528,534,563,582,608,624,639,641,642,643,675,714,757,766,776,779,790,815,824,836,853,868,875,897,900,944,970,1033,1085,1114,1146,1189,1195,1197,1229,1246,1292,1302,1346,1349,1394,1395,1399,1410,1505,1506,1510,1514,1608,1613,1626,1636,1652,1671,1703,1705,1729,1733,1754,1789,1830,1863,1880,1893,1904,1930,1942,1960,1979,1987,1999,2006,2009,2049,2063,2112,2173,2290
8	8	R-HSA-1266738	Developmental Biology R-HSA-1266738	2629	2629	29,87,182,186,200,346,365,652,709,874,916,963,1060,1352,1454	29,31,86,87,123,182,183,186,200,201,202,328,346,365,440,448,477,485,560,606,616,626,652,697,702,705,709,729,837,874,887,916,917,931,963,1041,1060,1107,1117,1120,1139,1173,1186,1215,1226,1232,1238,1249,1270,1271,1290,1352,1356,1380,1389,1438,1440,1454,1456,1465,1495,1551,1571,1583,1596,1628,1632,1650,1684,1720,1726,1739,1758,1768,1772,1793,1806,1820,1923,1983,2013,2038,2056,2092
9	9	R-HSA-212436	Generic Transcription Pathway R-HSA-212436	7	5,7,2629	45,76,207,298,469,490,582,608,714,757,815,824,944,1302	45,76,132,184,207,298,304,330,351,423,469,490,496,563,582,608,624,675,714,757,766,776,779,790,815,824,853,868,875,897,900,944,1033,1085,1114,1146,1189,1195,1197,1229,1246,1292,1302,1346,1349,1394,1395,1399,1410,1505,1506,1510,1514,1608,1613,1626,1636,1652,1671,1703,1705,1729,1733,1754,1789,1830,1863,1880,1893,1904,1930,1942,1960,1979,1987,1999,2006,2009,2049,2063,2112,2173,2290
10	10	R-HSA-168249	Innate Immune System R-HSA-168249	2	2,2629	33,113,127,155,162,223,286,374,480,551,673,777,1414,1557	33,113,127,154,155,162,171,210,222,223,224,233,234,247,249,253,264,265,268,277,280,281,286,299,302,303,352,360,370,374,384,435,436,446,480,484,489,494,551,585,672,673,690,777,781,806,866,901,929,980,1005,1050,1056,1075,1088,1109,1115,1124,1125,1188,1221,1228,1254,1264,1265,1266,1269,1317,1326,1328,1402,1406,1414,1431,1436,1447,1452,1459,1499,1526,1557,1567,1582,1618,1637,1644,1760,1779,1781,1817,1842,1868,1881,1911,1929,1937,1982,2011,2015,2168,2174,2194,2227,2277,2281,2384
11	11	R-HSA-5663205	Infectious disease R-HSA-5663205	4	4,2629	12,85,433	12,35,56,80,84,85,95,131,134,143,150,156,167,169,172,174,175,180,193,205,216,219,220,221,285,289,305,337,433,441,444,545,574,592,612,637,638,654,669,687,689,691,693,717,721,762,771,772,774,775,798,804,811,818,826,830,839,841,859,861,870,891,909,934,937,946,962,967,989,991,1049,1054,1059,1116,1156,1191,1279,1286,1296,1308,1335,1348,1368,1386,1387,1416,1430,1437,1439,1466,1468,1489,1525,1540,1561,1598,1612,1641,1662,1664,1665,1672,1680,1695,1744,1800,1815,1835,1841,1853,1858,1944,1946,1968,1986,1994,2016,2026,2044,2045,2054,2059,2061,2067,2109,2116,2124,2136,2148,2156,2172,2176,2213,2217,2235,2261,2270,2275,2285,2287,2301,2307,2317,2329,2334,2342,2345,2419,2420,2426,2448,2477,2479,2481,2483,2493,2495,2511,2531,2532,2548,2576,2593
12	12	R-HSA-9824446	Viral Infection Pathways R-HSA-9824446	11	4,11,2629	35,80,131,134,205	35,56,80,95,131,134,143,150,156,167,169,172,180,193,205,220,285,289,337,441,444,545,574,592,612,637,638,654,669,687,691,693,717,721,762,771,772,774,775,798,804,811,818,826,830,839,841,859,861,870,891,934,937,946,962,1049,1059,1116,1191,1279,1286,1296,1308,1348,1368,1386,1387,1416,1430,1437,1489,1525,1561,1612,1641,1672,1680,1695,1744,1835,1841,1944,1946,1986,2016,2026,2044,2045,2054,2059,2061,2067,2148,2156,2176,2217,2235,2261,2275,2287,2301,2307,2317,2334,2342,2345,2419,2426,2479,2481,2483,2493,2511,2531,2532,2548,2576
13	13	R-HSA-8953897	Cellular responses to stimuli R-HSA-8953897	2629	2629	15,1365	15,89,104,135,194,195,238,274,279,297,322,376,386,411,467,478,543,562,596,614,622,629,743,765,800,860,889,939,959,1187,1234,1329,1365,1464,1515,1518,1550,1578,1621,1682,1698,1734,1750,1770,1940,1953,1977,2090,2170,2215
14	14	R-HSA-1280218	Adaptive Immune System R-HSA-1280218	2	2,2629	43,109,128,190,196,414,1275,1502	43,52,109,128,190,196,258,272,342,358,380,414,461,502,613,735,829,933,948,972,1021,1086,1098,1275,1494,1502,1570,1666,1777,1955
15	15	R-HSA-2262752	Cellular responses to stress R-HSA-2262752	13	13,2629	89,104,135,279,322,411,543,622,1329,1682	89,104,135,194,195,238,274,279,297,322,376,386,411,467,478,543,562,596,614,622,629,743,765,800,860,889,939,959,1187,1234,1329,1464,1515,1518,1550,1621,1682,1698,1734,1750,1770,1940,1953,1977,2090,2215
16	16	R-HSA-1280215	Cytokine Signaling in Immune system R-HSA-1280215	2	2,2629	34,66,278,756,883,904,1037,1307	34,66,144,145,226,239,278,287,394,406,417,438,489,522,541,633,648,659,672,674,753,756,785,866,883,904,914,952,974,983,1010,1034,1035,1037,1056,1075,1088,1091,1105,1221,1247,1252,1265,1307,1340,1370,1397,1452,1476,1503,1522,1555,1584,1618,1663,1667,1674,1683,1763,1778,1817,1836,1838,1872,2048,2210
17	17	R-HSA-556833	Metabolism of lipids R-HSA-556833	1	1,2629	91,122,140,212,251,751,1170,1581,1794,1884	91,122,140,185,212,218,251,367,514,540,567,584,656,710,732,744,745,751,758,767,791,822,918,930,941,968,971,1023,1025,1031,1092,1108,1166,1170,1200,1203,1211,1250,1258,1276,1331,1344,1359,1375,1401,1425,1434,1445,1462,1482,1512,1516,1520,1543,1565,1581,1625,1640,1645,1651,1670,1718,1719,1722,1731,1771,1792,1794,1801,1840,1859,1860,1864,1871,1883,1884,1889,1892,1900,1908,1909,1926,1933,1935,1964,1970,1971,1972,1992,2031,2035,2042,2058,2071,2080,2082,2089,2103,2107,2125,2191,2202,2218,2239,2255,2260,2305,2311,2314,2323,2347,2380,2468,2555,2588,2613
18	18	R-HSA-382551	Transport of small molecules R-HSA-382551	2629	2629	73,116,271,409,529,597,978,1067,1426,1736,2155	73,116,252,255,271,366,409,529,559,597,677,696,761,816,844,886,940,978,1022,1067,1099,1163,1172,1178,1185,1219,1284,1298,1312,1330,1426,1448,1458,1487,1527,1574,1590,1605,1614,1617,1622,1630,1633,1639,1647,1678,1699,1717,1736,1773,1849,1862,1866,1895,1932,1943,1947,1985,2001,2002,2005,2022,2025,2155,2198,2203,2205,2225,2233
19	19	R-HSA-8953854	Metabolism of RNA R-HSA-8953854	2629	2629	64,94,217,235,355,549,576,912,913,1469,1624,2154	64,90,94,96,106,118,215,217,235,301,355,368,412,504,517,531,549,553,570,576,620,688,692,707,786,809,912,913,1016,1132,1245,1248,1256,1287,1313,1469,1486,1573,1585,1624,1685,1727,1738,1766,1780,1804,1873,1894,2154,2242,2312,2348
20	20	R-HSA-5653656	Vesicle-mediated transport R-HSA-5653656	2629	2629	27,291	27,97,139,153,173,199,260,275,283,291,343,431,432,445,456,548,589,603,623,627,666,671,747,794,840,878,1113,1154,1168,1461,1548,1874,1915,2096,2135,2140,2164
21	21	R-HSA-9716542	Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542	0	0,2629	22,1600,1774	22,38,50,115,141,149,163,315,324,349,413,418,443,468,524,558,581,683,699,701,704,730,763,764,788,793,862,1029,1055,1065,1103,1182,1183,1532,1600,1679,1774,1823,1963,2211
22	22	R-HSA-194315	Signaling by Rho GTPases R-HSA-194315	21	0,21,2629	38,50	38,50,115,141,149,163,315,324,349,413,418,443,468,524,558,581,683,699,701,704,730,763,764,788,793,862,1029,1055,1065,1103,1182,1183,1532,1679,2211
23	23	R-HSA-372790	Signaling by GPCR R-HSA-372790	0	0,2629	28,36	28,36,48,51,88,103,136,319,333,385,538,578,621,635,661,706,733,770,795,803,828,863,957,998,1040,1042,1129,1143,1153,1194,1209,1217,1300,1310,1362,1367,1481,1500,1501,1579,1602,1616,1654,1656,1660,1689,1713,1735,1759,1886,1927,1936,1939,1954,1973,2000,2050,2066,2093,2138,2283
24	24	R-HSA-1640170	Cell Cycle R-HSA-1640170	2629	2629	30,62,166,211	30,40,62,77,78,99,101,102,108,126,130,148,159,166,179,191,203,211,213,232,236,306,307,312,318,326,348,350,353,356,362,369,378,379,381,387,396,401,403,405,415,416,422,424,425,427,428,429,437,450,451,452,459,464,465,466,483,509,542,561,569,583,591,593,595,598,601,609,610,640,644,768,783,823,831,850,851,924,953,956,975,979,1008,1028,1053,1072,1111,1122,1131,1140,1150,1165,1167,1169,1235,1280,1295,1337,1339,1364,1381,1384,1385,1413,1421,1423,1435,1493,1536,1547,1593,1638,1687,1721,1803,1912,1921,1997,2012,2070,2084,2086,2157,2267,2310
25	25	R-HSA-109582	Hemostasis R-HSA-109582	2629	2629	71,105,124,359,731,1282,1420	71,105,124,178,189,359,499,731,736,799,845,858,947,957,966,1004,1015,1039,1061,1074,1081,1089,1192,1198,1244,1282,1288,1291,1324,1333,1420,1472,1488,1507,1975,1995,2000,2115
26	26	R-HSA-9709957	Sensory Perception R-HSA-9709957	2629	2629	39,282,400,650	39,42,282,400,447,568,650,662,711,810,835,1052,1556,1848,1890,1981,2224,2494
27	27	R-HSA-199991	Membrane Trafficking R-HSA-199991	20	20,2629	97,139,153,199,431,432,603,878	97,139,153,173,199,260,275,283,343,431,432,456,548,589,603,623,627,666,671,747,794,840,878,1113,1154,1461,1548,2135,2140,2164
28	28	R-HSA-388396	GPCR downstream signalling R-HSA-388396	23	0,23,2629	51,88,136,385,635,863	51,88,136,333,385,578,621,635,661,770,795,803,863,957,998,1040,1042,1129,1143,1153,1194,1209,1217,1362,1579,1616,1654,2000,2050,2283
29	29	R-HSA-9675108	Nervous system development R-HSA-9675108	8	8,2629	31,931	31,86,123,202,328,477,485,606,616,626,697,705,729,887,917,931,1041,1120,1139,1173,1186,1270,1290,1380,1389,1440,1571,1583,1628,1650,1684,1720,1739,1758,1772,1806,1820,1983,2038,2092
30	30	R-HSA-69278	Cell Cycle, Mitotic R-HSA-69278	24	24,2629	40,101,130,148,350	40,77,78,99,101,102,108,130,148,159,179,191,203,213,306,326,348,350,353,362,369,378,379,381,387,401,403,405,415,416,422,424,425,427,437,450,451,452,483,509,561,569,583,601,640,644,783,831,850,851,924,953,956,979,1008,1028,1072,1111,1122,1131,1140,1150,1165,1169,1280,1295,1337,1339,1364,1381,1384,1385,1421,1423,1493,1536,1547,1593,1638,1687,1721,1803,1912,1997,2012,2086,2157,2267,2310
31	31	R-HSA-422475	Axon guidance R-HSA-422475	29	8,29,2629	86,202,328,477,485,616,729,1983	86,123,202,328,477,485,606,616,626,697,705,729,887,917,1041,1120,1139,1173,1186,1270,1290,1380,1389,1440,1571,1583,1628,1650,1684,1720,1739,1758,1772,1806,1820,1983,2038,2092
32	32	R-HSA-9006934	Signaling by Receptor Tyrosine Kinases R-HSA-9006934	0	0,2629	176,254,347,373,389,533,537,580,586,615,681,908,1984	176,225,254,296,347,373,389,421,501,533,537,575,580,586,588,600,602,615,632,664,681,724,725,728,740,814,825,842,854,876,877,880,896,903,906,908,915,921,922,958,961,964,994,999,1003,1046,1064,1071,1075,1083,1087,1106,1121,1123,1130,1137,1144,1151,1160,1171,1202,1205,1216,1224,1239,1255,1262,1268,1273,1281,1301,1315,1332,1360,1388,1390,1392,1398,1404,1408,1409,1419,1427,1443,1444,1450,1452,1453,1455,1509,1519,1537,1563,1572,1594,1603,1606,1635,1646,1648,1675,1681,1696,1704,1712,1714,1746,1796,1805,1816,1817,1828,1831,1855,1861,1879,1887,1917,1945,1950,1961,1967,1974,1978,1984,1993,2028,2030,2052,2053,2062,2072,2079,2088,2126,2127,2134,2152,2159,2169,2214,2226,2234,2263,2276,2279,2293,2302,2331,2336
33	33	R-HSA-6798695	Neutrophil degranulation R-HSA-6798695	10	2,10,2629		
34	34	R-HSA-449147	Signaling by Interleukins R-HSA-449147	16	2,16,2629	144,239,438,541,633,659,674,785,983,1034,1035	144,226,239,438,489,541,633,648,659,672,674,753,785,866,952,983,1034,1035,1056,1075,1088,1091,1105,1221,1252,1265,1397,1452,1476,1503,1522,1555,1584,1618,1663,1667,1683,1778,1817,1838,2048,2210
35	35	R-HSA-9679506	SARS-CoV Infections R-HSA-9679506	12	4,11,12,2629	56,143,156	56,95,143,156,193,285,441,545,612,721,771,772,774,934,1191,1296,1308,1386,1430,1437,1489,1525,1561,1680,1695,1944,1986,2016,2026,2045,2054,2059,2061,2067,2148,2483,2511
36	36	R-HSA-500792	GPCR ligand binding R-HSA-500792	23	0,23,2629	48,319,733	48,103,319,538,706,733,828,1300,1310,1367,1481,1500,1501,1602,1656,1660,1689,1713,1735,1759,1886,1927,1936,1939,1954,1973,2066,2093,2138
37	37	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202	4	4,2629	261,325,375,488,520,527,817,938,986,997,1155,1157,1761	261,320,325,375,391,470,488,520,527,530,532,535,536,550,655,657,658,660,685,716,754,784,805,817,846,884,938,986,990,997,1006,1073,1077,1128,1155,1157,1177,1179,1181,1193,1214,1233,1293,1299,1304,1306,1311,1316,1318,1322,1327,1334,1336,1341,1369,1374,1376,1379,1382,1407,1463,1477,1479,1490,1498,1517,1533,1538,1631,1709,1730,1753,1761,1767,1775,1785,1790,1795,1798,1829,1839,1846,1847,1867,1885,1903,1952,1962,1969,2017,2020,2021,2024,2034,2040,2055,2057,2060,2068,2073,2074,2076,2128,2129,2151,2153,2163,2166,2175,2185,2189,2190,2192,2253,2330,2355,2356,2357,2361,2367,2374,2376,2393,2401,2402,2415,2421,2422,2424,2433,2436,2437,2438,2447,2457,2460,2469,2475,2485,2492,2498,2502,2503,2504,2508,2514,2518,2519,2522,2528,2530,2539,2543,2562,2571,2578,2579,2580,2587,2594,2595,2597,2599,2610,2612,2616,2621,2627
38	38	R-HSA-9012999	RHO GTPase cycle R-HSA-9012999	22	0,21,22,2629	115,141,149,315,349,413,418,443,524,558,581,683,699,701,704,730,763,764,793	115,141,149,315,349,413,418,443,524,558,581,683,699,701,704,730,763,764,793,1055,1065
39	39	R-HSA-381753	Olfactory Signaling Pathway R-HSA-381753	26	26,2629	42	42
40	40	R-HSA-68886	M Phase R-HSA-68886	30	24,30,2629	77,99,159,1423	77,78,99,108,159,191,213,306,405,424,583,783,851,956,1169,1337,1364,1423,1547,1593,1638,1803,2310
41	41	R-HSA-112316	Neuronal System R-HSA-112316	2629	2629	69,267,354,2004	69,93,267,311,354,383,505,552,605,667,679,682,694,797,867,885,894,910,920,926,927,951,1030,1058,1070,1097,1100,1104,1126,1133,1152,1190,1212,1222,1242,1253,1362,1383,1391,1467,1491,1513,1523,1541,1562,1580,1634,1655,1657,1783,1787,1808,1854,1925,1988,2004,2019,2051,2065,2077,2078,2095,2098,2106,2122,2141,2144,2182,2229,2232,2247,2248,2262,2265,2268,2385,2386
42	42	R-HSA-9752946	Expression and translocation of olfactory receptors R-HSA-9752946	39	26,39,2629		
43	43	R-HSA-983169	Class I MHC mediated antigen processing & presentation R-HSA-983169	14	2,14,2629	52,258,933	52,258,342,613,933,1570,1777
44	44	R-HSA-71291	Metabolism of amino acids and derivatives R-HSA-71291	1	1,2629	209,525,873,950,1112,1210,1350,1351,1475,1531,1546,1568,1619,1686,1762,1870,1958,2037,2101,2180,2257	209,314,525,604,873,950,1112,1210,1321,1350,1351,1475,1531,1546,1568,1615,1619,1686,1702,1762,1856,1865,1870,1877,1958,2003,2014,2032,2037,2043,2101,2110,2131,2180,2212,2257,2272,2303,2456,2559
45	45	R-HSA-3700989	Transcriptional Regulation by TP53 R-HSA-3700989	9	5,7,9,2629	132,351,496,624,675	132,330,351,496,624,675,766,779,897,1114,1146,1189,1197,1349,1394,1395,1505,1506,1671,2290
46	46	R-HSA-73894	DNA Repair R-HSA-73894	2629	2629	125,240,340,636,738,1345,1710	125,168,177,240,295,340,364,392,395,402,457,458,471,481,493,506,508,513,554,557,564,590,636,680,686,720,726,738,739,750,755,773,796,819,848,905,954,996,1002,1110,1174,1230,1260,1285,1345,1355,1403,1497,1669,1710,1748,1788,1813,1857,2029,2097,2243,2451,2454,2620
47	47	R-HSA-195721	Signaling by WNT R-HSA-195721	0	0,2629	79,152,361,976	79,152,327,331,361,479,495,546,565,700,888,976,1101,1251,1323,1342,1358,1417,1732,1740,2007
48	48	R-HSA-373076	Class A/1 (Rhodopsin-like receptors) R-HSA-373076	36	0,23,36,2629	103,706,1300,1310,1367,1500,1660,1936,2138	103,538,706,1300,1310,1367,1481,1500,1501,1656,1660,1689,1713,1735,1759,1886,1927,1936,1939,1954,1973,2066,2093,2138
49	49	R-HSA-5683057	MAPK family signaling cascades R-HSA-5683057	0	0,2629	63,323	63,65,323,455,678,727,820,1027,1066,1611,1700,1905
50	50	R-HSA-195258	RHO GTPase Effectors R-HSA-195258	22	0,21,22,2629	163,324,788,862,1029,1103,1182,1183,1532,1679,2211	163,324,468,788,862,1029,1103,1182,1183,1532,1679,2211
51	51	R-HSA-418594	G alpha (i) signalling events R-HSA-418594	28	0,23,28,2629	333	333,578,621,770,795,803,1040,1042,1129,1194,1362,1579,1616,2050,2283
52	52	R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation R-HSA-983168	43	2,14,43,2629		
53	53	R-HSA-9006925	Intracellular signaling by second messengers R-HSA-9006925	0	0,2629	70,719	70,164,227,257,449,497,719,795,803,1129,1194,1353,1599,1616,1653,1691,1751,2050
54	54	R-HSA-446203	Asparagine N-linked glycosylation R-HSA-446203	6	3,6,2629	114,390,792	114,139,275,390,456,487,792,827,840,981,985,1118,1303,1601,1708,1869,1878,1922,1956,2161,2184,2298,2622
55	55	R-HSA-1474244	Extracellular matrix organization R-HSA-1474244	2629	2629	161,336,363,404,523,668,899,1876,2108	161,336,363,404,460,482,498,523,668,676,769,838,899,973,1207,1343,1876,2108
56	56	R-HSA-9694516	SARS-CoV-2 Infection R-HSA-9694516	35	4,11,12,35,2629	95,441,772	95,193,441,545,612,771,772,1191,1308,1386,1437,1489,1525,1695,1944,2045,2061,2067,2511
57	57	R-HSA-5688426	Deubiquitination R-HSA-5688426	6	3,6,2629	81,273,734,760,1478	81,273,734,760,1478
58	58	R-HSA-71387	Metabolism of carbohydrates R-HSA-71387	1	1,2629	192,308,1012,1119,1325,1819,1966,2041,2083,2160	192,308,420,547,619,780,807,856,869,936,982,1012,1024,1119,1135,1218,1227,1314,1325,1361,1393,1405,1460,1473,1575,1819,1916,1928,1966,1990,2041,2083,2150,2160,2274,2325,2338
59	59	R-HSA-9006931	Signaling by Nuclear Receptors R-HSA-9006931	0	0,2629	83,649,695	83,151,410,649,695,759,1026,1082,1688,1701,1901,1934,1951,1989
60	60	R-HSA-72766	Translation R-HSA-72766	3	3,2629	206,230,300,309,310,698	204,206,228,230,231,276,300,309,310,332,335,338,341,511,516,518,599,698,1038,1127,1728
61	61	R-HSA-1852241	Organelle biogenesis and maintenance R-HSA-1852241	2629	2629	100,313	100,292,313,555,571,607,881,1051,1102,1604,1980,2158
62	62	R-HSA-69620	Cell Cycle Checkpoints R-HSA-69620	24	24,2629	126,236,459	126,236,307,312,318,459,465,466,542,591,593,595,598,768,1111,1122,1435,1921,2070,2084
63	63	R-HSA-5684996	MAPK1/MAPK3 signaling R-HSA-5684996	49	0,49,2629	65,1066	65,455,678,727,820,1027,1066,1611,1700,1905
64	64	R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA R-HSA-72203	19	19,2629	90,368,531	90,96,368,412,531,620,692,707,786,809
65	65	R-HSA-5673001	RAF/MAP kinase cascade R-HSA-5673001	63	0,49,63,2629	455,678,727,820,1027	455,678,727,820,1027,1905
66	66	R-HSA-913531	Interferon Signaling R-HSA-913531	16	2,16,2629	145,287,394	145,287,394,406,417,974,1370,1674,1763
67	67	R-HSA-3247509	Chromatin modifying enzymes R-HSA-3247509	68	68,2629	160,316,397,439,618	160,316,397,439,618
68	68	R-HSA-4839726	Chromatin organization R-HSA-4839726	2629	2629	67	67,160,316,397,439,618
69	69	R-HSA-112315	Transmission across Chemical Synapses R-HSA-112315	41	41,2629	93,605,1541,1562,2106	93,311,383,505,605,667,679,694,867,885,894,910,926,951,1030,1058,1070,1100,1104,1126,1133,1190,1212,1222,1242,1253,1362,1383,1391,1467,1491,1523,1541,1562,1580,1634,1655,1783,1787,1808,1854,1988,2051,2077,2078,2095,2106,2144,2229,2247,2248,2262,2268
70	70	R-HSA-1257604	PIP3 activates AKT signaling R-HSA-1257604	53	0,53,2629	164,227,1353,1599	164,227,257,449,497,1353,1599,1653,1691,1751
71	71	R-HSA-76002	Platelet activation, signaling and aggregation R-HSA-76002	25	25,2629	178,736,799,845,858,957,1507	178,189,736,799,845,858,957,966,1004,1039,1089,1324,1333,1507,1995,2000,2115
72	72	R-HSA-5668914	Diseases of metabolism R-HSA-5668914	4	4,2629	157,812,821,1093,1610,2069,2271,2332,2394,2606	157,454,718,748,812,821,1093,1138,1141,1147,1158,1243,1267,1274,1297,1305,1347,1357,1400,1564,1610,1643,1706,1715,1742,1745,1747,1749,1756,1764,1786,1818,1949,2036,2069,2114,2118,2149,2183,2193,2195,2196,2209,2216,2220,2223,2231,2249,2250,2266,2271,2273,2278,2286,2289,2291,2294,2299,2300,2306,2313,2316,2319,2322,2332,2340,2349,2350,2354,2358,2360,2362,2364,2369,2373,2379,2387,2390,2394,2395,2398,2399,2405,2409,2411,2412,2413,2423,2425,2431,2434,2441,2442,2443,2444,2445,2446,2449,2450,2455,2458,2461,2463,2464,2466,2467,2470,2471,2472,2482,2484,2487,2488,2489,2497,2499,2501,2505,2509,2510,2513,2515,2516,2517,2525,2533,2535,2538,2541,2545,2550,2552,2553,2554,2557,2560,2563,2564,2565,2566,2569,2572,2573,2574,2577,2584,2590,2591,2592,2596,2598,2604,2605,2606,2607,2611,2617,2618,2619,2623,2624,2628
73	73	R-HSA-425407	SLC-mediated transmembrane transport R-HSA-425407	18	18,2629	252,366,696,1099	252,366,696,844,1022,1099,1185,1312,1330,1487,1527,1574,1590,1614,1617,1622,1647,1678,1699,1773,1849,1866,1932,1985,2002,2005,2025,2198,2203,2205,2233
74	74	R-HSA-157118	Signaling by NOTCH R-HSA-157118	0	0,2629	208,371,419,625,843	208,269,371,419,572,625,630,843,879,1013,1018,1079,1145,1208,1484,1549,1769,1906
75	75	R-HSA-8951664	Neddylation R-HSA-8951664	6	3,6,2629		
76	76	R-HSA-8878171	Transcriptional regulation by RUNX1 R-HSA-8878171	9	5,7,9,2629	184,304,776,1229,1608,1705,1830,1863,1880,1904,1930,2009	184,304,776,1229,1608,1705,1830,1863,1880,1904,1930,2009
77	77	R-HSA-2555396	Mitotic Metaphase and Anaphase R-HSA-2555396	40	24,30,40,2629	78,2310	78,108,405,851,956,1169,2310
78	78	R-HSA-68882	Mitotic Anaphase R-HSA-68882	77	24,30,40,77,2629	108,405	108,405,851,956,1169
79	79	R-HSA-201681	TCF dependent signaling in response to WNT R-HSA-201681	47	0,47,2629	331,546,565,700,888,1101,1323,1740,2007	331,546,565,700,888,1101,1323,1732,1740,2007
80	80	R-HSA-162906	HIV Infection R-HSA-162906	12	4,11,12,2629	150,180	150,172,180,444,574,592,637,638,654,687,691,693,762,775,804,811,818,826,830,839,870,891,937,946,962,1049,1116,1279,1348,1368,1387,1612,1641,1672,1744,1835,1841,1946,2044,2156,2176,2217,2235,2275,2419,2493,2531,2548,2576
81	81	R-HSA-5689880	Ub-specific processing proteases R-HSA-5689880	57	3,6,57,2629		
82	82	R-HSA-211859	Biological oxidations R-HSA-211859	1	1,2629	243,263,1164	243,263,476,778,984,1020,1044,1069,1164,1319,1371,1474,1480,1496,1504,1530,1673,1697,1716,1896,1898,1916,1919,2039,2142,2188,2222,2246,2282,2304,2337,2491,2586
83	83	R-HSA-8939211	ESR-mediated signaling R-HSA-8939211	59	0,59,2629	151,410	151,410,1026,1901
84	84	R-HSA-9658195	Leishmania infection R-HSA-9658195	85	4,11,85,2629	175,216,991,1466	174,175,216,219,221,305,689,989,991,1466,1468,1662,1800
85	85	R-HSA-9824443	Parasitic Infection Pathways R-HSA-9824443	11	4,11,2629	84	84,174,175,216,219,221,305,689,989,991,1466,1468,1662,1800
86	86	R-HSA-376176	Signaling by ROBO receptors R-HSA-376176	31	8,29,31,2629	123,1440,1583,1684,1720,1739,2038,2092	123,1440,1583,1684,1720,1739,2038,2092
87	87	R-HSA-6805567	Keratinization R-HSA-6805567	8	8,2629	183	183
88	88	R-HSA-416476	G alpha (q) signalling events R-HSA-416476	28	0,23,28,2629	957,1217	957,1217,1654,2000
89	89	R-HSA-9711123	Cellular response to chemical stress R-HSA-9711123	15	13,15,2629	195,478,765	195,297,478,596,765,1187,1515,1550,1734,1750,1770,1940,1953,1977,2215
90	90	R-HSA-72172	mRNA Splicing R-HSA-72172	64	19,64,2629	96,620	96,620
91	91	R-HSA-1483257	Phospholipid metabolism R-HSA-1483257	17	1,17,2629	185,367	185,367,584,732,930,941,968,1092,1200,1203,1250,1276,1434,1543,1670,1718,1792,1801,1864,1971,1992,2071,2260,2311,2468,2555
92	92	R-HSA-5357801	Programmed Cell Death R-HSA-5357801	2629	2629	119,521	119,521,556,587,594,617,749,857,864,902,969,977,1149,1278,1320,1411,1442,1508,1529,1535,1542,1552,1553,1560,1607,1658,1690,1752,1812,1821,1850,1875,1998,2094,2117,2178,2197,2230,2244,2321,2326
93	93	R-HSA-112314	Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314	69	41,69,2629	311,505,867,894,1391	311,383,505,667,679,694,867,885,894,910,926,951,1070,1100,1104,1126,1133,1253,1362,1383,1391,1467,1491,1523,1580,1634,1655,1783,1787,1808,1854,2051,2268
94	94	R-HSA-72312	rRNA processing R-HSA-72312	19	19,2629	106,1486	106,118,504,1486,1738
95	95	R-HSA-9705683	SARS-CoV-2-host interactions R-HSA-9705683	56	4,11,12,35,56,2629	193,612,1489,1525,1944	193,612,1489,1525,1944
96	96	R-HSA-72163	mRNA Splicing - Major Pathway R-HSA-72163	90	19,64,90,2629		
97	97	R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic R-HSA-6811442	27	20,27,2629	173,623,671	173,283,589,623,671
98	98	R-HSA-397014	Muscle contraction R-HSA-397014	2629	2629	181,684,787	181,579,684,787,852,1175,1309,1378,1668,1844
99	99	R-HSA-68877	Mitotic Prometaphase R-HSA-68877	40	24,30,40,2629	191,213,306,1547	191,213,306,1547
100	100	R-HSA-5617833	Cilium Assembly R-HSA-5617833	61	61,2629	292,571,607	292,571,607,1051,1102,1980,2158
101	101	R-HSA-453274	Mitotic G2-G2/M phases R-HSA-453274	30	24,30,2629	102,1997	102,353,379,381,387,427,450,451,561,1008,1295,1997,2157,2267
102	102	R-HSA-69275	G2/M Transition R-HSA-69275	101	24,30,101,2629	353,381,387,427,561,1008,1295,2267	353,379,381,387,427,450,451,561,1008,1295,2157,2267
103	103	R-HSA-375276	Peptide ligand-binding receptors R-HSA-375276	48	0,23,36,48,2629	538,1713,1735,1759,1886,1939	538,1713,1735,1759,1886,1939
104	104	R-HSA-2559583	Cellular Senescence R-HSA-2559583	15	13,15,2629	194,238,386,800	194,238,386,800,1234
105	105	R-HSA-202733	Cell surface interactions at the vascular wall R-HSA-202733	25	25,2629	1015,1198,1472	1015,1198,1472
106	106	R-HSA-8868773	rRNA processing in the nucleus and cytosol R-HSA-8868773	94	19,94,2629	118,504	118,504
107	107	R-HSA-196854	Metabolism of vitamins and cofactors R-HSA-196854	1	1,2629	187,628,1184	187,628,662,872,1084,1134,1176,1184,1241,1559,1588,1589,1707,1776,1782,1797,1833,1845,1888,1941,2165,2187,2486,2561
108	108	R-HSA-2467813	Separation of Sister Chromatids R-HSA-2467813	78	24,30,40,77,78,2629		
109	109	R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell R-HSA-198933	14	2,14,2629		
110	110	R-HSA-2990846	SUMOylation R-HSA-2990846	6	3,6,2629	117,1620	117,399,434,647,651,665,742,802,907,1148,1277,1492,1620,1837,1882,1931,2207
111	111	R-HSA-212165	Epigenetic regulation of gene expression R-HSA-212165	5	5,2629	246,262,426,475,703,2064	246,259,262,339,408,426,462,475,703,2064
112	112	R-HSA-69306	DNA Replication R-HSA-69306	2629	2629	133,203	133,158,203,326,422,437,453,831,850,1131,1339,1381,1384,1385,1493,1721,1755
113	113	R-HSA-2454202	Fc epsilon receptor (FCERI) signaling R-HSA-2454202	10	2,10,2629	171,352,360,435	171,352,360,435
114	114	R-HSA-948021	Transport to the Golgi and subsequent modification R-HSA-948021	54	3,6,54,2629	139,985,1922	139,275,456,840,985,1303,1601,1922,2184,2622
115	115	R-HSA-9013149	RAC1 GTPase cycle R-HSA-9013149	38	0,21,22,38,2629		
116	116	R-HSA-983712	Ion channel transport R-HSA-983712	18	18,2629	255,559	255,559,940
117	117	R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins R-HSA-3108232	110	3,6,110,2629	399,434,647,651,665,742,802,907,1148,1277,1492,2207	399,434,647,651,665,742,802,907,1148,1277,1492,2207
118	118	R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol R-HSA-6791226	106	19,94,106,2629		
119	119	R-HSA-109581	Apoptosis R-HSA-109581	92	92,2629	556,587,594,977	556,587,594,617,749,902,977,1149,1278,1320,1411,1442,1508,1529,1535,1542,1553,1560,1607,1658,1690,1752,1812,1821,1850,1875,1998,2094,2117,2178,2197,2230,2244,2321,2326
120	120	R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport R-HSA-1428517	1	1,2629	188,566	188,270,539,566,865,1078,1196,1272,1899,1976,1991,2130,2378
121	121	R-HSA-5619115	Disorders of transmembrane transporters R-HSA-5619115	4	4,2629	284,393	284,393,500,847,2119,2228,2241,2245,2252,2264,2288,2289,2292,2308,2309,2315,2335,2343,2344,2352,2353,2359,2363,2365,2370,2371,2372,2375,2377,2381,2382,2383,2388,2389,2392,2396,2397,2400,2403,2406,2407,2408,2410,2417,2427,2428,2429,2430,2432,2435,2439,2440,2453,2462,2465,2473,2476,2478,2480,2496,2500,2506,2507,2512,2523,2526,2527,2529,2534,2536,2542,2544,2546,2549,2556,2566,2567,2568,2581,2582,2601,2602,2603,2608,2609,2614,2625,2626
122	122	R-HSA-8978868	Fatty acid metabolism R-HSA-8978868	17	1,17,2629	514,744,767,918,1359,1445	514,744,767,918,1023,1108,1331,1359,1425,1445,1520,1565,1640,1645,1651,1719,1722,1840,1883,1889,1900,1909,1926,1933,1935,1964,1970,2191,2218,2380
123	123	R-HSA-9010553	Regulation of expression of SLITs and ROBOs R-HSA-9010553	86	8,29,31,86,2629		
124	124	R-HSA-983231	Factors involved in megakaryocyte development and platelet production R-HSA-983231	25	25,2629	499	499
125	125	R-HSA-5693532	DNA Double-Strand Break Repair R-HSA-5693532	46	46,2629	168,395,457	168,177,295,395,402,457,458,686,726,773,796,819,954,1497,1857
126	126	R-HSA-69481	G2/M Checkpoints R-HSA-69481	62	24,62,2629	318,768,1921	318,768,1435,1921
127	127	R-HSA-168898	Toll-like Receptor Cascades R-HSA-168898	10	2,10,2629	154,224,253,264,268,299,302,1115,1447	154,222,224,233,234,247,249,253,264,268,277,280,299,302,303,489,672,866,1050,1056,1075,1088,1115,1188,1221,1254,1265,1266,1317,1402,1406,1447,1452,1459,1499,1567,1618,1637,1644,1817,1911,2227
128	128	R-HSA-983705	Signaling by the B Cell Receptor (BCR) R-HSA-983705	14	2,14,2629	358,380,502	358,380,461,502,1666,1955
129	129	R-HSA-9609507	Protein localization R-HSA-9609507	2629	2629	473,486,1094,1161	473,486,1094,1161,1852
130	130	R-HSA-69242	S Phase R-HSA-69242	30	24,30,2629	203,362,601,1536	203,326,362,422,437,509,601,850,1131,1339,1381,1384,1385,1493,1536,1721
131	131	R-HSA-9609646	HCMV Infection R-HSA-9609646	12	4,11,12,2629	167,220	167,220
132	132	R-HSA-5633007	Regulation of TP53 Activity R-HSA-5633007	45	5,7,9,45,2629	330,766,897,1189,1349	330,766,779,897,1189,1349,1671,2290
133	133	R-HSA-69002	DNA Replication Pre-Initiation R-HSA-69002	112	112,2629	158,831	158,453,831,1755
134	134	R-HSA-168255	Influenza Infection R-HSA-168255	12	4,11,12,2629	169,717,841,861,2301,2307,2317	169,337,669,717,841,859,861,2301,2307,2317,2334,2342,2345,2426,2481,2532
135	135	R-HSA-9711097	Cellular response to starvation R-HSA-9711097	15	13,15,2629	274,562	274,562
136	136	R-HSA-418555	G alpha (s) signalling events R-HSA-418555	28	0,23,28,2629	661	661
137	137	R-HSA-1474165	Reproduction R-HSA-1474165	2629	2629	211,988,1485	211,356,396,988,1485,1521,1692,1897
138	138	R-HSA-1500931	Cell-Cell communication R-HSA-1500931	2629	2629	214,1057,1261	214,334,526,849,855,895,923,1057,1213,1261,1545,1577,1592,1597,1737,1826,1832,1851,2081,2221
139	139	R-HSA-199977	ER to Golgi Anterograde Transport R-HSA-199977	27,114	3,6,20,27,54,114,2629	275,456,840	275,456,840
140	140	R-HSA-8957322	Metabolism of steroids R-HSA-8957322	17	1,17,2629	567,656,791,971,1512	567,656,710,791,822,971,1025,1211,1344,1375,1462,1512,1516,1625,1859,1860,2082,2107
141	141	R-HSA-9013148	CDC42 GTPase cycle R-HSA-9013148	38	0,21,22,38,2629		
142	142	R-HSA-73887	Death Receptor Signaling R-HSA-73887	0	0,2629	294,544,1743,1965	294,407,519,544,631,833,1007,1283,1294,1422,1446,1569,1586,1659,1743,1902,1910,1914,1965,2085,2201,2259
143	143	R-HSA-9679191	Potential therapeutics for SARS R-HSA-9679191	35	4,11,12,35,2629		
144	144	R-HSA-446652	Interleukin-1 family signaling R-HSA-446652	34	2,16,34,2629	226,1105,1667,1778,1838,2048,2210	226,672,1105,1221,1265,1667,1778,1838,2048,2210
145	145	R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes R-HSA-1169410	66	2,16,66,2629	406,417,1674	406,417,1674
146	146	R-HSA-9612973	Autophagy R-HSA-9612973	2629	2629	170,813,1095	170,372,670,813,928,1076,1095,1534,1554,1661
147	147	R-HSA-5358351	Signaling by Hedgehog R-HSA-5358351	0	0,2629	229,357,474	229,357,474,507,510,512,1204,1723,1725,1791
148	148	R-HSA-453279	Mitotic G1 phase and G1/S transition R-HSA-453279	30	24,30,2629	179,640,953	179,369,509,640,644,831,924,953,1072,1165,1280,1421,1687,2012,2086
149	149	R-HSA-8980692	RHOA GTPase cycle R-HSA-8980692	38	0,21,22,38,2629		
150	150	R-HSA-162587	HIV Life Cycle R-HSA-162587	80	4,11,12,80,2629	172,1368	172,444,637,638,654,687,691,693,804,826,830,839,870,891,946,962,1049,1279,1348,1368,1387,1641,1835,2044,2156,2176,2419,2493,2531,2548,2576
151	151	R-HSA-9018519	Estrogen-dependent gene expression R-HSA-9018519	83	0,59,83,2629		
152	152	R-HSA-3858494	Beta-catenin independent WNT signaling R-HSA-3858494	47	0,47,2629	327,495	327,479,495,1342,1417
153	153	R-HSA-8856828	Clathrin-mediated endocytosis R-HSA-8856828	27	20,27,2629	260	260
154	154	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016	127	2,10,127,2629	233,247,2227	233,247,249,489,672,866,1050,1056,1075,1088,1221,1254,1265,1266,1406,1452,1618,1637,1644,1817,2227
155	155	R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480	10	2,10,2629	210,370,446	210,370,446
156	156	R-HSA-9678108	SARS-CoV-1 Infection R-HSA-9678108	35	4,11,12,35,2629	285,934,1430,2026,2054	285,721,774,934,1296,1430,1561,1680,1986,2016,2026,2054,2059,2148,2483
157	157	R-HSA-3781865	Diseases of glycosylation R-HSA-3781865	72	4,72,2629	454,718,1141,1305	454,718,748,1138,1141,1147,1158,1243,1267,1297,1305,1347,1357,1742,1745,1747,1749,1756,1764,1949,2114,2149,2183,2195,2209,2216,2250,2313,2316,2319,2360,2387,2409,2411,2412,2431,2434,2445,2446,2458,2488,2489,2515,2516,2525,2533,2538,2552,2553,2557,2560,2564,2566,2573,2574,2598,2607,2617,2619
158	158	R-HSA-68867	Assembly of the pre-replicative complex R-HSA-68867	133	112,133,2629	453,1755	453,1755
159	159	R-HSA-68875	Mitotic Prophase R-HSA-68875	40	24,30,40,2629	424,583,1364,1638	424,583,783,1337,1364,1638,1803
160	160	R-HSA-3214847	HATs acetylate histones R-HSA-3214847	67	67,68,2629		
161	161	R-HSA-1474228	Degradation of the extracellular matrix R-HSA-1474228	55	55,2629	482,838	482,838
162	162	R-HSA-5621481	C-type lectin receptors (CLRs) R-HSA-5621481	10	2,10,2629	281,980,1125	281,494,980,1125,1526,1868
163	163	R-HSA-5663220	RHO GTPases Activate Formins R-HSA-5663220	50	0,21,22,50,2629		
164	164	R-HSA-6807070	PTEN Regulation R-HSA-6807070	70	0,53,70,2629	449,497,1653,1691	449,497,1653,1691,1751
165	165	R-HSA-211000	Gene Silencing by RNA R-HSA-211000	5	5,2629	256,932,1017,1676,1809,2162	256,932,1017,1676,1809,2162
166	166	R-HSA-73886	Chromosome Maintenance R-HSA-73886	24	24,2629	232,428	232,428,429,464,609,610,823,975,1053,1167,1235,1413
167	167	R-HSA-9609690	HCMV Early Events R-HSA-9609690	131	4,11,12,131,2629		
168	168	R-HSA-5693538	Homology Directed Repair R-HSA-5693538	125	46,125,2629	177,1497	177,295,458,686,726,773,796,819,954,1497
169	169	R-HSA-168273	Influenza Viral RNA Transcription and Replication R-HSA-168273	134	4,11,12,134,2629	337,669,2334,2532	337,669,2334,2532
170	170	R-HSA-1632852	Macroautophagy R-HSA-1632852	146	146,2629	372	372,670,928,1076,1534,1554,1661
171	171	R-HSA-2871837	FCERI mediated NF-kB activation R-HSA-2871837	113	2,10,113,2629		
172	172	R-HSA-162599	Late Phase of HIV Life Cycle R-HSA-162599	150	4,11,12,80,150,2629	444,804,946,1279	444,637,638,654,687,691,693,804,826,830,839,870,891,946,962,1049,1279,1348,1387,2548
173	173	R-HSA-8856688	Golgi-to-ER retrograde transport R-HSA-8856688	97	20,27,97,2629	283,589	283,589
174	174	R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851	175	4,11,84,85,175,2629	305,689,1662,1800	305,689,1662,1800
175	175	R-HSA-9664433	Leishmania parasite growth and survival R-HSA-9664433	84	4,11,84,85,2629	174	174,305,689,1662,1800
176	176	R-HSA-166520	Signaling by NTRKs R-HSA-166520	32	0,32,2629	225,999,1255,2053	225,501,740,825,999,1075,1137,1255,1390,1392,1452,1453,1509,1572,1648,1681,1704,1805,1816,1817,1828,1855,1879,1917,1950,1961,1993,2028,2030,2053,2126,2127,2134,2152,2226,2263,2276,2279,2331,2336
177	177	R-HSA-5693567	HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) R-HSA-5693567	168	46,125,168,2629	295,458,773	295,458,686,726,773,796,819,954
178	178	R-HSA-76005	Response to elevated platelet cytosolic Ca2+ R-HSA-76005	71	25,71,2629	189,1995	189,1995
179	179	R-HSA-69206	G1/S Transition R-HSA-69206	148	24,30,148,2629	369,831,924,1072	369,509,831,924,1072,1421,1687,2086
180	180	R-HSA-162909	Host Interactions of HIV factors R-HSA-162909	80	4,11,12,80,2629	574,592,762,775,937,1946,2235	574,592,762,775,804,811,818,937,1116,1612,1672,1744,1841,1946,2217,2235,2275
181	181	R-HSA-5576891	Cardiac conduction R-HSA-5576891	98	98,2629	579,852,1175,1309,1378,1668,1844	579,852,1175,1309,1378,1668,1844
182	182	R-HSA-9758941	Gastrulation R-HSA-9758941	8	8,2629	448,1232,1238,1249,1356,1551,1596,1768,1793,2013	448,560,1232,1238,1249,1356,1551,1596,1768,1793,2013
183	183	R-HSA-6809371	Formation of the cornified envelope R-HSA-6809371	87	8,87,2629		
184	184	R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs R-HSA-8939236	76	5,7,9,76,2629		
185	185	R-HSA-1483206	Glycerophospholipid biosynthesis R-HSA-1483206	91	1,17,91,2629	732,930,941,968,1092,1203,1250,1434,1670,1718,1792,1864,1971,2260,2311,2468,2555	732,930,941,968,1092,1203,1250,1434,1670,1718,1792,1864,1971,2260,2311,2468,2555
186	186	R-HSA-9816359	Maternal to zygotic transition (MZT) R-HSA-9816359	8	8,2629	440,702,837,1226,1495	440,702,837,1226,1495
187	187	R-HSA-196849	Metabolism of water-soluble vitamins and cofactors R-HSA-196849	107	1,107,2629	872,1084,1134,1241,1559,1782,1845,1888,1941,2187	872,1084,1134,1176,1241,1559,1588,1776,1782,1797,1833,1845,1888,1941,2187
188	188	R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. R-HSA-163200	120	1,120,2629	270,1196,1899	270,539,1196,1899,1976,1991,2378
189	189	R-HSA-114608	Platelet degranulation  R-HSA-114608	178	25,71,178,2629		
190	190	R-HSA-2132295	MHC class II antigen presentation R-HSA-2132295	14	2,14,2629		
191	191	R-HSA-2500257	Resolution of Sister Chromatid Cohesion R-HSA-2500257	99	24,30,40,99,2629		
192	192	R-HSA-1630316	Glycosaminoglycan metabolism R-HSA-1630316	58	1,58,2629	547,619,780,1227,1916	547,619,780,869,936,982,1024,1135,1227,1314,1361,1460,1575,1916,1990
193	193	R-HSA-9705671	SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671	95	4,11,12,35,56,95,2629		
194	194	R-HSA-2559580	Oxidative Stress Induced Senescence R-HSA-2559580	104	13,15,104,2629		
195	195	R-HSA-9755511	KEAP1-NFE2L2 pathway R-HSA-9755511	89	13,15,89,2629	297,1550	297,596,1187,1515,1550,1734,1750,1770,1940,1977,2215
196	196	R-HSA-202403	TCR signaling R-HSA-202403	14	2,14,2629	272,735,972,1021	272,735,972,1021
197	197	R-HSA-9006936	Signaling by TGFB family members R-HSA-9006936	0	0,2629	317,890,1237	317,608,646,790,868,890,992,1237,1289,2023
198	198	R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) R-HSA-381426	3	3,2629		
199	199	R-HSA-9007101	Rab regulation of trafficking R-HSA-9007101	27	20,27,2629	343,666	343,666
200	200	R-HSA-5619507	Activation of HOX genes during differentiation R-HSA-5619507	8	8,2629	201	201
201	201	R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis R-HSA-5617472	200	8,200,2629		
202	202	R-HSA-373760	L1CAM interactions R-HSA-373760	31	8,29,31,2629	626,887,1120,1650,1806,1820	626,887,1120,1650,1806,1820
203	203	R-HSA-69239	Synthesis of DNA R-HSA-69239	112,130	24,30,112,130,2629	326,850,1721	326,422,437,850,1131,1339,1381,1384,1385,1493,1721
204	204	R-HSA-72737	Cap-dependent Translation Initiation R-HSA-72737	206	3,60,206,2629	228,276,511,518,599,1728	228,276,511,516,518,599,1728
205	205	R-HSA-9820952	Respiratory Syncytial Virus Infection Pathway R-HSA-9820952	12	4,11,12,2629	289,1059,1286,2261	289,798,1059,1286,1416,2261,2287,2479
206	206	R-HSA-72613	Eukaryotic Translation Initiation R-HSA-72613	60	3,60,2629	204,231	204,228,231,276,511,516,518,599,1728
207	207	R-HSA-8878166	Transcriptional regulation by RUNX2 R-HSA-8878166	9	5,7,9,2629	423,875,1754,2063	423,875,1033,1754,1999,2063
208	208	R-HSA-1912422	Pre-NOTCH Expression and Processing R-HSA-1912422	74	0,74,2629	269,1208,1906	269,1208,1906
209	209	R-HSA-2408522	Selenoamino acid metabolism R-HSA-2408522	44	1,44,2629	314,1702,2110,2456,2559	314,1702,2110,2456,2559
210	210	R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482	155	2,10,155,2629		
211	211	R-HSA-1500620	Meiosis R-HSA-1500620	24,137	24,137,2629	356,396	356,396
212	212	R-HSA-400206	Regulation of lipid metabolism by PPARalpha R-HSA-400206	17	1,17,2629	218	218
213	213	R-HSA-9648025	EML4 and NUDC in mitotic spindle formation R-HSA-9648025	99	24,30,40,99,2629		
214	214	R-HSA-446728	Cell junction organization R-HSA-446728	138	138,2629	334,1213,1545	334,526,849,855,895,923,1213,1545,1577,1592,1597,1737,1826,1832,1851,2081,2221
215	215	R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) R-HSA-975957	217	19,217,2629		
216	216	R-HSA-9664407	Parasite infection R-HSA-9664407	84	4,11,84,85,2629	221	219,221
217	217	R-HSA-927802	Nonsense-Mediated Decay (NMD) R-HSA-927802	19	19,2629	215,301	215,301
218	218	R-HSA-1989781	PPARA activates gene expression R-HSA-1989781	212	1,17,212,2629		
219	219	R-HSA-9664422	FCGR3A-mediated phagocytosis R-HSA-9664422	221	4,11,84,85,216,221,2629		
220	220	R-HSA-9610379	HCMV Late Events R-HSA-9610379	131	4,11,12,131,2629		
221	221	R-HSA-9664417	Leishmania phagocytosis R-HSA-9664417	216	4,11,84,85,216,2629	219	219
222	222	R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade R-HSA-168179	224	2,10,127,224,2629	233	233,489,672,866,1056,1075,1088,1221,1265,1406,1452,1618,1637,1817
223	223	R-HSA-166658	Complement cascade R-HSA-166658	10	2,10,2629	265,384,1760,1781	265,384,436,484,1760,1779,1781,1929,2011
224	224	R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade R-HSA-181438	127	2,10,127,2629	222,234	222,233,234,489,672,866,1056,1075,1088,1221,1265,1406,1452,1618,1637,1817
225	225	R-HSA-187037	Signaling by NTRK1 (TRKA) R-HSA-187037	176	0,32,176,2629	501,825,1390,1648,1855,2134,2152,2226	501,740,825,1075,1137,1390,1392,1452,1453,1509,1648,1816,1817,1855,1961,1993,2134,2152,2226,2336
226	226	R-HSA-9020702	Interleukin-1 signaling R-HSA-9020702	144	2,16,34,144,2629	672,1265	672,1221,1265
227	227	R-HSA-199418	Negative regulation of the PI3K/AKT network R-HSA-199418	70	0,53,70,2629	257	257
228	228	R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit R-HSA-72706	204	3,60,204,206,2629		
229	229	R-HSA-5610787	Hedgehog 'off' state R-HSA-5610787	147	0,147,2629	507,510,512	507,510,512
230	230	R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane R-HSA-1799339	60	3,60,2629		
231	231	R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression R-HSA-156827	206	3,60,206,2629		
232	232	R-HSA-157579	Telomere Maintenance R-HSA-157579	166	24,166,2629	464,609,610	464,609,610,823,975,1053,1167,1235,1413
233	233	R-HSA-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane R-HSA-166058	154,222,234	2,10,127,154,222,224,234,2629	489,672,1406,1637	489,672,866,1056,1075,1088,1221,1265,1406,1452,1618,1637,1817
234	234	R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade R-HSA-168188	224	2,10,127,224,2629	233	233,489,672,866,1056,1075,1088,1221,1265,1406,1452,1618,1637,1817
235	235	R-HSA-72306	tRNA processing R-HSA-72306	19	19,2629	517,688,1685,1804	517,688,1685,1804,1873
236	236	R-HSA-69618	Mitotic Spindle Checkpoint R-HSA-69618	62	24,62,2629	312,1122	307,312,1111,1122
237	237	R-HSA-5173105	O-linked glycosylation R-HSA-5173105	6	3,6,2629	491,741	491,741,1047
238	238	R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582	104	13,15,104,2629		
239	239	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling R-HSA-6785807	34	2,16,34,2629		
240	240	R-HSA-5696398	Nucleotide Excision Repair R-HSA-5696398	46	46,2629	364,392	364,392,471,481,590,680,720,755,996
241	241	R-HSA-977225	Amyloid fiber formation R-HSA-977225	3	3,2629		
242	242	R-HSA-73864	RNA Polymerase I Transcription R-HSA-73864	5	5,2629	245,871	245,344,492,645,871
243	243	R-HSA-156580	Phase II - Conjugation of compounds R-HSA-156580	82	1,82,2629	778,1020,1044,1371,1673,2246	778,1020,1044,1371,1474,1673,1697,1716,1916,1919,2142,2246,2282
244	244	R-HSA-9748784	Drug ADME R-HSA-9748784	2629	2629	663,925,1045,1524,1629,1693,1694,1948	663,925,1045,1524,1629,1693,1694,1948,1957,2105
245	245	R-HSA-73854	RNA Polymerase I Promoter Clearance R-HSA-73854	242	5,242,2629	344,492,645	344,492,645
246	246	R-HSA-5250941	Negative epigenetic regulation of rRNA expression R-HSA-5250941	111	5,111,2629	259,462	259,462
247	247	R-HSA-166166	MyD88-independent TLR4 cascade  R-HSA-166166	154	2,10,127,154,2629	249	249,489,672,866,1050,1056,1075,1088,1221,1254,1265,1266,1452,1618,1644,1817
248	248	R-HSA-163685	Integration of energy metabolism R-HSA-163685	1	1,2629	398,832,1757,1784,1822,1938,2269	398,708,832,949,1259,1566,1587,1724,1757,1784,1822,1938,2137,2269
249	249	R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling  R-HSA-937061	247	2,10,127,154,247,2629	489,672,1050,1254,1266,1644	489,672,866,1050,1056,1075,1088,1221,1254,1265,1266,1452,1618,1644,1817
250	250	R-HSA-8957275	Post-translational protein phosphorylation R-HSA-8957275	6	3,6,2629		
251	251	R-HSA-428157	Sphingolipid metabolism R-HSA-428157	17	1,17,2629	540,758,1482	540,745,758,1166,1482
252	252	R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides R-HSA-425393	73	18,73,2629	844,1574,1614,1617,1647,1699,1849,1932,2025,2233	844,1574,1614,1617,1647,1699,1849,1932,2025,2203,2233
253	253	R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138	127	2,10,127,2629	277	277,280,489,672,866,1056,1075,1088,1221,1265,1317,1402,1452,1459,1618,1817
254	254	R-HSA-194138	Signaling by VEGF R-HSA-194138	32	0,32,2629	296,1712,2062	296,964,1171,1712,1746,2062
255	255	R-HSA-2672351	Stimuli-sensing channels R-HSA-2672351	116	18,116,2629	940	940
256	256	R-HSA-5578749	Transcriptional regulation by small RNAs R-HSA-5578749	165	5,165,2629		
257	257	R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558	227	0,53,70,227,2629		
258	258	R-HSA-1236975	Antigen processing-Cross presentation R-HSA-1236975	43	2,14,43,2629	342,613,1570,1777	342,613,1570,1777
259	259	R-HSA-427413	NoRC negatively regulates rRNA expression R-HSA-427413	246	5,111,246,2629		
260	260	R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis R-HSA-8856825	153	20,27,153,2629		
261	261	R-HSA-2219528	PI3K/AKT Signaling in Cancer R-HSA-2219528	37	4,37,2629	391,990,2571	391,990,2571
262	262	R-HSA-5250913	Positive epigenetic regulation of rRNA expression R-HSA-5250913	111	5,111,2629	339,408	339,408
263	263	R-HSA-211945	Phase I - Functionalization of compounds R-HSA-211945	82	1,82,2629	476,1504,1896,2039,2188,2491	476,984,1069,1319,1480,1496,1504,1530,1896,1898,2039,2188,2222,2304,2337,2491,2586
264	264	R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164	127	2,10,127,2629	489,672,1188,1499,1567,1911	489,672,866,1056,1075,1088,1188,1221,1265,1452,1499,1567,1618,1817,1911
265	265	R-HSA-977606	Regulation of Complement cascade R-HSA-977606	223	2,10,223,2629		
266	266	R-HSA-9645723	Diseases of programmed cell death R-HSA-9645723	4	4,2629	430,1014,1825	430,1014,1080,1090,1825,2047,2328,2351,2452
267	267	R-HSA-1296071	Potassium Channels R-HSA-1296071	41	41,2629	682,797,1513,1657,2019	682,797,920,927,1513,1657,2019,2065,2098,2122,2141,2182,2232,2265,2385,2386
268	268	R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181	127	2,10,127,2629	277	277,280,489,672,866,1056,1075,1088,1221,1265,1317,1402,1452,1459,1618,1817
269	269	R-HSA-1912408	Pre-NOTCH Transcription and Translation R-HSA-1912408	208	0,74,208,2629		
270	270	R-HSA-611105	Respiratory electron transport R-HSA-611105	188	1,120,188,2629	539	539
271	271	R-HSA-382556	ABC-family proteins mediated transport R-HSA-382556	18	18,2629	1219,2022	1219,2022
272	272	R-HSA-202424	Downstream TCR signaling R-HSA-202424	196	2,14,196,2629		
273	273	R-HSA-5689603	UCH proteinases R-HSA-5689603	57	3,6,57,2629		
274	274	R-HSA-9633012	Response of EIF2AK4 (GCN2) to amino acid deficiency R-HSA-9633012	135	13,15,135,2629		
275	275	R-HSA-6807878	COPI-mediated anterograde transport R-HSA-6807878	139	3,6,20,27,54,114,139,2629		
276	276	R-HSA-72689	Formation of a pool of free 40S subunits R-HSA-72689	204	3,60,204,206,2629		
277	277	R-HSA-975155	MyD88 dependent cascade initiated on endosome R-HSA-975155	253,268	2,10,127,253,268,2629	280,1459	280,489,672,866,1056,1075,1088,1221,1265,1317,1402,1452,1459,1618,1817
278	278	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway R-HSA-5668541	16	2,16,2629	522,914,1247	522,914,1247
279	279	R-HSA-3371556	Cellular response to heat stress R-HSA-3371556	15	13,15,2629	376,743,889	376,743,889,939
280	280	R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation R-HSA-975138	277	2,10,127,253,268,277,2629	489,672,1317,1402	489,672,866,1056,1075,1088,1221,1265,1317,1402,1452,1618,1817
281	281	R-HSA-5607764	CLEC7A (Dectin-1) signaling R-HSA-5607764	162	2,10,162,2629	494,1526,1868	494,1526,1868
282	282	R-HSA-2187338	Visual phototransduction R-HSA-2187338	26	26,2629	662,810,1052,1848	662,810,835,1052,1556,1848,2494
283	283	R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic R-HSA-6811434	173	20,27,97,173,2629		
284	284	R-HSA-5619102	SLC transporter disorders R-HSA-5619102	121	4,121,2629	847,2119,2228,2241,2292,2308,2309,2315,2335,2344,2352,2353,2365,2370,2377,2381,2382,2389,2392,2396,2397,2400,2403,2406,2407,2408,2410,2417,2427,2428,2429,2430,2432,2435,2440,2453,2462,2465,2473,2476,2478,2480,2496,2500,2506,2507,2512,2523,2526,2527,2529,2534,2536,2542,2544,2546,2549,2556,2566,2567,2568,2581,2582,2601,2602,2603,2608,2609,2614,2625,2626	847,2119,2228,2241,2292,2308,2309,2315,2335,2344,2352,2353,2365,2370,2377,2381,2382,2389,2392,2396,2397,2400,2403,2406,2407,2408,2410,2417,2427,2428,2429,2430,2432,2435,2440,2453,2462,2465,2473,2476,2478,2480,2496,2500,2506,2507,2512,2523,2526,2527,2529,2534,2536,2542,2544,2546,2549,2556,2566,2567,2568,2581,2582,2601,2602,2603,2608,2609,2614,2625,2626
285	285	R-HSA-9692914	SARS-CoV-1-host interactions R-HSA-9692914	156	4,11,12,35,156,2629	721,774,1296,2148,2483	721,774,1296,2148,2483
286	286	R-HSA-6803157	Antimicrobial peptides R-HSA-6803157	10	2,10,2629	585,1881,2015	585,690,1582,1881,2015
287	287	R-HSA-877300	Interferon gamma signaling R-HSA-877300	66	2,16,66,2629	1370,1763	1370,1763
288	288	R-HSA-9837999	Mitochondrial protein degradation R-HSA-9837999	3	3,2629		
289	289	R-HSA-9833110	RSV-host interactions R-HSA-9833110	205	4,11,12,205,2629	798	798
290	290	R-HSA-391251	Protein folding R-HSA-391251	3	3,2629	329,1062	329,737,746,834,942,987,1062,1595
291	291	R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782	20	20,2629	445,1168,1874,1915,2096	445,1168,1874,1915,2096
292	292	R-HSA-5620912	Anchoring of the basal body to the plasma membrane R-HSA-5620912	100	61,100,2629		
293	293	R-HSA-15869	Metabolism of nucleotides R-HSA-15869	1	1,2629	808,919,1068,1354	808,919,1068,1240,1354,1418,1511,1558,1576,1711,1807,2147
294	294	R-HSA-193704	p75 NTR receptor-mediated signalling R-HSA-193704	142	0,142,2629	407,1283,1569,1586,1914,2201,2259	407,519,1283,1294,1422,1446,1569,1586,1659,1910,1914,2085,2201,2259
295	295	R-HSA-5693607	Processing of DNA double-strand break ends R-HSA-5693607	177	46,125,168,177,2629		
296	296	R-HSA-4420097	VEGFA-VEGFR2 Pathway R-HSA-4420097	254	0,32,254,2629	964,1171	964,1171
297	297	R-HSA-9759194	Nuclear events mediated by NFE2L2 R-HSA-9759194	195	13,15,89,195,2629	596,1187,1515,1734,1750,1770,1940,1977,2215	596,1187,1515,1734,1750,1770,1940,1977,2215
298	298	R-HSA-8878159	Transcriptional regulation by RUNX3 R-HSA-8878159	9	5,7,9,2629	563,1399,1613,1703,1733,1789,1893,1979,2112	563,1399,1613,1703,1733,1789,1893,1979,2112
299	299	R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade R-HSA-168142	127	2,10,127,2629	303	303,489,672,866,1056,1075,1088,1221,1265,1406,1452,1618,1637,1817
300	300	R-HSA-5368287	Mitochondrial translation R-HSA-5368287	60	3,60,2629	332,335,338	332,335,338
301	301	R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) R-HSA-975956	217	19,217,2629		
302	302	R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade R-HSA-168176	127	2,10,127,2629	303	303,489,672,866,1056,1075,1088,1221,1265,1406,1452,1618,1637,1817
303	303	R-HSA-975871	MyD88 cascade initiated on plasma membrane R-HSA-975871	299,302	2,10,127,299,302,2629	489,672,1406,1637	489,672,866,1056,1075,1088,1221,1265,1406,1452,1618,1637,1817
304	304	R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function R-HSA-8936459	76	5,7,9,76,2629		
305	305	R-HSA-9664323	FCGR3A-mediated IL10 synthesis R-HSA-9664323	174	4,11,84,85,174,175,2629		
306	306	R-HSA-380320	Recruitment of NuMA to mitotic centrosomes R-HSA-380320	99	24,30,40,99,2629		
307	307	R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal R-HSA-141444	312	24,62,236,312,2629		
308	308	R-HSA-70326	Glucose metabolism R-HSA-70326	58	1,58,2629	420,807	420,807,856,1473
309	309	R-HSA-72764	Eukaryotic Translation Termination R-HSA-72764	60	3,60,2629		
310	310	R-HSA-156842	Eukaryotic Translation Elongation R-HSA-156842	60	3,60,2629	341	341
311	311	R-HSA-442755	Activation of NMDA receptors and postsynaptic events R-HSA-442755	93	41,69,93,2629	383,667,1104,1126	383,667,910,951,1070,1104,1126,1133,1467,1783,1787,1854
312	312	R-HSA-141424	Amplification of signal from the kinetochores R-HSA-141424	236	24,62,236,2629	307	307
313	313	R-HSA-1592230	Mitochondrial biogenesis R-HSA-1592230	61	61,2629	555,881,1604	555,881,1604
314	314	R-HSA-2408557	Selenocysteine synthesis R-HSA-2408557	209	1,44,209,2629		
315	315	R-HSA-9013423	RAC3 GTPase cycle R-HSA-9013423	38	0,21,22,38,2629		
316	316	R-HSA-3214815	HDACs deacetylate histones R-HSA-3214815	67	67,68,2629		
317	317	R-HSA-170834	Signaling by TGF-beta Receptor Complex R-HSA-170834	197	0,197,2629	608,646,1289	608,646,790,868,992,1289
318	318	R-HSA-69473	G2/M DNA damage checkpoint R-HSA-69473	126	24,62,126,2629	1435	1435
319	319	R-HSA-373080	Class B/2 (Secretin family receptors) R-HSA-373080	36	0,23,36,2629	828,1602	828,1602
320	320	R-HSA-9725370	Signaling by ALK fusions and activated point mutants R-HSA-9725370	325	4,37,325,2629	805	805
321	321	R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins R-HSA-163125	6	3,6,2629	1199,1811,2161	1199,1811,2161
322	322	R-HSA-381119	Unfolded Protein Response (UPR) R-HSA-381119	15	13,15,2629	614,860,1464,1698,2090	614,629,860,959,1464,1621,1698,2090
323	323	R-HSA-5687128	MAPK6/MAPK4 signaling R-HSA-5687128	49	0,49,2629		
324	324	R-HSA-5625740	RHO GTPases activate PKNs R-HSA-5625740	50	0,21,22,50,2629	468	468
325	325	R-HSA-9700206	Signaling by ALK in cancer R-HSA-9700206	37	4,37,2629	320,1498,2422	320,805,1498,2356,2357,2393,2422,2438,2492,2562,2621
326	326	R-HSA-69052	Switching of origins to a post-replicative state R-HSA-69052	203	24,30,112,130,203,2629	422,437	422,437
327	327	R-HSA-4086400	PCP/CE pathway R-HSA-4086400	152	0,47,152,2629	479,1342,1417	479,1342,1417
328	328	R-HSA-2682334	EPH-Ephrin signaling R-HSA-2682334	31	8,29,31,2629	606,697,917,1186	606,697,917,1186
329	329	R-HSA-390466	Chaperonin-mediated protein folding R-HSA-390466	290	3,290,2629	737,746,834	737,746,834,942,987,1595
330	330	R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation R-HSA-6804756	132	5,7,9,45,132,2629		
331	331	R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex R-HSA-201722	79	0,47,79,2629	1732	1732
332	332	R-HSA-5389840	Mitochondrial translation elongation R-HSA-5389840	300	3,60,300,2629		
333	333	R-HSA-111885	Opioid Signalling R-HSA-111885	51	0,23,28,51,2629	578,1040,1042	578,621,770,795,803,1040,1042,1129,1194,1362,1579,1616,2050,2283
334	334	R-HSA-421270	Cell-cell junction organization R-HSA-421270	214	138,214,2629	526,895,2221	526,849,855,895,923,1577,1592,1597,1826,1832,1851,2221
335	335	R-HSA-5419276	Mitochondrial translation termination R-HSA-5419276	300	3,60,300,2629		
336	336	R-HSA-1474290	Collagen formation R-HSA-1474290	55	55,2629	460,498	460,498,676,1207,1343
337	337	R-HSA-192823	Viral mRNA Translation R-HSA-192823	169	4,11,12,134,169,2629		
338	338	R-HSA-5368286	Mitochondrial translation initiation R-HSA-5368286	300	3,60,300,2629		
339	339	R-HSA-5250924	B-WICH complex positively regulates rRNA expression R-HSA-5250924	262	5,111,262,2629		
340	340	R-HSA-73884	Base Excision Repair R-HSA-73884	46	46,2629	493,750	493,506,508,513,554,557,564,750,1002,1110,1669,1748,1788,2029,2243,2451
341	341	R-HSA-156902	Peptide chain elongation R-HSA-156902	310	3,60,310,2629		
342	342	R-HSA-1236974	ER-Phagosome pathway R-HSA-1236974	258	2,14,43,258,2629		
343	343	R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198	199	20,27,199,2629		
344	344	R-HSA-73772	RNA Polymerase I Promoter Escape R-HSA-73772	245	5,242,245,2629		
345	345	R-HSA-2980736	Peptide hormone metabolism R-HSA-2980736	3	3,2629	1011,1032,1180,1201,1366	1011,1032,1096,1180,1201,1366,1415,1483
346	346	R-HSA-9616222	Transcriptional regulation of granulopoiesis R-HSA-9616222	8	8,2629		
347	347	R-HSA-190236	Signaling by FGFR R-HSA-190236	32	0,32,2629	421,602,725,728	421,602,725,728,814,842,876,877,903,915,958,961,994,1003,1046,1064,1071,1083,1106,1123,1130,1144,1151,1160,1202,1205,1216,1224,1268,1281,1332,1388,1404,1408,1409,1427,1443,1450,1606,1714,1796,2159,2214
348	348	R-HSA-174143	APC/C-mediated degradation of cell cycle proteins R-HSA-174143	350	24,30,350,2629	378,401,415,483,1150	378,401,403,415,416,425,452,483,569,979,1028,1111,1122,1140,1150,1912
349	349	R-HSA-9013404	RAC2 GTPase cycle R-HSA-9013404	38	0,21,22,38,2629		
350	350	R-HSA-453276	Regulation of mitotic cell cycle R-HSA-453276	30	24,30,2629	348	348,378,401,403,415,416,425,452,483,569,979,1028,1111,1122,1140,1150,1912
351	351	R-HSA-5628897	TP53 Regulates Metabolic Genes R-HSA-5628897	45	5,7,9,45,2629		
352	352	R-HSA-2871796	FCERI mediated MAPK activation R-HSA-2871796	113	2,10,113,2629		
353	353	R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942	102	24,30,101,102,2629		
354	354	R-HSA-6794362	Protein-protein interactions at synapses R-HSA-6794362	41	41,2629	552,1097,1152	552,1097,1152
355	355	R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements R-HSA-450531	19	19,2629	553,1245,1248,1256,1766	553,1245,1248,1256,1766
356	356	R-HSA-912446	Meiotic recombination R-HSA-912446	211	24,137,211,2629		
357	357	R-HSA-5632684	Hedgehog 'on' state R-HSA-5632684	147	0,147,2629	1204,1723,1791	1204,1723,1791
358	358	R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers R-HSA-983695	128	2,14,128,2629		
359	359	R-HSA-418346	Platelet homeostasis R-HSA-418346	25	25,2629	947,1081,1192,1244	947,1081,1192,1244,1288,1291,1488
360	360	R-HSA-2871809	FCERI mediated Ca+2 mobilization R-HSA-2871809	113	2,10,113,2629		
361	361	R-HSA-195253	Degradation of beta-catenin by the destruction complex R-HSA-195253	47	0,47,2629	1251,1358	1251,1358
362	362	R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656	130	24,30,130,2629	509	509
363	363	R-HSA-216083	Integrin cell surface interactions R-HSA-216083	55	55,2629		
364	364	R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399	240	46,240,2629	680,720,755,996	680,720,755,996
365	365	R-HSA-381340	Transcriptional regulation of white adipocyte differentiation R-HSA-381340	8	8,2629		
366	366	R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds R-HSA-425366	73	18,73,2629	1022,1185,1330,1866,2002,2198,2205	1022,1185,1312,1330,1590,1622,1866,1985,2002,2005,2198,2205
367	367	R-HSA-1483255	PI Metabolism R-HSA-1483255	91	1,17,91,2629	584,1200,1276,1543,1801,1992,2071,2468	584,1200,1276,1543,1801,1992,2071,2468
368	368	R-HSA-72202	Transport of Mature Transcript to Cytoplasm R-HSA-72202	64	19,64,2629	412,692	412,692,707,786,809
369	369	R-HSA-69202	Cyclin E associated events during G1/S transition  R-HSA-69202	179	24,30,148,179,2629	509,2086	509,2086
370	370	R-HSA-2029485	Role of phospholipids in phagocytosis R-HSA-2029485	155	2,10,155,2629		
371	371	R-HSA-9013694	Signaling by NOTCH4 R-HSA-9013694	74	0,74,2629	572,1145,1549	572,1145,1549
372	372	R-HSA-9663891	Selective autophagy R-HSA-9663891	170	146,170,2629	670,928,1534,1661	670,928,1076,1534,1554,1661
373	373	R-HSA-74752	Signaling by Insulin receptor R-HSA-74752	32	0,32,2629	575,906	575,632,664,906,1635,1831,1974,2088,2234,2302
374	374	R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928	10	2,10,2629	806,901,1005,1326,1436	806,901,1005,1326,1436
375	375	R-HSA-6802957	Oncogenic MAPK signaling R-HSA-6802957	37	4,37,2629	470,655,658,660,716,784,1767,1790,1839,2021	470,655,657,658,660,716,784,1709,1767,1775,1790,1839,2021,2129,2189,2192
376	376	R-HSA-3371453	Regulation of HSF1-mediated heat shock response R-HSA-3371453	279	13,15,279,2629		
377	377	R-HSA-6807505	RNA polymerase II transcribes snRNA genes R-HSA-6807505	7	5,7,2629		
378	378	R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase R-HSA-176408	348	24,30,348,350,2629	569,1122,1912	569,1111,1122,1912
379	379	R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes R-HSA-380270	381	24,30,101,102,381,2629		
380	380	R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372	128	2,14,128,2629	461,1666,1955	461,1666,1955
381	381	R-HSA-380287	Centrosome maturation R-HSA-380287	102	24,30,101,102,2629	379,451	379,450,451
382	382	R-HSA-674695	RNA Polymerase II Pre-transcription Events R-HSA-674695	7	5,7,2629		
383	383	R-HSA-438064	Post NMDA receptor activation events R-HSA-438064	311	41,69,93,311,2629	910,951,1070,1467,1783,1787	910,951,1070,1133,1467,1783,1787,1854
384	384	R-HSA-166663	Initial triggering of complement R-HSA-166663	223	2,10,223,2629	436,1929	436,484,1779,1929,2011
385	385	R-HSA-416482	G alpha (12/13) signalling events R-HSA-416482	28	0,23,28,2629		
386	386	R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586	104	13,15,104,2629	1234	1234
387	387	R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276	102	24,30,101,102,2629		
388	388	R-HSA-8852135	Protein ubiquitination R-HSA-8852135	6	3,6,2629	515,898	515,898
389	389	R-HSA-6806834	Signaling by MET R-HSA-6806834	32	0,32,2629	724,1121,1563,1594,1861,1887,1945,2169	724,896,1121,1519,1563,1594,1861,1887,1945,1967,2169,2293
390	390	R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein R-HSA-446193	54	3,6,54,2629	487	487,827,1708,1869,1878,1956,2161,2298
391	391	R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530	261	4,37,261,2629		
392	392	R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827	240	46,240,2629	471,481,590	471,481,590
393	393	R-HSA-5619084	ABC transporter disorders R-HSA-5619084	121	4,121,2629	500,2245,2252,2264,2288,2289,2343,2359,2363,2371,2372,2375,2383,2388,2439	500,2245,2252,2264,2288,2289,2343,2359,2363,2371,2372,2375,2383,2388,2439
394	394	R-HSA-909733	Interferon alpha/beta signaling R-HSA-909733	66	2,16,66,2629	974	974
395	395	R-HSA-5693606	DNA Double Strand Break Response R-HSA-5693606	125	46,125,2629	402,1857	402,1857
396	396	R-HSA-1221632	Meiotic synapsis R-HSA-1221632	211	24,137,211,2629		
397	397	R-HSA-3214858	RMTs methylate histone arginines R-HSA-3214858	67	67,68,2629		
398	398	R-HSA-422356	Regulation of insulin secretion R-HSA-422356	248	1,248,2629	708,949,1566,1587	708,949,1566,1587,1724,2137
399	399	R-HSA-3108214	SUMOylation of DNA damage response and repair proteins R-HSA-3108214	117	3,6,110,117,2629		
400	400	R-HSA-9659379	Sensory processing of sound R-HSA-9659379	26	26,2629	447,568	447,568,1981
401	401	R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176814	348	24,30,348,350,2629	403,1140	403,416,425,452,979,1028,1140
402	402	R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks R-HSA-5693565	395	46,125,395,2629		
403	403	R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176409	401	24,30,348,350,401,2629	416,452,1028	416,425,452,979,1028
404	404	R-HSA-3000178	ECM proteoglycans R-HSA-3000178	55	55,2629		
405	405	R-HSA-2995410	Nuclear Envelope (NE) Reassembly R-HSA-2995410	78	24,30,40,77,78,2629	851,956,1169	851,956,1169
406	406	R-HSA-9833482	PKR-mediated signaling R-HSA-9833482	145	2,16,66,145,2629		
407	407	R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE R-HSA-204998	294	0,142,294,2629	519,1294,1910	519,1294,1910
408	408	R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression R-HSA-427389	262	5,111,262,2629		
409	409	R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance R-HSA-174824	18	18,2629	761,816,1172	761,816,1163,1172,1178,1298,1605,1630,1633,1717,1862,1895,1943,1947,2001
410	410	R-HSA-9009391	Extra-nuclear estrogen signaling R-HSA-9009391	83	0,59,83,2629	1026,1901	1026,1901
411	411	R-HSA-1234174	Cellular response to hypoxia R-HSA-1234174	15	13,15,2629	467,1518	467,1518
412	412	R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript R-HSA-159236	368	19,64,368,2629		
413	413	R-HSA-9013106	RHOC GTPase cycle R-HSA-9013106	38	0,21,22,38,2629		
414	414	R-HSA-388841	Costimulation by the CD28 family R-HSA-388841	14	2,14,2629	829,948,1098	829,948,1086,1098,1494
415	415	R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 R-HSA-174178	348	24,30,348,350,2629		
416	416	R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint R-HSA-179419	403	24,30,348,350,401,403,2629	425,979	425,979
417	417	R-HSA-1169408	ISG15 antiviral mechanism R-HSA-1169408	145	2,16,66,145,2629		
418	418	R-HSA-9013408	RHOG GTPase cycle R-HSA-9013408	38	0,21,22,38,2629		
419	419	R-HSA-1980143	Signaling by NOTCH1 R-HSA-1980143	74	0,74,2629	630,879	630,879
420	420	R-HSA-70171	Glycolysis R-HSA-70171	308	1,58,308,2629	856,1473	856,1473
421	421	R-HSA-5654738	Signaling by FGFR2 R-HSA-5654738	347	0,32,347,2629	814,903,958,1160	814,903,958,1003,1064,1071,1160,1224,1268,1450,1606
422	422	R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6 R-HSA-69017	326	24,30,112,130,203,326,2629		
423	423	R-HSA-8939902	Regulation of RUNX2 expression and activity R-HSA-8939902	207	5,7,9,207,2629		
424	424	R-HSA-2299718	Condensation of Prophase Chromosomes R-HSA-2299718	159	24,30,40,159,2629		
425	425	R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A R-HSA-174184	416	24,30,348,350,401,403,416,2629		
426	426	R-HSA-212300	PRC2 methylates histones and DNA R-HSA-212300	111	5,111,2629		
427	427	R-HSA-8854518	AURKA Activation by TPX2 R-HSA-8854518	102	24,30,101,102,2629		
428	428	R-HSA-774815	Nucleosome assembly R-HSA-774815	166	24,166,2629	429	429
429	429	R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere R-HSA-606279	428	24,166,428,2629		
430	430	R-HSA-9710421	Defective pyroptosis R-HSA-9710421	266	4,266,2629		
431	431	R-HSA-199992	trans-Golgi Network Vesicle Budding R-HSA-199992	27	20,27,2629	548,794	548,794
432	432	R-HSA-1445148	Translocation of SLC2A4 (GLUT4) to the plasma membrane R-HSA-1445148	27	20,27,2629		
433	433	R-HSA-9824439	Bacterial Infection Pathways R-HSA-9824439	11	4,11,2629	909,967,1156	909,967,1054,1156,1335,1439,1540,1598,1664,1665,1815,1853,1858,1968,1994,2109,2116,2124,2136,2172,2213,2270,2285,2329,2420,2448,2477,2495,2593
434	434	R-HSA-4551638	SUMOylation of chromatin organization proteins R-HSA-4551638	117	3,6,110,117,2629		
435	435	R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization R-HSA-2730905	113	2,10,113,2629		
436	436	R-HSA-166786	Creation of C4 and C2 activators R-HSA-166786	384	2,10,223,384,2629	484,1779	484,1779,2011
437	437	R-HSA-68949	Orc1 removal from chromatin R-HSA-68949	326	24,30,112,130,203,326,2629		
438	438	R-HSA-448424	Interleukin-17 signaling R-HSA-448424	34	2,16,34,2629	489	489,866,1056,1075,1088,1265,1452,1618,1817
439	439	R-HSA-3214841	PKMTs methylate histone lysines R-HSA-3214841	67	67,68,2629		
440	440	R-HSA-9821002	Chromatin modifications during the maternal to zygotic transition (MZT) R-HSA-9821002	186	8,186,2629		
441	441	R-HSA-9772573	Late SARS-CoV-2 Infection Events R-HSA-9772573	56	4,11,12,35,56,2629	545,1437	545,771,1308,1437,1695,2045
442	442	R-HSA-400253	Circadian Clock R-HSA-400253	2629	2629	965,1206,2018	965,1206,2018
443	443	R-HSA-9013026	RHOB GTPase cycle R-HSA-9013026	38	0,21,22,38,2629		
444	444	R-HSA-167172	Transcription of the HIV genome R-HSA-167172	172	4,11,12,80,150,172,2629	637,638,654,691,830,839,870,891,962	637,638,654,687,691,693,826,830,839,870,891,962,1049
445	445	R-HSA-2168880	Scavenging of heme from plasma R-HSA-2168880	291	20,291,2629		
446	446	R-HSA-2029481	FCGR activation R-HSA-2029481	155	2,10,155,2629		
447	447	R-HSA-9662360	Sensory processing of sound by inner hair cells of the cochlea R-HSA-9662360	400	26,400,2629		
448	448	R-HSA-9793380	Formation of paraxial mesoderm R-HSA-9793380	182	8,182,2629	560	560
449	449	R-HSA-8948751	Regulation of PTEN stability and activity R-HSA-8948751	164	0,53,70,164,2629		
450	450	R-HSA-380259	Loss of Nlp from mitotic centrosomes R-HSA-380259	451	24,30,101,102,381,451,2629		
451	451	R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284	381	24,30,101,102,381,2629	450	450
452	452	R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin R-HSA-174154	403	24,30,348,350,401,403,2629		
453	453	R-HSA-68616	Assembly of the ORC complex at the origin of replication R-HSA-68616	158	112,133,158,2629		
454	454	R-HSA-3906995	Diseases associated with O-glycosylation of proteins R-HSA-3906995	157	4,72,157,2629	748,1243,1267,1297,1949,2183,2195,2313,2319	748,1243,1267,1297,1949,2183,2195,2313,2319
455	455	R-HSA-5658442	Regulation of RAS by GAPs R-HSA-5658442	65	0,49,63,65,2629		
456	456	R-HSA-204005	COPII-mediated vesicle transport R-HSA-204005	139	3,6,20,27,54,114,139,2629		
457	457	R-HSA-5693571	Nonhomologous End-Joining (NHEJ) R-HSA-5693571	125	46,125,2629		
458	458	R-HSA-5685942	HDR through Homologous Recombination (HRR) R-HSA-5685942	177	46,125,168,177,2629	686,796	686,726,796,819,954
459	459	R-HSA-69615	G1/S DNA Damage Checkpoints R-HSA-69615	62	24,62,2629	466,598	465,466,542,591,593,595,598,2070,2084
460	460	R-HSA-1650814	Collagen biosynthesis and modifying enzymes R-HSA-1650814	336	55,336,2629	676	676
461	461	R-HSA-1169091	Activation of NF-kappaB in B cells R-HSA-1169091	380	2,14,128,380,2629		
462	462	R-HSA-427359	SIRT1 negatively regulates rRNA expression R-HSA-427359	246	5,111,246,2629		
463	463	R-HSA-73856	RNA Polymerase II Transcription Termination R-HSA-73856	7	5,7,2629		
464	464	R-HSA-9670095	Inhibition of DNA recombination at telomere R-HSA-9670095	232	24,166,232,2629		
465	465	R-HSA-69563	p53-Dependent G1 DNA Damage Response R-HSA-69563	466	24,62,459,466,2629	542,2084	542,591,2070,2084
466	466	R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint R-HSA-69580	459	24,62,459,2629	465	465,542,591,2070,2084
467	467	R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha R-HSA-1234176	411	13,15,411,2629		
468	468	R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 R-HSA-5625886	324	0,21,22,50,324,2629		
469	469	R-HSA-9614085	FOXO-mediated transcription R-HSA-9614085	9	5,7,9,2629	900,1246,1292,1514,1626	900,1246,1292,1514,1626
470	470	R-HSA-6802952	Signaling by BRAF and RAF1 fusions R-HSA-6802952	375	4,37,375,2629		
471	471	R-HSA-6782135	Dual incision in TC-NER R-HSA-6782135	392	46,240,392,2629		
472	472	R-HSA-8873719	RAB geranylgeranylation R-HSA-8873719	6	3,6,2629		
473	473	R-HSA-1268020	Mitochondrial protein import R-HSA-1268020	129	129,2629		
474	474	R-HSA-5358346	Hedgehog ligand biogenesis R-HSA-5358346	147	0,147,2629	1725	1725
475	475	R-HSA-5334118	DNA methylation R-HSA-5334118	111	5,111,2629		
476	476	R-HSA-211897	Cytochrome P450 - arranged by substrate type R-HSA-211897	263	1,82,263,2629	984,1069,1319,1480,1496,1898	984,1069,1319,1480,1496,1530,1898,2222,2586
477	477	R-HSA-373755	Semaphorin interactions R-HSA-373755	31	8,29,31,2629	1041,1173,1270,1290,1380	1041,1139,1173,1270,1290,1380,1772
478	478	R-HSA-9707564	Cytoprotection by HMOX1 R-HSA-9707564	89	13,15,89,2629	1953	1953
479	479	R-HSA-4608870	Asymmetric localization of PCP proteins R-HSA-4608870	327	0,47,152,327,2629		
480	480	R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA  R-HSA-1834949	10	2,10,2629	1109,1269,1328,1842,1982	1109,1228,1269,1328,1431,1842,1937,1982,2194,2384
481	481	R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER R-HSA-6782210	392	46,240,392,2629		
482	482	R-HSA-1442490	Collagen degradation R-HSA-1442490	161	55,161,2629		
483	483	R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C R-HSA-174084	348	24,30,348,350,2629		
484	484	R-HSA-173623	Classical antibody-mediated complement activation R-HSA-173623	436	2,10,223,384,436,2629		
485	485	R-HSA-375165	NCAM signaling for neurite out-growth R-HSA-375165	31	8,29,31,2629	705	705
486	486	R-HSA-9033241	Peroxisomal protein import R-HSA-9033241	129	129,2629	1852	1852
487	487	R-HSA-446219	Synthesis of substrates in N-glycan biosythesis R-HSA-446219	390	3,6,54,390,2629	827,1708,1869,1878,1956,2161,2298	827,1708,1869,1878,1956,2161,2298
488	488	R-HSA-1226099	Signaling by FGFR in disease R-HSA-1226099	37	4,37,2629	685,754,1077,1517	685,754,846,884,1077,1193,1214,1233,1479,1490,1517,1538,2153,2401,2457,2508,2518,2587,2595
489	489	R-HSA-450294	MAP kinase activation R-HSA-450294	233,249,264,280,303,438	2,10,16,34,127,154,222,224,233,234,247,249,253,264,268,277,280,299,302,303,438,2629	866,1056,1088,1265	866,1056,1075,1088,1265,1452,1618,1817
490	490	R-HSA-8986944	Transcriptional Regulation by MECP2 R-HSA-8986944	9	5,7,9,2629	853,1195,1729,1960,2173	853,1195,1729,1960,2173
491	491	R-HSA-913709	O-linked glycosylation of mucins R-HSA-913709	237	3,6,237,2629	1047	1047
492	492	R-HSA-73728	RNA Polymerase I Promoter Opening R-HSA-73728	245	5,242,245,2629		
493	493	R-HSA-73929	Base-Excision Repair, AP Site Formation R-HSA-73929	340	46,340,2629	513,554,2451	506,508,513,554,557,564,2451
494	494	R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling R-HSA-5607761	281	2,10,162,281,2629		
495	495	R-HSA-4086398	Ca2+ pathway R-HSA-4086398	152	0,47,152,2629		
496	496	R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes R-HSA-6796648	45	5,7,9,45,2629		
497	497	R-HSA-8943724	Regulation of PTEN gene transcription R-HSA-8943724	164	0,53,70,164,2629		
498	498	R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures R-HSA-2022090	336	55,336,2629	1207,1343	1207,1343
499	499	R-HSA-983189	Kinesins R-HSA-983189	124	25,124,2629		
500	500	R-HSA-5678895	Defective CFTR causes cystic fibrosis R-HSA-5678895	393	4,121,393,2629		
501	501	R-HSA-198725	Nuclear Events (kinase and transcription factor activation) R-HSA-198725	225	0,32,176,225,2629	740,1075,1817	740,1075,1452,1817
502	502	R-HSA-5690714	CD22 mediated BCR regulation R-HSA-5690714	128	2,14,128,2629		
503	503	R-HSA-163841	Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation R-HSA-163841	6	3,6,2629	1136,1424,1539,1741,2087	1136,1424,1539,1623,1627,1649,1741,2087
504	504	R-HSA-6790901	rRNA modification in the nucleus and cytosol R-HSA-6790901	106	19,94,106,2629		
505	505	R-HSA-977443	GABA receptor activation R-HSA-977443	93	41,69,93,2629	679	679,694,926,1362
506	506	R-HSA-110329	Cleavage of the damaged pyrimidine  R-HSA-110329	513	46,340,493,513,2629		
507	507	R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome R-HSA-5610785	229	0,147,229,2629		
508	508	R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine R-HSA-110328	513	46,340,493,513,2629		
509	509	R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577	362,369	24,30,130,148,179,362,369,2629		
510	510	R-HSA-5610783	Degradation of GLI2 by the proteasome R-HSA-5610783	229	0,147,229,2629		
511	511	R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S R-HSA-72662	204	3,60,204,206,2629	516	516
512	512	R-HSA-5610780	Degradation of GLI1 by the proteasome R-HSA-5610780	229	0,147,229,2629		
513	513	R-HSA-73928	Depyrimidination R-HSA-73928	493	46,340,493,2629	506,508	506,508
514	514	R-HSA-2142753	Arachidonic acid metabolism R-HSA-2142753	122	1,17,122,2629	1108,1331,1645,1651,1719,1840,1883,2380	1108,1331,1645,1651,1719,1840,1883,2380
515	515	R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins R-HSA-8866654	388	3,6,388,2629		
516	516	R-HSA-72649	Translation initiation complex formation R-HSA-72649	511	3,60,204,206,511,2629		
517	517	R-HSA-6784531	tRNA processing in the nucleus R-HSA-6784531	235	19,235,2629		
518	518	R-HSA-72702	Ribosomal scanning and start codon recognition R-HSA-72702	204	3,60,204,206,2629		
519	519	R-HSA-193648	NRAGE signals death through JNK R-HSA-193648	407	0,142,294,407,2629		
520	520	R-HSA-5387390	Hh mutants abrogate ligand secretion R-HSA-5387390	37	4,37,2629	550,2020	550,2020
521	521	R-HSA-5218859	Regulated Necrosis R-HSA-5218859	92	92,2629	864,969	857,864,969,1552
522	522	R-HSA-5676590	NIK-->noncanonical NF-kB signaling R-HSA-5676590	278	2,16,278,2629		
523	523	R-HSA-3000171	Non-integrin membrane-ECM interactions R-HSA-3000171	55	55,2629	973	973
524	524	R-HSA-9013406	RHOQ GTPase cycle R-HSA-9013406	38	0,21,22,38,2629		
525	525	R-HSA-351202	Metabolism of polyamines R-HSA-351202	44	1,44,2629	604,2131,2272	604,2131,2272
526	526	R-HSA-418990	Adherens junctions interactions R-HSA-418990	334	138,214,334,2629	849,1851	849,855,923,1577,1592,1597,1826,1832,1851
527	527	R-HSA-2644603	Signaling by NOTCH1 in Cancer R-HSA-2644603	37	4,37,2629	530,536,1318,1847,1962	530,532,535,536,1304,1318,1798,1847,1962,1969
528	528	R-HSA-75955	RNA Polymerase II Transcription Elongation R-HSA-75955	7	5,7,2629	534,836	534,836
529	529	R-HSA-917937	Iron uptake and transport R-HSA-917937	18	18,2629	886	886
530	530	R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer R-HSA-2644602	527	4,37,527,2629	532	532
531	531	R-HSA-72187	mRNA 3'-end processing R-HSA-72187	64	19,64,2629		
532	532	R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants R-HSA-2644606	530	4,37,527,530,2629		
533	533	R-HSA-1236394	Signaling by ERBB4 R-HSA-1236394	32	0,32,2629	854,1398,1603,1646	854,1398,1603,1646
534	534	R-HSA-112382	Formation of RNA Pol II elongation complex  R-HSA-112382	528	5,7,528,2629		
535	535	R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants R-HSA-2894862	536	4,37,527,536,2629		
536	536	R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer R-HSA-2894858	527	4,37,527,2629	535	535
537	537	R-HSA-186797	Signaling by PDGF R-HSA-186797	32	0,32,2629	921	921
538	538	R-HSA-380108	Chemokine receptors bind chemokines R-HSA-380108	103	0,23,36,48,103,2629		
539	539	R-HSA-6799198	Complex I biogenesis R-HSA-6799198	270	1,120,188,270,2629		
540	540	R-HSA-1660662	Glycosphingolipid metabolism R-HSA-1660662	251	1,17,251,2629	745,1166	745,1166
541	541	R-HSA-447115	Interleukin-12 family signaling R-HSA-447115	34	2,16,34,2629	648,1503,1522,1683	648,753,1503,1522,1683
542	542	R-HSA-69541	Stabilization of p53 R-HSA-69541	465	24,62,459,465,466,2629	591	591
543	543	R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497	15	13,15,2629		
544	544	R-HSA-75893	TNF signaling R-HSA-75893	142	0,142,2629	631,833,1007,1902	631,833,1007,1902
545	545	R-HSA-9694635	Translation of Structural Proteins R-HSA-9694635	441	4,11,12,35,56,441,2629	771,1308,1695,2045	771,1308,1695,2045
546	546	R-HSA-4641258	Degradation of DVL R-HSA-4641258	79	0,47,79,2629		
547	547	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism R-HSA-1638091	192	1,58,192,2629	869,982,1024	869,982,1024
548	548	R-HSA-432722	Golgi Associated Vesicle Biogenesis R-HSA-432722	431	20,27,431,2629		
549	549	R-HSA-429914	Deadenylation-dependent mRNA decay R-HSA-429914	19	19,2629	1016,1287,1313	1016,1287,1313
550	550	R-HSA-5362768	Hh mutants are degraded by ERAD R-HSA-5362768	520	4,37,520,2629		
551	551	R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways R-HSA-168643	10	2,10,2629	781,1124	781,1124,1264,2168,2174,2281
552	552	R-HSA-6794361	Neurexins and neuroligins R-HSA-6794361	354	41,354,2629		
553	553	R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA R-HSA-450408	355	19,355,2629		
554	554	R-HSA-73927	Depurination R-HSA-73927	493	46,340,493,2629	557,564	557,564
555	555	R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis R-HSA-2151201	313	61,313,2629		
556	556	R-HSA-109606	Intrinsic Pathway for Apoptosis R-HSA-109606	119	92,119,2629	902,1149,1690,2094,2230,2244	902,1149,1320,1411,1535,1542,1658,1690,1752,1812,1821,1850,1875,1998,2094,2117,2197,2230,2244
557	557	R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine R-HSA-110330	554	46,340,493,554,2629		
558	558	R-HSA-9013409	RHOJ GTPase cycle R-HSA-9013409	38	0,21,22,38,2629		
559	559	R-HSA-936837	Ion transport by P-type ATPases R-HSA-936837	116	18,116,2629		
560	560	R-HSA-9824272	Somitogenesis R-HSA-9824272	448	8,182,448,2629		
561	561	R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis R-HSA-8854050	102	24,30,101,102,2629		
562	562	R-HSA-9639288	Amino acids regulate mTORC1 R-HSA-9639288	135	13,15,135,2629		
563	563	R-HSA-8941858	Regulation of RUNX3 expression and activity R-HSA-8941858	298	5,7,9,298,2629		
564	564	R-HSA-110331	Cleavage of the damaged purine R-HSA-110331	554	46,340,493,554,2629		
565	565	R-HSA-4641257	Degradation of AXIN R-HSA-4641257	79	0,47,79,2629		
566	566	R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle R-HSA-71406	120	1,120,2629	865,1078,2130	865,1078,1272,2130
567	567	R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF) R-HSA-1655829	140	1,17,140,2629	710	710
568	568	R-HSA-9662361	Sensory processing of sound by outer hair cells of the cochlea R-HSA-9662361	400	26,400,2629	1981	1981
569	569	R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1 R-HSA-174113	378	24,30,348,350,378,2629		
570	570	R-HSA-191859	snRNP Assembly R-HSA-191859	576	19,576,2629		
571	571	R-HSA-5620924	Intraflagellar transport R-HSA-5620924	100	61,100,2629		
572	572	R-HSA-9604323	Negative regulation of NOTCH4 signaling R-HSA-9604323	371	0,74,371,2629		
573	573	R-HSA-8848021	Signaling by PTK6 R-HSA-8848021	577	0,577,2629	1373,1419,1642,1891,1913,1920,1959,2033,2177	1373,1419,1642,1891,1913,1920,1959,2033,2177
574	574	R-HSA-180585	Vif-mediated degradation of APOBEC3G R-HSA-180585	180	4,11,12,80,180,2629		
575	575	R-HSA-74751	Insulin receptor signalling cascade R-HSA-74751	373	0,32,373,2629	632,1635,1974	632,664,1635,1831,1974,2088,2234,2302
576	576	R-HSA-194441	Metabolism of non-coding RNA R-HSA-194441	19	19,2629	570	570
577	577	R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927	0	0,2629	573	573,1373,1419,1642,1891,1913,1920,1959,2033,2177
578	578	R-HSA-112040	G-protein mediated events R-HSA-112040	333	0,23,28,51,333,2629	621,1362,1579	621,770,795,803,1129,1194,1362,1579,1616,2050,2283
579	579	R-HSA-5578775	Ion homeostasis R-HSA-5578775	181	98,181,2629		
580	580	R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192	32	0,32,2629	588	588,600,632,664,1696,1831,2088,2234,2302
581	581	R-HSA-9013405	RHOD GTPase cycle R-HSA-9013405	38	0,21,22,38,2629		
582	582	R-HSA-383280	Nuclear Receptor transcription pathway R-HSA-383280	9	5,7,9,2629		
583	583	R-HSA-2980766	Nuclear Envelope Breakdown R-HSA-2980766	159	24,30,40,159,2629	783,1337,1803	783,1337,1803
584	584	R-HSA-1660499	Synthesis of PIPs at the plasma membrane R-HSA-1660499	367	1,17,91,367,2629		
585	585	R-HSA-1461973	Defensins R-HSA-1461973	286	2,10,286,2629	690,1582	690,1582
586	586	R-HSA-177929	Signaling by EGFR R-HSA-177929	32	0,32,2629	880,1239,1360,1455,1675	880,1239,1360,1455,1675
587	587	R-HSA-169911	Regulation of Apoptosis R-HSA-169911	119	92,119,2629	617,2321	617,2321
588	588	R-HSA-2428924	IGF1R signaling cascade R-HSA-2428924	580	0,32,580,2629	600,1696	600,632,664,1696,1831,2088,2234,2302
589	589	R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic R-HSA-6811436	173	20,27,97,173,2629		
590	590	R-HSA-6781823	Formation of TC-NER Pre-Incision Complex R-HSA-6781823	392	46,240,392,2629		
591	591	R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1 R-HSA-349425	542	24,62,459,465,466,542,2629		
592	592	R-HSA-180534	Vpu mediated degradation of CD4 R-HSA-180534	180	4,11,12,80,180,2629		
593	593	R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A R-HSA-69601	595	24,62,459,595,598,2629		
594	594	R-HSA-75153	Apoptotic execution phase R-HSA-75153	119	92,119,2629	749,1442,2326	749,1442,1508,1553,2178,2326
595	595	R-HSA-69610	p53-Independent DNA Damage Response R-HSA-69610	598	24,62,459,598,2629	593	593
596	596	R-HSA-9762114	GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 R-HSA-9762114	297	13,15,89,195,297,2629		
597	597	R-HSA-445717	Aquaporin-mediated transport R-HSA-445717	18	18,2629	677,1448,2225	677,1448,2225
598	598	R-HSA-69613	p53-Independent G1/S DNA damage checkpoint R-HSA-69613	459	24,62,459,2629	595	593,595
599	599	R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex R-HSA-72695	204	3,60,204,206,2629		
600	600	R-HSA-2428928	IRS-related events triggered by IGF1R R-HSA-2428928	588	0,32,580,588,2629	632	632,664,1831,2088,2234,2302
601	601	R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D R-HSA-75815	130	24,30,130,2629		
602	602	R-HSA-5654736	Signaling by FGFR1 R-HSA-5654736	347	0,32,347,2629	842,877,1205,1409	842,877,1046,1106,1123,1205,1268,1281,1388,1409,1714,2214
603	603	R-HSA-157858	Gap junction trafficking and regulation R-HSA-157858	27	20,27,2629	627,2135	627,747,1113,1154,1461,1548,2135,2140,2164
604	604	R-HSA-350562	Regulation of ornithine decarboxylase (ODC) R-HSA-350562	525	1,44,525,2629		
605	605	R-HSA-112310	Neurotransmitter release cycle R-HSA-112310	69	41,69,2629	1030,1058,1190,1212,1222,1242	1030,1058,1190,1212,1222,1242,2095,2229,2247
606	606	R-HSA-3928665	EPH-ephrin mediated repulsion of cells R-HSA-3928665	328	8,29,31,328,2629		
607	607	R-HSA-5620920	Cargo trafficking to the periciliary membrane R-HSA-5620920	100	61,100,2629	1051,1102,1980,2158	1051,1102,1980,2158
608	608	R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer R-HSA-2173793	9,317	0,5,7,9,197,317,2629	790,868	790,868
609	609	R-HSA-180786	Extension of Telomeres R-HSA-180786	232	24,166,232,2629	823,1053	823,975,1053,1167,1235,1413
610	610	R-HSA-171306	Packaging Of Telomere Ends R-HSA-171306	232	24,166,232,2629		
611	611	R-HSA-9675135	Diseases of DNA repair R-HSA-9675135	4	4,2629	723,2008,2010	722,723,801,995,1001,1009,1019,1036,2008,2010,2186,2236,2238,2258,2280,2318,2320,2333,2341,2391,2404,2414,2416,2474,2490,2524,2537,2540,2583,2585,2589
612	612	R-HSA-9754678	SARS-CoV-2 modulates host translation machinery R-HSA-9754678	95	4,11,12,35,56,95,2629		
613	613	R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes) R-HSA-1236978	258	2,14,43,258,2629		
614	614	R-HSA-381070	IRE1alpha activates chaperones R-HSA-381070	322	13,15,322,2629	629	629
615	615	R-HSA-1227986	Signaling by ERBB2 R-HSA-1227986	32	0,32,2629	922,1087,1262,1301,1315,1419,1978,2072,2079	922,1087,1262,1301,1315,1419,1444,1978,2072,2079
616	616	R-HSA-373752	Netrin-1 signaling R-HSA-373752	31	8,29,31,2629	1389,1571,1628,1758	1389,1571,1628,1758
617	617	R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation R-HSA-211733	587	92,119,587,2629		
618	618	R-HSA-3214842	HDMs demethylate histones R-HSA-3214842	67	67,68,2629		
619	619	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism R-HSA-1793185	192	1,58,192,2629	982,1135,1361,1575	982,1135,1361,1575
620	620	R-HSA-72165	mRNA Splicing - Minor Pathway R-HSA-72165	90	19,64,90,2629		
621	621	R-HSA-112043	PLC beta mediated events R-HSA-112043	578	0,23,28,51,333,578,2629	770	770,795,803,1129,1194,1616,2050,2283
622	622	R-HSA-9707616	Heme signaling R-HSA-9707616	15	13,15,2629		
623	623	R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network R-HSA-6811440	97	20,27,97,2629		
624	624	R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes R-HSA-6791312	45	5,7,9,45,2629	1114,1197,1395	1114,1197,1395
625	625	R-HSA-9012852	Signaling by NOTCH3 R-HSA-9012852	74	0,74,2629	1013,1018	1013,1018,1769
626	626	R-HSA-437239	Recycling pathway of L1 R-HSA-437239	202	8,29,31,202,2629		
627	627	R-HSA-190828	Gap junction trafficking R-HSA-190828	603	20,27,603,2629	747,1461	747,1113,1154,1461,1548,2140,2164
628	628	R-HSA-6806667	Metabolism of fat-soluble vitamins R-HSA-6806667	107	1,107,2629	662,2165,2561	662,2165,2561
629	629	R-HSA-381038	XBP1(S) activates chaperone genes R-HSA-381038	614	13,15,322,614,2629		
630	630	R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947	419	0,74,419,2629		
631	631	R-HSA-5357905	Regulation of TNFR1 signaling R-HSA-5357905	544	0,142,544,2629		
632	632	R-HSA-112399	IRS-mediated signalling R-HSA-112399	575,600	0,32,373,575,580,588,600,2629	664,1831	664,1831,2088,2234,2302
633	633	R-HSA-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988	34	2,16,34,2629	952,1091	952,1091
634	634	R-HSA-1483249	Inositol phosphate metabolism R-HSA-1483249	1	1,2629	993,1372,1591,2102,2551	993,1372,1591,2102,2551
635	635	R-HSA-418597	G alpha (z) signalling events R-HSA-418597	28	0,23,28,2629		
636	636	R-HSA-73893	DNA Damage Bypass R-HSA-73893	46	46,2629	739,905	739,848,905,1174,1230,1260,1285
637	637	R-HSA-167162	RNA Polymerase II HIV Promoter Escape R-HSA-167162	444	4,11,12,80,150,172,444,2629		
638	638	R-HSA-167161	HIV Transcription Initiation R-HSA-167161	444	4,11,12,80,150,172,444,2629		
639	639	R-HSA-75953	RNA Polymerase II Transcription Initiation R-HSA-75953	643	5,7,643,2629		
640	640	R-HSA-69236	G1 Phase R-HSA-69236	148	24,30,148,2629	644	644,2012
641	641	R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening R-HSA-73779	7	5,7,2629		
642	642	R-HSA-73776	RNA Polymerase II Promoter Escape R-HSA-73776	643	5,7,643,2629		
643	643	R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance R-HSA-76042	7	5,7,2629	639,642	639,642
644	644	R-HSA-69231	Cyclin D associated events in G1 R-HSA-69231	640	24,30,148,640,2629	2012	2012
645	645	R-HSA-73762	RNA Polymerase I Transcription Initiation R-HSA-73762	245	5,242,245,2629		
646	646	R-HSA-2173789	TGF-beta receptor signaling activates SMADs R-HSA-2173789	317	0,197,317,2629	992	992
647	647	R-HSA-4570464	SUMOylation of RNA binding proteins R-HSA-4570464	117	3,6,110,117,2629		
648	648	R-HSA-9020591	Interleukin-12 signaling R-HSA-9020591	541	2,16,34,541,2629	753	753
649	649	R-HSA-9024446	NR1H2 and NR1H3-mediated signaling R-HSA-9024446	59	0,59,2629	759,1688,1701,1934,1951,1989	759,1688,1701,1934,1951,1989
650	650	R-HSA-9717189	Sensory perception of taste R-HSA-9717189	26	26,2629	711,1890,2224	711,1890,2224
651	651	R-HSA-4615885	SUMOylation of DNA replication proteins R-HSA-4615885	117	3,6,110,117,2629		
652	652	R-HSA-9830369	Kidney development R-HSA-9830369	8	8,2629	1117,1215,1456	1117,1215,1456
653	653	R-HSA-8955332	Carboxyterminal post-translational modifications of tubulin R-HSA-8955332	6	3,6,2629		
654	654	R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat R-HSA-167152	444	4,11,12,80,150,172,444,2629		
655	655	R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955	375	4,37,375,2629		
656	656	R-HSA-194068	Bile acid and bile salt metabolism R-HSA-194068	140	1,17,140,2629	822,1211	822,1025,1211,1344,1375
657	657	R-HSA-9649948	Signaling downstream of RAS mutants R-HSA-9649948	660	4,37,375,660,2629		
658	658	R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants R-HSA-6802946	375	4,37,375,2629		
659	659	R-HSA-6783783	Interleukin-10 signaling R-HSA-6783783	34	2,16,34,2629		
660	660	R-HSA-6802949	Signaling by RAS mutants R-HSA-6802949	375	4,37,375,2629	657,2129	657,2129,2189,2192
661	661	R-HSA-9634597	GPER1 signaling R-HSA-9634597	136	0,23,28,136,2629		
662	662	R-HSA-975634	Retinoid metabolism and transport R-HSA-975634	282,628	1,26,107,282,628,2629		
663	663	R-HSA-9749641	Aspirin ADME R-HSA-9749641	244	244,2629		
664	664	R-HSA-109704	PI3K Cascade R-HSA-109704	632	0,32,373,575,580,588,600,632,2629	2088,2302	2088,2234,2302
665	665	R-HSA-3899300	SUMOylation of transcription cofactors R-HSA-3899300	117	3,6,110,117,2629		
666	666	R-HSA-8854214	TBC/RABGAPs R-HSA-8854214	199	20,27,199,2629		
667	667	R-HSA-9609736	Assembly and cell surface presentation of NMDA receptors R-HSA-9609736	311	41,69,93,311,2629		
668	668	R-HSA-1566948	Elastic fibre formation R-HSA-1566948	55	55,2629	769	769
669	669	R-HSA-168325	Viral Messenger RNA Synthesis R-HSA-168325	169	4,11,12,134,169,2629		
670	670	R-HSA-9646399	Aggrephagy R-HSA-9646399	372	146,170,372,2629		
671	671	R-HSA-6811438	Intra-Golgi traffic R-HSA-6811438	97	20,27,97,2629		
672	672	R-HSA-445989	TAK1-dependent IKK and NF-kappa-B activation   R-HSA-445989	226,233,249,264,280,303	2,10,16,34,127,144,154,222,224,226,233,234,247,249,253,264,268,277,280,299,302,303,2629	1221	1221
673	673	R-HSA-2172127	DAP12 interactions R-HSA-2172127	10	2,10,2629	929	929
674	674	R-HSA-451927	Interleukin-2 family signaling R-HSA-451927	34	2,16,34,2629	952,1397,1476,1584,1663	952,1397,1476,1584,1663
675	675	R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes R-HSA-5633008	45	5,7,9,45,2629	1146,1394,1505,1506	1146,1394,1505,1506
676	676	R-HSA-8948216	Collagen chain trimerization R-HSA-8948216	460	55,336,460,2629		
677	677	R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins R-HSA-432040	597	18,597,2629		
678	678	R-HSA-5675221	Negative regulation of MAPK pathway R-HSA-5675221	65	0,49,63,65,2629	1905	1905
679	679	R-HSA-977444	GABA B receptor activation R-HSA-977444	505	41,69,93,505,2629	694	694,926,1362
680	680	R-HSA-5696395	Formation of Incision Complex in GG-NER R-HSA-5696395	364	46,240,364,2629		
681	681	R-HSA-1433557	Signaling by SCF-KIT R-HSA-1433557	32	0,32,2629	1273	1273
682	682	R-HSA-1296072	Voltage gated Potassium channels R-HSA-1296072	267	41,267,2629		
683	683	R-HSA-9696270	RND2 GTPase cycle R-HSA-9696270	38	0,21,22,38,2629		
684	684	R-HSA-445355	Smooth Muscle Contraction R-HSA-445355	98	98,2629		
685	685	R-HSA-5655253	Signaling by FGFR2 in disease R-HSA-5655253	488	4,37,488,2629	846	846,1193,1233,2457,2595
686	686	R-HSA-5693579	Homologous DNA Pairing and Strand Exchange R-HSA-5693579	458	46,125,168,177,458,2629	726	726
687	687	R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript R-HSA-167246	691	4,11,12,80,150,172,444,691,2629	693	693
688	688	R-HSA-6782315	tRNA modification in the nucleus and cytosol R-HSA-6782315	235	19,235,2629	1873	1873
689	689	R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production R-HSA-9660821	174	4,11,84,85,174,175,2629		
690	690	R-HSA-1461957	Beta defensins R-HSA-1461957	585	2,10,286,585,2629		
691	691	R-HSA-167169	HIV Transcription Elongation R-HSA-167169	444	4,11,12,80,150,172,444,2629	687,826,1049	687,693,826,1049
692	692	R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts R-HSA-159234	368	19,64,368,2629	707,786,809	707,786,809
693	693	R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat R-HSA-167200	687	4,11,12,80,150,172,444,687,691,2629		
694	694	R-HSA-991365	Activation of GABAB receptors R-HSA-991365	679	41,69,93,505,679,2629	926,1362	926,1362
695	695	R-HSA-5362517	Signaling by Retinoic Acid R-HSA-5362517	59	0,59,2629	1082	1082
696	696	R-HSA-425397	Transport of vitamins, nucleosides, and related molecules R-HSA-425397	73	18,73,2629	1487,1527,1678,1773	1487,1527,1678,1773
697	697	R-HSA-3928662	EPHB-mediated forward signaling R-HSA-3928662	328	8,29,31,328,2629		
698	698	R-HSA-379724	tRNA Aminoacylation R-HSA-379724	60	3,60,2629	1038,1127	1038,1127
699	699	R-HSA-9696264	RND3 GTPase cycle R-HSA-9696264	38	0,21,22,38,2629		
700	700	R-HSA-3769402	Deactivation of the beta-catenin transactivating complex R-HSA-3769402	79	0,47,79,2629		
701	701	R-HSA-9035034	RHOF GTPase cycle R-HSA-9035034	38	0,21,22,38,2629		
702	702	R-HSA-9821993	Replacement of protamines by nucleosomes in the male pronucleus R-HSA-9821993	186	8,186,2629		
703	703	R-HSA-9772755	Formation of WDR5-containing histone-modifying complexes R-HSA-9772755	111	5,111,2629		
704	704	R-HSA-9696273	RND1 GTPase cycle R-HSA-9696273	38	0,21,22,38,2629		
705	705	R-HSA-419037	NCAM1 interactions R-HSA-419037	485	8,29,31,485,2629		
706	706	R-HSA-375280	Amine ligand-binding receptors R-HSA-375280	48	0,23,36,48,2629	1481,1656,1954,1973,2066	1481,1656,1954,1973,2066
707	707	R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript R-HSA-159231	692	19,64,368,692,2629		
708	708	R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion R-HSA-381676	398	1,248,398,2629		
709	709	R-HSA-186712	Regulation of beta-cell development R-HSA-186712	8	8,2629	1107,1271,1726,1923	1107,1271,1726,1923,2056
710	710	R-HSA-2426168	Activation of gene expression by SREBF (SREBP) R-HSA-2426168	567	1,17,140,567,2629		
711	711	R-HSA-9717207	Sensory perception of sweet, bitter, and umami (glutamate) taste R-HSA-9717207	650	26,650,2629		
712	712	R-HSA-165159	MTOR signalling R-HSA-165159	0	0,2629	911,1043,2146	911,1043,2146
713	713	R-HSA-74158	RNA Polymerase III Transcription R-HSA-74158	5	5,2629	715,789,1063,1223	715,789,943,945,960,1063,1223
714	714	R-HSA-8853884	Transcriptional Regulation by VENTX R-HSA-8853884	9	5,7,9,2629		
715	715	R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476	713	5,713,2629		
716	716	R-HSA-9656223	Signaling by RAF1 mutants R-HSA-9656223	375	4,37,375,2629		
717	717	R-HSA-168276	NS1 Mediated Effects on Host Pathways R-HSA-168276	134	4,11,12,134,2629	2342,2481	2342,2481
718	718	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism R-HSA-3560782	157	4,72,157,2629	1138,1147,1158,1347,1357,1742,1745,1747,1749,1756,1764,2431,2445,2553,2566	1138,1147,1158,1347,1357,1742,1745,1747,1749,1756,1764,2431,2445,2553,2566
719	719	R-HSA-1489509	DAG and IP3 signaling R-HSA-1489509	53	0,53,2629	795	795,803,1129,1194,1616,2050
720	720	R-HSA-5696400	Dual Incision in GG-NER R-HSA-5696400	364	46,240,364,2629		
721	721	R-HSA-9692916	SARS-CoV-1 activates/modulates innate immune responses R-HSA-9692916	285	4,11,12,35,156,285,2629		
722	722	R-HSA-9701190	Defective homologous recombination repair (HRR) due to BRCA2 loss of function R-HSA-9701190	723	4,611,723,2629	801,1036,2320,2341	801,1036,2320,2341
723	723	R-HSA-9675136	Diseases of DNA Double-Strand Break Repair R-HSA-9675136	611	4,611,2629	722,1001,1009,2238,2318	722,801,995,1001,1009,1019,1036,2238,2318,2320,2341
724	724	R-HSA-8875878	MET promotes cell motility R-HSA-8875878	389	0,32,389,2629	896,1519,1967	896,1519,1967
725	725	R-HSA-5654743	Signaling by FGFR4 R-HSA-5654743	347	0,32,347,2629	876,961,1404	876,961,1083,1130,1151,1268,1332,1404,2159
726	726	R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange R-HSA-5693616	686	46,125,168,177,458,686,2629		
727	727	R-HSA-5674135	MAP2K and MAPK activation R-HSA-5674135	65	0,49,63,65,2629		
728	728	R-HSA-5654741	Signaling by FGFR3 R-HSA-5654741	347	0,32,347,2629	915,994,1443	915,994,1144,1202,1216,1268,1408,1427,1443,1796
729	729	R-HSA-8853659	RET signaling R-HSA-8853659	31	8,29,31,2629		
730	730	R-HSA-9013420	RHOU GTPase cycle R-HSA-9013420	38	0,21,22,38,2629		
731	731	R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade) R-HSA-140877	25	25,2629	1061,1074,1975	1061,1074,1975
732	732	R-HSA-1483166	Synthesis of PA R-HSA-1483166	185	1,17,91,185,2629		
733	733	R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors) R-HSA-420499	36	0,23,36,2629		
734	734	R-HSA-5689896	Ovarian tumor domain proteases R-HSA-5689896	57	3,6,57,2629		
735	735	R-HSA-202433	Generation of second messenger molecules R-HSA-202433	196	2,14,196,2629		
736	736	R-HSA-76009	Platelet Aggregation (Plug Formation) R-HSA-76009	71	25,71,2629	966,2115	966,1324,1333,2115
737	737	R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis R-HSA-390471	329	3,290,329,2629		
738	738	R-HSA-6783310	Fanconi Anemia Pathway R-HSA-6783310	46	46,2629		
739	739	R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template R-HSA-110313	636	46,636,2629	848,1174,1230,1260,1285	848,1174,1230,1260,1285
740	740	R-HSA-9031628	NGF-stimulated transcription R-HSA-9031628	501	0,32,176,225,501,2629		
741	741	R-HSA-5173214	O-glycosylation of TSR domain-containing proteins R-HSA-5173214	237	3,6,237,2629		
742	742	R-HSA-3232142	SUMOylation of ubiquitinylation proteins R-HSA-3232142	117	3,6,110,117,2629		
743	743	R-HSA-3371571	HSF1-dependent transactivation R-HSA-3371571	279	13,15,279,2629	939	939
744	744	R-HSA-75105	Fatty acyl-CoA biosynthesis R-HSA-75105	122	1,17,122,2629	1023	1023
745	745	R-HSA-9840310	Glycosphingolipid catabolism R-HSA-9840310	540	1,17,251,540,2629		
746	746	R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding R-HSA-6814122	329	3,290,329,2629		
747	747	R-HSA-190861	Gap junction assembly R-HSA-190861	627	20,27,603,627,2629	1113,2140,2164	1113,1154,2140,2164
748	748	R-HSA-5083635	Defective B3GALTL causes PpS R-HSA-5083635	454	4,72,157,454,2629		
749	749	R-HSA-111465	Apoptotic cleavage of cellular proteins R-HSA-111465	594	92,119,594,2629	1508,1553,2178	1508,1553,2178
750	750	R-HSA-73933	Resolution of Abasic Sites (AP sites) R-HSA-73933	340	46,340,2629	1002,1669,1788,2029	1002,1110,1669,1748,1788,2029,2243
751	751	R-HSA-8979227	Triglyceride metabolism R-HSA-8979227	17	1,17,2629	1031,1401	1031,1401
752	752	R-HSA-9675126	Diseases of mitotic cell cycle R-HSA-9675126	4	4,2629	782,2237	782,1159,1236,1257,2237,2251,2256,2296,2297,2547
753	753	R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation R-HSA-8950505	648	2,16,34,541,648,2629		
754	754	R-HSA-5655302	Signaling by FGFR1 in disease R-HSA-5655302	488	4,37,488,2629	884	884,1214,1538,2153,2401
755	755	R-HSA-5696394	DNA Damage Recognition in GG-NER R-HSA-5696394	364	46,240,364,2629		
756	756	R-HSA-9607240	FLT3 Signaling R-HSA-9607240	16	2,16,2629	1340,1836,1872	1340,1836,1872
757	757	R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors R-HSA-8864260	9	5,7,9,2629	1346,1510,1636,1942,2006,2049	1346,1510,1636,1942,2006,2049
758	758	R-HSA-1660661	Sphingolipid de novo biosynthesis R-HSA-1660661	251	1,17,251,2629		
759	759	R-HSA-9029569	NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux R-HSA-9029569	649	0,59,649,2629		
760	760	R-HSA-5689901	Metalloprotease DUBs R-HSA-5689901	57	3,6,57,2629		
761	761	R-HSA-8964043	Plasma lipoprotein clearance R-HSA-8964043	409	18,409,2629	1163,1298,1895,1943,1947	1163,1298,1895,1943,1947
762	762	R-HSA-176033	Interactions of Vpr with host cellular proteins R-HSA-176033	180	4,11,12,80,180,2629	818,2217	818,2217
763	763	R-HSA-9013424	RHOV GTPase cycle R-HSA-9013424	38	0,21,22,38,2629		
764	764	R-HSA-9013407	RHOH GTPase cycle R-HSA-9013407	38	0,21,22,38,2629		
765	765	R-HSA-3299685	Detoxification of Reactive Oxygen Species R-HSA-3299685	89	13,15,89,2629		
766	766	R-HSA-6806003	Regulation of TP53 Expression and Degradation R-HSA-6806003	132	5,7,9,45,132,2629	779,2290	779,2290
767	767	R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289	122	1,17,122,2629	1565,1900,1933	1565,1900,1909,1926,1933,1935,1964,1970,2191,2218
768	768	R-HSA-176187	Activation of ATR in response to replication stress R-HSA-176187	126	24,62,126,2629		
769	769	R-HSA-2129379	Molecules associated with elastic fibres R-HSA-2129379	668	55,668,2629		
770	770	R-HSA-111996	Ca-dependent events R-HSA-111996	621	0,23,28,51,333,578,621,2629	795,2283	795,803,1129,1194,1616,2050,2283
771	771	R-HSA-9694548	Maturation of spike protein R-HSA-9694548	545	4,11,12,35,56,441,545,2629		
772	772	R-HSA-9772572	Early SARS-CoV-2 Infection Events R-HSA-9772572	56	4,11,12,35,56,2629	1191,1386,2061	1191,1386,2061,2067,2511
773	773	R-HSA-5685938	HDR through Single Strand Annealing (SSA) R-HSA-5685938	177	46,125,168,177,2629		
774	774	R-HSA-9735869	SARS-CoV-1 modulates host translation machinery R-HSA-9735869	285	4,11,12,35,156,285,2629		
775	775	R-HSA-177243	Interactions of Rev with host cellular proteins R-HSA-177243	180	4,11,12,80,180,2629	804,811	804,811
776	776	R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known R-HSA-8939243	76	5,7,9,76,2629		
777	777	R-HSA-1222556	ROS and RNS production in phagocytes R-HSA-1222556	10	2,10,2629	2277	2277
778	778	R-HSA-156590	Glutathione conjugation R-HSA-156590	243	1,82,243,2629	1474	1474
779	779	R-HSA-6804757	Regulation of TP53 Degradation R-HSA-6804757	766	5,7,9,45,132,766,2629		
780	780	R-HSA-1638074	Keratan sulfate/keratin metabolism R-HSA-1638074	192	1,58,192,2629	936,1314	936,1314
781	781	R-HSA-168638	NOD1/2 Signaling Pathway R-HSA-168638	551	2,10,551,2629		
782	782	R-HSA-9687139	Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139	752	4,752,2629	1159,1236	1159,1236,1257,2547
783	783	R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854	583	24,30,40,159,583,2629		
784	784	R-HSA-6802948	Signaling by high-kinase activity BRAF mutants R-HSA-6802948	375	4,37,375,2629		
785	785	R-HSA-1266695	Interleukin-7 signaling R-HSA-1266695	34	2,16,34,2629		
786	786	R-HSA-159230	Transport of the SLBP Dependant Mature mRNA R-HSA-159230	692	19,64,368,692,2629		
787	787	R-HSA-390522	Striated Muscle Contraction R-HSA-390522	98	98,2629		
788	788	R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs R-HSA-5663213	50	0,21,22,50,2629		
789	789	R-HSA-76046	RNA Polymerase III Transcription Initiation R-HSA-76046	713	5,713,2629	943,945,960	943,945,960
790	790	R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription R-HSA-2173796	608	0,5,7,9,197,317,608,2629		
791	791	R-HSA-196071	Metabolism of steroid hormones R-HSA-196071	140	1,17,140,2629	1462,1516,1625,1859,1860	1462,1516,1625,1859,1860
792	792	R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle R-HSA-532668	54	3,6,54,2629	981	981,1118
793	793	R-HSA-9706574	RHOBTB GTPase Cycle R-HSA-9706574	38	0,21,22,38,2629	1055,1065	1055,1065
794	794	R-HSA-432720	Lysosome Vesicle Biogenesis R-HSA-432720	431	20,27,431,2629		
795	795	R-HSA-111997	CaM pathway R-HSA-111997	719,770	0,23,28,51,53,333,578,621,719,770,2629	803	803,1129,1194,1616,2050
796	796	R-HSA-5693537	Resolution of D-Loop Structures R-HSA-5693537	458	46,125,168,177,458,2629	819,954	819,954
797	797	R-HSA-1296065	Inwardly rectifying K+ channels R-HSA-1296065	267	41,267,2629	920,2065,2098,2182	920,927,2065,2098,2182
798	798	R-HSA-9833109	Evasion by RSV of host interferon responses R-HSA-9833109	289	4,11,12,205,289,2629		
799	799	R-HSA-114604	GPVI-mediated activation cascade R-HSA-114604	71	25,71,2629		
800	800	R-HSA-2559585	Oncogene Induced Senescence R-HSA-2559585	104	13,15,104,2629		
801	801	R-HSA-9709570	Impaired BRCA2 binding to RAD51 R-HSA-9709570	722	4,611,722,723,2629		
802	802	R-HSA-4085377	SUMOylation of SUMOylation proteins R-HSA-4085377	117	3,6,110,117,2629		
803	803	R-HSA-111933	Calmodulin induced events R-HSA-111933	795	0,23,28,51,53,333,578,621,719,770,795,2629	1129,1616,2050	1129,1194,1616,2050
804	804	R-HSA-165054	Rev-mediated nuclear export of HIV RNA R-HSA-165054	172,775	4,11,12,80,150,172,180,775,2629		
805	805	R-HSA-9725371	Nuclear events stimulated by ALK signaling in cancer R-HSA-9725371	320	4,37,320,325,2629		
806	806	R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling R-HSA-936440	374	2,10,374,2629		
807	807	R-HSA-70263	Gluconeogenesis R-HSA-70263	308	1,58,308,2629		
808	808	R-HSA-8956319	Nucleotide catabolism R-HSA-8956319	293	1,293,2629	1240,1511,1711	1240,1511,1711,1807
809	809	R-HSA-159227	Transport of the SLBP independent Mature mRNA R-HSA-159227	692	19,64,368,692,2629		
810	810	R-HSA-2514856	The phototransduction cascade R-HSA-2514856	282	26,282,2629	835,1556	835,1556
811	811	R-HSA-180746	Nuclear import of Rev protein R-HSA-180746	775	4,11,12,80,180,775,2629		
812	812	R-HSA-5579029	Metabolic disorders of biological oxidation enzymes R-HSA-5579029	72	4,72,2629	2036,2299,2350,2354,2362,2369,2379,2395,2405,2441,2443,2449,2461,2463,2466,2467,2470,2484,2497,2499,2505,2509,2510,2513,2535,2541,2565,2596,2604,2623,2624	2036,2299,2350,2354,2362,2369,2379,2395,2405,2441,2443,2449,2461,2463,2466,2467,2470,2484,2497,2499,2505,2509,2510,2513,2535,2541,2565,2596,2604,2623,2624
813	813	R-HSA-9615710	Late endosomal microautophagy R-HSA-9615710	146	146,2629		
814	814	R-HSA-5654727	Negative regulation of FGFR2 signaling R-HSA-5654727	421	0,32,347,421,2629	1268	1268
815	815	R-HSA-8953750	Transcriptional Regulation by E2F6 R-HSA-8953750	9	5,7,9,2629		
816	816	R-HSA-8963899	Plasma lipoprotein remodeling R-HSA-8963899	409	18,409,2629	1178,1605,1630,1862	1178,1605,1630,1862
817	817	R-HSA-4791275	Signaling by WNT in cancer R-HSA-4791275	37	4,37,2629	1306,1341,1369,1379,1382,1730,1903,2128,2330,2402	1306,1316,1322,1327,1334,1341,1369,1374,1376,1379,1382,1407,1730,1903,2128,2330,2402,2437,2503,2514
818	818	R-HSA-180910	Vpr-mediated nuclear import of PICs R-HSA-180910	762	4,11,12,80,180,762,2629		
819	819	R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates R-HSA-5693568	796	46,125,168,177,458,796,2629		
820	820	R-HSA-5673000	RAF activation R-HSA-5673000	65	0,49,63,65,2629		
821	821	R-HSA-5663084	Diseases of carbohydrate metabolism R-HSA-5663084	72	4,72,2629	1274,1564,2223,2322,2501,2577,2605	1274,1564,1643,2193,2223,2273,2286,2291,2294,2322,2364,2413,2425,2442,2450,2471,2472,2487,2501,2517,2545,2563,2569,2572,2577,2584,2590,2592,2605,2618,2628
822	822	R-HSA-192105	Synthesis of bile acids and bile salts R-HSA-192105	656	1,17,140,656,2629	1025,1344,1375	1025,1344,1375
823	823	R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417	609	24,166,232,609,2629	975,1167,1413	975,1167,1235,1413
824	824	R-HSA-9634815	Transcriptional Regulation by NPAS4 R-HSA-9634815	9	5,7,9,2629	1085,1410	1085,1410,1652,1987
825	825	R-HSA-187687	Signalling to ERKs R-HSA-187687	225	0,32,176,225,2629	1137,1392,1993	1137,1392,1453,1509,1816,1993
826	826	R-HSA-167158	Formation of the HIV-1 Early Elongation Complex R-HSA-167158	691	4,11,12,80,150,172,444,691,2629		
827	827	R-HSA-4085001	Sialic acid metabolism R-HSA-4085001	487	3,6,54,390,487,2629		
828	828	R-HSA-420092	Glucagon-type ligand receptors R-HSA-420092	319	0,23,36,319,2629		
829	829	R-HSA-389356	CD28 co-stimulation R-HSA-389356	414	2,14,414,2629	1086,1494	1086,1494
830	830	R-HSA-167287	HIV elongation arrest and recovery R-HSA-167287	444	4,11,12,80,150,172,444,2629		
831	831	R-HSA-68962	Activation of the pre-replicative complex R-HSA-68962	133,179	24,30,112,133,148,179,2629		
832	832	R-HSA-163359	Glucagon signaling in metabolic regulation R-HSA-163359	248	1,248,2629	1259	1259
833	833	R-HSA-5357956	TNFR1-induced NF-kappa-B signaling pathway R-HSA-5357956	544	0,142,544,2629		
834	834	R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding R-HSA-389958	329	3,290,329,2629	942,987,1595	942,987,1595
835	835	R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade R-HSA-2514859	810	26,282,810,2629		
836	836	R-HSA-113418	Formation of the Early Elongation Complex R-HSA-113418	528	5,7,528,2629		
837	837	R-HSA-9820841	M-decay: degradation of maternal mRNAs by maternally stored factors R-HSA-9820841	186	8,186,2629		
838	838	R-HSA-1592389	Activation of Matrix Metalloproteinases R-HSA-1592389	161	55,161,2629		
839	839	R-HSA-167290	Pausing and recovery of HIV elongation R-HSA-167290	444	4,11,12,80,150,172,444,2629		
840	840	R-HSA-5694530	Cargo concentration in the ER R-HSA-5694530	139	3,6,20,27,54,114,139,2629		
841	841	R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus R-HSA-168274	134	4,11,12,134,2629	859,2426	859,2426
842	842	R-HSA-5654726	Negative regulation of FGFR1 signaling R-HSA-5654726	602	0,32,347,602,2629	1268	1268
843	843	R-HSA-1980145	Signaling by NOTCH2 R-HSA-1980145	74	0,74,2629	1079,1484	1079,1484
844	844	R-HSA-352230	Amino acid transport across the plasma membrane R-HSA-352230	252	18,73,252,2629		
845	845	R-HSA-392518	Signal amplification R-HSA-392518	71	25,71,2629	1004,1039,1089	1004,1039,1089
846	846	R-HSA-1839126	FGFR2 mutant receptor activation R-HSA-1839126	685	4,37,488,685,2629	1193,1233,2457,2595	1193,1233,2457,2595
847	847	R-HSA-5619107	Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) R-HSA-5619107	284	4,121,284,2629		
848	848	R-HSA-5656169	Termination of translesion DNA synthesis R-HSA-5656169	739	46,636,739,2629		
849	849	R-HSA-9759476	Regulation of Homotypic Cell-Cell Adhesion R-HSA-9759476	526	138,214,334,526,2629	855	855,923,1577,1592,1597,1826,1832
850	850	R-HSA-69190	DNA strand elongation R-HSA-69190	203	24,30,112,130,203,2629	1131,1384,1493	1131,1339,1381,1384,1385,1493
851	851	R-HSA-9668328	Sealing of the nuclear envelope (NE) by ESCRT-III R-HSA-9668328	405	24,30,40,77,78,405,2629		
852	852	R-HSA-5576892	Phase 0 - rapid depolarisation R-HSA-5576892	181	98,181,2629		
853	853	R-HSA-9022692	Regulation of MECP2 expression and activity R-HSA-9022692	490	5,7,9,490,2629		
854	854	R-HSA-1251985	Nuclear signaling by ERBB4 R-HSA-1251985	533	0,32,533,2629		
855	855	R-HSA-9764260	Regulation of Expression and Function of Type II Classical Cadherins R-HSA-9764260	849	138,214,334,526,849,2629	923,1826	923,1577,1592,1597,1826,1832
856	856	R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein R-HSA-170822	420	1,58,308,420,2629		
857	857	R-HSA-5675482	Regulation of necroptotic cell death R-HSA-5675482	864	92,521,864,2629	1552	1552
858	858	R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs) R-HSA-456926	71	25,71,2629		
859	859	R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery R-HSA-168333	841	4,11,12,134,841,2629		
860	860	R-HSA-381042	PERK regulates gene expression R-HSA-381042	322	13,15,322,2629	959	959
861	861	R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus R-HSA-168271	134	4,11,12,134,2629		
862	862	R-HSA-5626467	RHO GTPases activate IQGAPs R-HSA-5626467	50	0,21,22,50,2629		
863	863	R-HSA-397795	G-protein beta:gamma signalling R-HSA-397795	28	0,23,28,2629	998,1143,1153,1209	998,1143,1153,1209
864	864	R-HSA-5213460	RIPK1-mediated regulated necrosis R-HSA-5213460	521	92,521,2629	857	857,1552
865	865	R-HSA-70268	Pyruvate metabolism R-HSA-70268	566	1,120,566,2629	1272	1272
866	866	R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases R-HSA-450282	489	2,10,16,34,127,154,222,224,233,234,247,249,253,264,268,277,280,299,302,303,438,489,2629	1075,1618,1817	1075,1452,1618,1817
867	867	R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721	93	41,69,93,2629	885,2051	885,1253,2051
868	868	R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity R-HSA-2173795	608	0,5,7,9,197,317,608,2629		
869	869	R-HSA-2022928	HS-GAG biosynthesis R-HSA-2022928	547	1,58,192,547,2629		
870	870	R-HSA-167243	Tat-mediated HIV elongation arrest and recovery R-HSA-167243	444	4,11,12,80,150,172,444,2629		
871	871	R-HSA-73863	RNA Polymerase I Transcription Termination R-HSA-73863	242	5,242,2629		
872	872	R-HSA-196807	Nicotinate metabolism R-HSA-196807	187	1,107,187,2629	1176	1176
873	873	R-HSA-389661	Glyoxylate metabolism and glycine degradation R-HSA-389661	44	1,44,2629	2032	2032
874	874	R-HSA-452723	Transcriptional regulation of pluripotent stem cells R-HSA-452723	8	8,2629	1438,1632	1438,1632
875	875	R-HSA-8941326	RUNX2 regulates bone development R-HSA-8941326	207	5,7,9,207,2629	1033,1999	1033,1999
876	876	R-HSA-5654733	Negative regulation of FGFR4 signaling R-HSA-5654733	725	0,32,347,725,2629	1268	1268
877	877	R-HSA-5654687	Downstream signaling of activated FGFR1 R-HSA-5654687	602	0,32,347,602,2629	1046,1106,1123,1281	1046,1106,1123,1281
878	878	R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729	27	20,27,2629		
879	879	R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus R-HSA-2122948	419	0,74,419,2629		
880	880	R-HSA-182971	EGFR downregulation R-HSA-182971	586	0,32,586,2629		
881	881	R-HSA-8949613	Cristae formation R-HSA-8949613	313	61,313,2629		
882	882	R-HSA-5602358	Diseases associated with the TLR signaling cascade R-HSA-5602358	892	4,892,2629	1220,1225,1843,2046,2143,2199,2219,2240,2295,2346,2418	1220,1225,1843,2046,2143,2199,2219,2240,2295,2346,2418
883	883	R-HSA-9680350	Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350	16	2,16,2629		
884	884	R-HSA-1839124	FGFR1 mutant receptor activation R-HSA-1839124	754	4,37,488,754,2629	1214,1538,2153,2401	1214,1538,2153,2401
885	885	R-HSA-399719	Trafficking of AMPA receptors R-HSA-399719	867	41,69,93,867,2629	1253	1253
886	886	R-HSA-917977	Transferrin endocytosis and recycling R-HSA-917977	529	18,529,2629		
887	887	R-HSA-445095	Interaction between L1 and Ankyrins R-HSA-445095	202	8,29,31,202,2629		
888	888	R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane R-HSA-4641262	79	0,47,79,2629		
889	889	R-HSA-3371511	HSF1 activation R-HSA-3371511	279	13,15,279,2629		
890	890	R-HSA-201451	Signaling by BMP R-HSA-201451	197	0,197,2629		
891	891	R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation R-HSA-167238	444	4,11,12,80,150,172,444,2629		
892	892	R-HSA-5260271	Diseases of Immune System R-HSA-5260271	4	4,2629	882	882,1220,1225,1843,2046,2143,2199,2219,2240,2295,2346,2418
893	893	R-HSA-5683826	Surfactant metabolism R-HSA-5683826	3	3,2629		
894	894	R-HSA-451326	Activation of kainate receptors upon glutamate binding R-HSA-451326	93	41,69,93,2629	1100,1580	1100,1580,1634,2268
895	895	R-HSA-420029	Tight junction interactions R-HSA-420029	334	138,214,334,2629		
896	896	R-HSA-8874081	MET activates PTK2 signaling R-HSA-8874081	724	0,32,389,724,2629		
897	897	R-HSA-6804758	Regulation of TP53 Activity through Acetylation R-HSA-6804758	132	5,7,9,45,132,2629	1671	1671
898	898	R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes R-HSA-8866652	388	3,6,388,2629		
899	899	R-HSA-3000157	Laminin interactions R-HSA-3000157	55	55,2629		
900	900	R-HSA-9615017	FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes R-HSA-9615017	469	5,7,9,469,2629		
901	901	R-HSA-933541	TRAF6 mediated IRF7 activation R-HSA-933541	374	2,10,374,2629		
902	902	R-HSA-114452	Activation of BH3-only proteins R-HSA-114452	556	92,119,556,2629	1320,1658,1998,2117,2197	1320,1658,1998,2117,2197
903	903	R-HSA-5654696	Downstream signaling of activated FGFR2 R-HSA-5654696	421	0,32,347,421,2629	1003,1064,1071,1224	1003,1064,1071,1224
904	904	R-HSA-9674555	Signaling by CSF3 (G-CSF) R-HSA-9674555	16	2,16,2629	1010	1010
905	905	R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex R-HSA-110314	636	46,636,2629		
906	906	R-HSA-77387	Insulin receptor recycling R-HSA-77387	373	0,32,373,2629		
907	907	R-HSA-4090294	SUMOylation of intracellular receptors R-HSA-4090294	117	3,6,110,117,2629		
908	908	R-HSA-201556	Signaling by ALK R-HSA-201556	32	0,32,2629	1537,2052	1537,2052
909	909	R-HSA-5339562	Uptake and actions of bacterial toxins R-HSA-5339562	433	4,11,433,2629	1540,1598,1858,2329	1540,1598,1858,1968,1994,2109,2116,2136,2172,2213,2329,2420
910	910	R-HSA-9619483	Activation of AMPK downstream of NMDARs R-HSA-9619483	383	41,69,93,311,383,2629		
911	911	R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK R-HSA-380972	712	0,712,2629		
912	912	R-HSA-72086	mRNA Capping R-HSA-72086	19	19,2629		
913	913	R-HSA-75067	Processing of Capped Intronless Pre-mRNA R-HSA-75067	19	19,2629	1132,1573,1585	1132,1573,1585
914	914	R-HSA-5669034	TNFs bind their physiological receptors R-HSA-5669034	278	2,16,278,2629		
915	915	R-HSA-5654732	Negative regulation of FGFR3 signaling R-HSA-5654732	728	0,32,347,728,2629	1268	1268
916	916	R-HSA-525793	Myogenesis R-HSA-525793	8	8,2629		
917	917	R-HSA-3928663	EPHA-mediated growth cone collapse R-HSA-3928663	328	8,29,31,328,2629		
918	918	R-HSA-390918	Peroxisomal lipid metabolism R-HSA-390918	122	1,17,122,2629	1520,1640,1889	1520,1640,1889
919	919	R-HSA-499943	Interconversion of nucleotide di- and triphosphates R-HSA-499943	293	1,293,2629		
920	920	R-HSA-1296059	G protein gated Potassium channels R-HSA-1296059	797	41,267,797,2629	927	927
921	921	R-HSA-186763	Downstream signal transduction R-HSA-186763	537	0,32,537,2629		
922	922	R-HSA-8863795	Downregulation of ERBB2 signaling R-HSA-8863795	615	0,32,615,2629	1444	1444
923	923	R-HSA-9759475	Regulation of CDH11 Expression and Function R-HSA-9759475	855	138,214,334,526,849,855,2629	1577,1592,1597	1577,1592,1597,1832
924	924	R-HSA-69205	G1/S-Specific Transcription R-HSA-69205	179	24,30,148,179,2629		
925	925	R-HSA-9753281	Paracetamol ADME R-HSA-9753281	244	244,2629		
926	926	R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits R-HSA-997272	694	41,69,93,505,679,694,2629		
927	927	R-HSA-1296041	Activation of G protein gated Potassium channels R-HSA-1296041	920	41,267,797,920,2629		
928	928	R-HSA-5205647	Mitophagy R-HSA-5205647	372	146,170,372,2629	1076,1554	1076,1554
929	929	R-HSA-2424491	DAP12 signaling R-HSA-2424491	673	2,10,673,2629		
930	930	R-HSA-1482839	Acyl chain remodelling of PE R-HSA-1482839	185	1,17,91,185,2629		
931	931	R-HSA-9619665	EGR2 and SOX10-mediated initiation of Schwann cell myelination R-HSA-9619665	29	8,29,2629		
932	932	R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884	165	5,165,2629		
933	933	R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC R-HSA-983170	43	2,14,43,2629		
934	934	R-HSA-9683701	Translation of Structural Proteins R-HSA-9683701	156	4,11,12,35,156,2629	1561,1680,1986,2059	1561,1680,1986,2059
935	935	R-HSA-8963743	Digestion and absorption R-HSA-8963743	2629	2629	1048,1924	1048,1544,1802,1924,2075,2615
936	936	R-HSA-2022854	Keratan sulfate biosynthesis R-HSA-2022854	780	1,58,192,780,2629		
937	937	R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952	180	4,11,12,80,180,2629	1116,1744	1116,1612,1672,1744,1841,2275
938	938	R-HSA-9682385	FLT3 signaling in disease R-HSA-9682385	37	4,37,2629	1181,1293,1829,2436,2578	1181,1293,1631,1829,2367,2374,2415,2424,2436,2447,2460,2469,2485,2519,2522,2530,2543,2578,2597,2616
939	939	R-HSA-3371568	Attenuation phase R-HSA-3371568	743	13,15,279,743,2629		
940	940	R-HSA-3295583	TRP channels R-HSA-3295583	255	18,116,255,2629		
941	941	R-HSA-1483191	Synthesis of PC R-HSA-1483191	185	1,17,91,185,2629		
942	942	R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC R-HSA-389957	834	3,290,329,834,2629		
943	943	R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071	789	5,713,789,2629		
944	944	R-HSA-350054	Notch-HLH transcription pathway R-HSA-350054	9	5,7,9,2629		
945	945	R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061	789	5,713,789,2629		
946	946	R-HSA-162588	Budding and maturation of HIV virion R-HSA-162588	172	4,11,12,80,150,172,2629		
947	947	R-HSA-418360	Platelet calcium homeostasis R-HSA-418360	359	25,359,2629	1291,1488	1291,1488
948	948	R-HSA-389948	PD-1 signaling R-HSA-389948	414	2,14,414,2629		
949	949	R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion R-HSA-400042	398	1,248,398,2629		
950	950	R-HSA-1614635	Sulfur amino acid metabolism R-HSA-1614635	44	1,44,2629	1321,1865,2303	1321,1856,1865,2303
951	951	R-HSA-442742	CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling R-HSA-442742	383	41,69,93,311,383,2629	1133,1854	1133,1854
952	952	R-HSA-912526	Interleukin receptor SHC signaling R-HSA-912526	633,674	2,16,34,633,674,2629		
953	953	R-HSA-1538133	G0 and Early G1 R-HSA-1538133	148	24,30,148,2629	1165,1280	1165,1280
954	954	R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554	796	46,125,168,177,458,796,2629		
955	955	R-HSA-189445	Metabolism of porphyrins R-HSA-189445	1	1,2629	1338,1363	1338,1363
956	956	R-HSA-9615933	Postmitotic nuclear pore complex (NPC) reformation R-HSA-9615933	405	24,30,40,77,78,405,2629		
957	957	R-HSA-114508	Effects of PIP2 hydrolysis R-HSA-114508	71,88	0,23,25,28,71,88,2629	2000	2000
958	958	R-HSA-6803529	FGFR2 alternative splicing R-HSA-6803529	421	0,32,347,421,2629		
959	959	R-HSA-380994	ATF4 activates genes in response to endoplasmic reticulum  stress R-HSA-380994	860	13,15,322,860,2629		
960	960	R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066	789	5,713,789,2629		
961	961	R-HSA-5654716	Downstream signaling of activated FGFR4 R-HSA-5654716	725	0,32,347,725,2629	1083,1130,1151,1332	1083,1130,1151,1332
962	962	R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection R-HSA-167160	444	4,11,12,80,150,172,444,2629		
963	963	R-HSA-9733709	Cardiogenesis R-HSA-9733709	8	8,2629		
964	964	R-HSA-5218920	VEGFR2 mediated vascular permeability R-HSA-5218920	296	0,32,254,296,2629		
965	965	R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression R-HSA-1368108	442	442,2629		
966	966	R-HSA-354192	Integrin signaling R-HSA-354192	0,736	0,25,71,736,2629	1324,1333	1324,1333
967	967	R-HSA-9635486	Infection with Mycobacterium tuberculosis R-HSA-9635486	433	4,11,433,2629	1054,1815,2593	1054,1439,1665,1815,1853,2124,2270,2285,2448,2477,2495,2593
968	968	R-HSA-1482788	Acyl chain remodelling of PC R-HSA-1482788	185	1,17,91,185,2629		
969	969	R-HSA-5620971	Pyroptosis R-HSA-5620971	521	92,521,2629		
970	970	R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE R-HSA-77075	7	5,7,2629		
971	971	R-HSA-191273	Cholesterol biosynthesis R-HSA-191273	140	1,17,140,2629	2082,2107	2082,2107
972	972	R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains R-HSA-202427	196	2,14,196,2629		
973	973	R-HSA-3000170	Syndecan interactions R-HSA-3000170	523	55,523,2629		
974	974	R-HSA-912694	Regulation of IFNA/IFNB signaling R-HSA-912694	394	2,16,66,394,2629		
975	975	R-HSA-174411	Polymerase switching on the C-strand of the telomere R-HSA-174411	823	24,166,232,609,823,2629		
976	976	R-HSA-3238698	WNT ligand biogenesis and trafficking R-HSA-3238698	47	0,47,2629		
977	977	R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway R-HSA-5357769	119	92,119,2629	1278,1607	1278,1529,1560,1607
978	978	R-HSA-5223345	Miscellaneous transport and binding events R-HSA-5223345	18	18,2629		
979	979	R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A R-HSA-179409	416	24,30,348,350,401,403,416,2629		
980	980	R-HSA-5621480	Dectin-2 family R-HSA-5621480	162	2,10,162,2629		
981	981	R-HSA-901042	Calnexin/calreticulin cycle R-HSA-901042	792	3,6,54,792,2629	1118	1118
982	982	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis R-HSA-1971475	547,619	1,58,192,547,619,2629		
983	983	R-HSA-8854691	Interleukin-20 family signaling R-HSA-8854691	34	2,16,34,2629		
984	984	R-HSA-211976	Endogenous sterols R-HSA-211976	476	1,82,263,476,2629	2222	2222
985	985	R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi R-HSA-975576	114	3,6,54,114,2629	1303,1601,2622	1303,1601,2622
986	986	R-HSA-1227990	Signaling by ERBB2 in Cancer R-HSA-1227990	37	4,37,2629	1006,1073,1299,1533,2055,2076	1006,1073,1299,1533,2024,2034,2040,2055,2057,2060,2068,2073,2074,2076
987	987	R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC R-HSA-389960	834	3,290,329,834,2629		
988	988	R-HSA-1187000	Fertilization R-HSA-1187000	137	137,2629	1521,1692,1897	1521,1692,1897
989	989	R-HSA-9660826	Purinergic signaling in leishmaniasis infection R-HSA-9660826	991	4,11,84,85,991,2629		
990	990	R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400	261	4,37,261,2629		
991	991	R-HSA-9664424	Cell recruitment (pro-inflammatory response) R-HSA-9664424	84	4,11,84,85,2629	989	989
992	992	R-HSA-2173788	Downregulation of TGF-beta receptor signaling R-HSA-2173788	646	0,197,317,646,2629		
993	993	R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol R-HSA-1855204	634	1,634,2629		
994	994	R-HSA-5654708	Downstream signaling of activated FGFR3 R-HSA-5654708	728	0,32,347,728,2629	1144,1202,1216,1427	1144,1202,1216,1427
995	995	R-HSA-9704646	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function R-HSA-9704646	1001	4,611,723,1001,2629		
996	996	R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER R-HSA-5696397	364	46,240,364,2629		
997	997	R-HSA-1643713	Signaling by EGFR in Cancer R-HSA-1643713	37	4,37,2629	1179,1336,1753	1177,1179,1311,1336,1753,1785
998	998	R-HSA-392451	G beta:gamma signalling through PI3Kgamma R-HSA-392451	863	0,23,28,863,2629		
999	999	R-HSA-9006115	Signaling by NTRK2 (TRKB) R-HSA-9006115	176	0,32,176,2629	1572,1681,1805,1828,1917,2028,2263,2279,2331	1572,1681,1805,1828,1917,1950,2028,2263,2279,2331
1000	1000	R-HSA-9006335	Signaling by Erythropoietin R-HSA-9006335	0	0,2629	1377,1471,1827,1834	1377,1471,1827,1834
1001	1001	R-HSA-9701193	Defective homologous recombination repair (HRR) due to PALB2 loss of function R-HSA-9701193	723	4,611,723,2629	995,1019	995,1019
1002	1002	R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway R-HSA-110373	750	46,340,750,2629	1110,1748	1110,1748
1003	1003	R-HSA-5654700	FRS-mediated FGFR2 signaling R-HSA-5654700	903	0,32,347,421,903,2629		
1004	1004	R-HSA-418592	ADP signalling through P2Y purinoceptor 1 R-HSA-418592	845	25,71,845,2629		
1005	1005	R-HSA-933542	TRAF6 mediated NF-kB activation R-HSA-933542	374	2,10,374,2629		
1006	1006	R-HSA-9664565	Signaling by ERBB2 KD Mutants R-HSA-9664565	986	4,37,986,2629		
1007	1007	R-HSA-5357786	TNFR1-induced proapoptotic signaling R-HSA-5357786	544	0,142,544,2629		
1008	1008	R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition R-HSA-69273	102	24,30,101,102,2629	2157	2157
1009	1009	R-HSA-9701192	Defective homologous recombination repair (HRR) due to BRCA1 loss of function R-HSA-9701192	723	4,611,723,2629		
1010	1010	R-HSA-9705462	Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462	904	2,16,904,2629		
1011	1011	R-HSA-264876	Insulin processing R-HSA-264876	345	3,345,2629		
1012	1012	R-HSA-8982491	Glycogen metabolism R-HSA-8982491	58	1,58,2629	1393,1405	1393,1405
1013	1013	R-HSA-9013508	NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508	625	0,74,625,2629		
1014	1014	R-HSA-9734009	Defective Intrinsic Pathway for Apoptosis R-HSA-9734009	266	4,266,2629	1090,2328,2452	1080,1090,2328,2351,2452
1015	1015	R-HSA-210991	Basigin interactions R-HSA-210991	105	25,105,2629		
1016	1016	R-HSA-429947	Deadenylation of mRNA R-HSA-429947	549	19,549,2629		
1017	1017	R-HSA-203927	MicroRNA (miRNA) biogenesis R-HSA-203927	165	5,165,2629		
1018	1018	R-HSA-9013507	NOTCH3 Activation and Transmission of Signal to the Nucleus R-HSA-9013507	625	0,74,625,2629	1769	1769
1019	1019	R-HSA-9704331	Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function R-HSA-9704331	1001	4,611,723,1001,2629		
1020	1020	R-HSA-156588	Glucuronidation R-HSA-156588	243	1,82,243,2629	2142	2142
1021	1021	R-HSA-202430	Translocation of ZAP-70 to Immunological synapse R-HSA-202430	196	2,14,196,2629		
1022	1022	R-HSA-425410	Metal ion SLC transporters R-HSA-425410	366	18,73,366,2629	1312	1312,1622,2005
1023	1023	R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs R-HSA-75876	744	1,17,122,744,2629		
1024	1024	R-HSA-2024096	HS-GAG degradation R-HSA-2024096	547	1,58,192,547,2629		
1025	1025	R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol R-HSA-193368	822	1,17,140,656,822,2629		
1026	1026	R-HSA-9634638	Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638	410	0,59,83,410,2629		
1027	1027	R-HSA-9648002	RAS processing R-HSA-9648002	65	0,49,63,65,2629		
1028	1028	R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B R-HSA-174048	403	24,30,348,350,401,403,2629		
1029	1029	R-HSA-5668599	RHO GTPases Activate NADPH Oxidases R-HSA-5668599	50	0,21,22,50,2629		
1030	1030	R-HSA-210500	Glutamate Neurotransmitter Release Cycle R-HSA-210500	605	41,69,605,2629		
1031	1031	R-HSA-163560	Triglyceride catabolism R-HSA-163560	751	1,17,751,2629		
1032	1032	R-HSA-400508	Incretin synthesis, secretion, and inactivation R-HSA-400508	345	3,345,2629	1096,1415	1096,1415
1033	1033	R-HSA-8940973	RUNX2 regulates osteoblast differentiation R-HSA-8940973	875	5,7,9,207,875,2629		
1034	1034	R-HSA-449836	Other interleukin signaling R-HSA-449836	34	2,16,34,2629		
1035	1035	R-HSA-6783589	Interleukin-6 family signaling R-HSA-6783589	34	2,16,34,2629	1252,1555	1252,1555
1036	1036	R-HSA-9709603	Impaired BRCA2 binding to PALB2 R-HSA-9709603	722	4,611,722,723,2629		
1037	1037	R-HSA-982772	Growth hormone receptor signaling R-HSA-982772	16	2,16,2629		
1038	1038	R-HSA-379716	Cytosolic tRNA aminoacylation R-HSA-379716	698	3,60,698,2629		
1039	1039	R-HSA-428930	Thromboxane signalling through TP receptor R-HSA-428930	845	25,71,845,2629		
1040	1040	R-HSA-202040	G-protein activation R-HSA-202040	333	0,23,28,51,333,2629		
1041	1041	R-HSA-400685	Sema4D in semaphorin signaling R-HSA-400685	477	8,29,31,477,2629	1139,1772	1139,1772
1042	1042	R-HSA-180024	DARPP-32 events R-HSA-180024	333	0,23,28,51,333,2629		
1043	1043	R-HSA-166208	mTORC1-mediated signalling R-HSA-166208	712	0,712,2629		
1044	1044	R-HSA-156584	Cytosolic sulfonation of small molecules R-HSA-156584	243	1,82,243,2629	1916	1916
1045	1045	R-HSA-9748787	Azathioprine ADME R-HSA-9748787	244	244,2629		
1046	1046	R-HSA-5654693	FRS-mediated FGFR1 signaling R-HSA-5654693	877	0,32,347,602,877,2629		
1047	1047	R-HSA-977068	Termination of O-glycan biosynthesis R-HSA-977068	491	3,6,237,491,2629		
1048	1048	R-HSA-8935690	Digestion R-HSA-8935690	935	935,2629	1544,1802	1544,1802
1049	1049	R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat R-HSA-167242	691	4,11,12,80,150,172,444,691,2629		
1050	1050	R-HSA-937041	IKK complex recruitment mediated by RIP1 R-HSA-937041	249	2,10,127,154,247,249,2629		
1051	1051	R-HSA-5620922	BBSome-mediated cargo-targeting to cilium R-HSA-5620922	607	61,100,607,2629		
1052	1052	R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision) R-HSA-2453902	282	26,282,2629	2494	2494
1053	1053	R-HSA-171319	Telomere Extension By Telomerase R-HSA-171319	609	24,166,232,609,2629		
1054	1054	R-HSA-9637690	Response of Mtb to phagocytosis R-HSA-9637690	967	4,11,433,967,2629	1439,1853,2270,2285,2448	1439,1665,1853,2124,2270,2285,2448,2477
1055	1055	R-HSA-9013422	RHOBTB1 GTPase cycle R-HSA-9013422	793	0,21,22,38,793,2629		
1056	1056	R-HSA-450302	activated TAK1 mediates p38 MAPK activation R-HSA-450302	489	2,10,16,34,127,154,222,224,233,234,247,249,253,264,268,277,280,299,302,303,438,489,2629		
1057	1057	R-HSA-373753	Nephrin family interactions R-HSA-373753	138	138,2629		
1058	1058	R-HSA-212676	Dopamine Neurotransmitter Release Cycle R-HSA-212676	605	41,69,605,2629		
1059	1059	R-HSA-9820960	Respiratory syncytial virus (RSV) attachment and entry R-HSA-9820960	205	4,11,12,205,2629		
1060	1060	R-HSA-1181150	Signaling by NODAL R-HSA-1181150	8	8,2629	1465	1465
1061	1061	R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation R-HSA-140837	731	25,731,2629		
1062	1062	R-HSA-389977	Post-chaperonin tubulin folding pathway R-HSA-389977	290	3,290,2629		
1063	1063	R-HSA-73980	RNA Polymerase III Transcription Termination R-HSA-73980	713	5,713,2629		
1064	1064	R-HSA-5654699	SHC-mediated cascade:FGFR2 R-HSA-5654699	903	0,32,347,421,903,2629		
1065	1065	R-HSA-9013418	RHOBTB2 GTPase cycle R-HSA-9013418	793	0,21,22,38,793,2629		
1066	1066	R-HSA-112409	RAF-independent MAPK1/3 activation R-HSA-112409	63	0,49,63,2629	1611,1700	1611,1700
1067	1067	R-HSA-8949215	Mitochondrial calcium ion transport R-HSA-8949215	18	18,2629	1284	1284
1068	1068	R-HSA-8956321	Nucleotide salvage R-HSA-8956321	293	1,293,2629	1418,1558	1418,1558
1069	1069	R-HSA-211981	Xenobiotics R-HSA-211981	476	1,82,263,476,2629	1530,2586	1530,2586
1070	1070	R-HSA-9620244	Long-term potentiation R-HSA-9620244	383	41,69,93,311,383,2629		
1071	1071	R-HSA-5654695	PI-3K cascade:FGFR2 R-HSA-5654695	903	0,32,347,421,903,2629		
1072	1072	R-HSA-113510	E2F mediated regulation of DNA replication R-HSA-113510	179	24,30,148,179,2629	1421,1687	1421,1687
1073	1073	R-HSA-9665686	Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686	986	4,37,986,2629		
1074	1074	R-HSA-140875	Common Pathway of Fibrin Clot Formation R-HSA-140875	731	25,731,2629		
1075	1075	R-HSA-198753	ERK/MAPK targets R-HSA-198753	501,866	0,2,10,16,32,34,127,154,176,222,224,225,233,234,247,249,253,264,268,277,280,299,302,303,438,489,501,866,2629	1452	1452
1076	1076	R-HSA-5205685	PINK1-PRKN Mediated Mitophagy R-HSA-5205685	928	146,170,372,928,2629		
1077	1077	R-HSA-5655332	Signaling by FGFR3 in disease R-HSA-5655332	488	4,37,488,2629	1490	1479,1490,2508,2518
1078	1078	R-HSA-71403	Citric acid cycle (TCA cycle) R-HSA-71403	566	1,120,566,2629		
1079	1079	R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus R-HSA-2979096	843	0,74,843,2629		
1080	1080	R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models R-HSA-8862803	1090	4,266,1014,1090,2629		
1081	1081	R-HSA-392154	Nitric oxide stimulates guanylate cyclase R-HSA-392154	359	25,359,2629	1288	1288
1082	1082	R-HSA-5365859	RA biosynthesis pathway R-HSA-5365859	695	0,59,695,2629		
1083	1083	R-HSA-5654712	FRS-mediated FGFR4 signaling R-HSA-5654712	961	0,32,347,725,961,2629		
1084	1084	R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism R-HSA-196741	187	1,107,187,2629	1588,1776,1833	1588,1776,1833
1085	1085	R-HSA-9768919	NPAS4 regulates expression of target genes R-HSA-9768919	824	5,7,9,824,2629		
1086	1086	R-HSA-389357	CD28 dependent PI3K/Akt signaling R-HSA-389357	829	2,14,414,829,2629		
1087	1087	R-HSA-1250196	SHC1 events in ERBB2 signaling R-HSA-1250196	615	0,32,615,2629		
1088	1088	R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1 R-HSA-450321	489	2,10,16,34,127,154,222,224,233,234,247,249,253,264,268,277,280,299,302,303,438,489,2629		
1089	1089	R-HSA-392170	ADP signalling through P2Y purinoceptor 12 R-HSA-392170	845	25,71,845,2629		
1090	1090	R-HSA-8863678	Neurodegenerative Diseases R-HSA-8863678	1014	4,266,1014,2629	1080	1080
1091	1091	R-HSA-912631	Regulation of signaling by CBL R-HSA-912631	633	2,16,34,633,2629		
1092	1092	R-HSA-1482801	Acyl chain remodelling of PS R-HSA-1482801	185	1,17,91,185,2629		
1093	1093	R-HSA-3296482	Defects in vitamin and cofactor metabolism R-HSA-3296482	72	4,72,2629	1400,1715	1400,1715,1818,2118,2196,2231,2249,2266,2289,2306,2340,2358,2399,2455,2464,2554
1094	1094	R-HSA-9609523	Insertion of tail-anchored proteins into the endoplasmic reticulum membrane R-HSA-9609523	129	129,2629		
1095	1095	R-HSA-9613829	Chaperone Mediated Autophagy R-HSA-9613829	146	146,2629		
1096	1096	R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771	1032	3,345,1032,2629		
1097	1097	R-HSA-8849932	Synaptic adhesion-like molecules R-HSA-8849932	354	41,354,2629		
1098	1098	R-HSA-389513	CTLA4 inhibitory signaling R-HSA-389513	414	2,14,414,2629		
1099	1099	R-HSA-189200	Cellular hexose transport R-HSA-189200	73	18,73,2629		
1100	1100	R-HSA-500657	Presynaptic function of Kainate receptors R-HSA-500657	894	41,69,93,894,2629		
1101	1101	R-HSA-4641263	Regulation of FZD by ubiquitination R-HSA-4641263	79	0,47,79,2629		
1102	1102	R-HSA-5620916	VxPx cargo-targeting to cilium R-HSA-5620916	607	61,100,607,2629		
1103	1103	R-HSA-5627123	RHO GTPases activate PAKs R-HSA-5627123	50	0,21,22,50,2629		
1104	1104	R-HSA-9617324	Negative regulation of NMDA receptor-mediated neuronal transmission R-HSA-9617324	311	41,69,93,311,2629		
1105	1105	R-HSA-9008059	Interleukin-37 signaling R-HSA-9008059	144	2,16,34,144,2629		
1106	1106	R-HSA-5654689	PI-3K cascade:FGFR1 R-HSA-5654689	877	0,32,347,602,877,2629		
1107	1107	R-HSA-210745	Regulation of gene expression in beta cells R-HSA-210745	709	8,709,2629	2056	2056
1108	1108	R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX) R-HSA-2142691	514	1,17,122,514,2629		
1109	1109	R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs R-HSA-1606322	480	2,10,480,2629	1228,1937	1228,1937
1110	1110	R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801	1002	46,340,750,1002,2629		
1111	1111	R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex R-HSA-141430	1122	24,30,62,236,348,350,378,1122,2629		
1112	1112	R-HSA-70895	Branched-chain amino acid catabolism R-HSA-70895	44	1,44,2629		
1113	1113	R-HSA-190872	Transport of connexons to the plasma membrane R-HSA-190872	747	20,27,603,627,747,2629	1154	1154
1114	1114	R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain R-HSA-6804115	624	5,7,9,45,624,2629		
1115	1115	R-HSA-5686938	Regulation of TLR by endogenous ligand R-HSA-5686938	127	2,10,127,2629		
1116	1116	R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters R-HSA-164938	937	4,11,12,80,180,937,2629	1612,1672,1841,2275	1612,1672,1841,2275
1117	1117	R-HSA-9830674	Formation of the ureteric bud R-HSA-9830674	652	8,652,2629		
1118	1118	R-HSA-901032	ER Quality Control Compartment (ERQC) R-HSA-901032	981	3,6,54,792,981,2629		
1119	1119	R-HSA-9033658	Blood group systems biosynthesis R-HSA-9033658	58	1,58,2629	1218,2325,2338	1218,2325,2338
1120	1120	R-HSA-445144	Signal transduction by L1 R-HSA-445144	202	8,29,31,202,2629		
1121	1121	R-HSA-6807004	Negative regulation of MET activity R-HSA-6807004	389	0,32,389,2629	2293	2293
1122	1122	R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components R-HSA-141405	236,378	24,30,62,236,348,350,378,2629	1111	1111
1123	1123	R-HSA-5654688	SHC-mediated cascade:FGFR1 R-HSA-5654688	877	0,32,347,602,877,2629		
1124	1124	R-HSA-622312	Inflammasomes R-HSA-622312	551	2,10,551,2629	1264,2168,2174,2281	1264,2168,2174,2281
1125	1125	R-HSA-5621575	CD209 (DC-SIGN) signaling R-HSA-5621575	162	2,10,162,2629		
1126	1126	R-HSA-438066	Unblocking of NMDA receptors, glutamate binding and activation R-HSA-438066	311	41,69,93,311,2629		
1127	1127	R-HSA-379726	Mitochondrial tRNA aminoacylation R-HSA-379726	698	3,60,698,2629		
1128	1128	R-HSA-9670439	Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439	1155	4,37,1155,2629		
1129	1129	R-HSA-111931	PKA-mediated phosphorylation of CREB R-HSA-111931	803	0,23,28,51,53,333,578,621,719,770,795,803,2629	1194	1194
1130	1130	R-HSA-5654719	SHC-mediated cascade:FGFR4 R-HSA-5654719	961	0,32,347,725,961,2629		
1131	1131	R-HSA-69186	Lagging Strand Synthesis R-HSA-69186	850	24,30,112,130,203,850,2629	1339,1385	1339,1381,1385
1132	1132	R-HSA-77595	Processing of Intronless Pre-mRNAs R-HSA-77595	913	19,913,2629		
1133	1133	R-HSA-442982	Ras activation upon Ca2+ influx through NMDA receptor R-HSA-442982	951	41,69,93,311,383,951,2629		
1134	1134	R-HSA-199220	Vitamin B5 (pantothenate) metabolism R-HSA-199220	187	1,107,187,2629	1797	1797
1135	1135	R-HSA-2022870	Chondroitin sulfate biosynthesis R-HSA-2022870	619	1,58,192,619,2629		
1136	1136	R-HSA-9629569	Protein hydroxylation R-HSA-9629569	503	3,6,503,2629		
1137	1137	R-HSA-167044	Signalling to RAS R-HSA-167044	825	0,32,176,225,825,2629	1453	1453
1138	1138	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1 R-HSA-4420332	718	4,72,157,718,2629		
1139	1139	R-HSA-416572	Sema4D induced cell migration and growth-cone collapse R-HSA-416572	1041	8,29,31,477,1041,2629		
1140	1140	R-HSA-176412	Phosphorylation of the APC/C R-HSA-176412	401	24,30,348,350,401,2629		
1141	1141	R-HSA-3781860	Diseases associated with N-glycosylation of proteins R-HSA-3781860	157	4,72,157,2629	2216,2250,2360,2387,2411,2412,2434,2446,2488,2515,2525,2538,2552,2564,2574,2617,2619	2216,2250,2360,2387,2411,2412,2434,2446,2488,2515,2525,2538,2552,2564,2574,2617,2619
1142	1142	R-HSA-2028269	Signaling by Hippo R-HSA-2028269	0	0,2629		
1143	1143	R-HSA-418217	G beta:gamma signalling through PLC beta R-HSA-418217	863	0,23,28,863,2629		
1144	1144	R-HSA-5654706	FRS-mediated FGFR3 signaling R-HSA-5654706	994	0,32,347,728,994,2629		
1145	1145	R-HSA-9013695	NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695	371	0,74,371,2629		
1146	1146	R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release R-HSA-6803204	675	5,7,9,45,675,2629		
1147	1147	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type R-HSA-3560783	718	4,72,157,718,2629		
1148	1148	R-HSA-3232118	SUMOylation of transcription factors R-HSA-3232118	117	3,6,110,117,2629		
1149	1149	R-HSA-111471	Apoptotic factor-mediated response R-HSA-111471	556	92,119,556,2629	1411,1752,1821	1411,1535,1542,1752,1812,1821,1850,1875
1150	1150	R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase R-HSA-176407	348	24,30,348,350,2629		
1151	1151	R-HSA-5654720	PI-3K cascade:FGFR4 R-HSA-5654720	961	0,32,347,725,961,2629		
1152	1152	R-HSA-388844	Receptor-type tyrosine-protein phosphatases R-HSA-388844	354	41,354,2629		
1153	1153	R-HSA-8964616	G beta:gamma signalling through CDC42 R-HSA-8964616	863	0,23,28,863,2629		
1154	1154	R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane R-HSA-190840	1113	20,27,603,627,747,1113,2629		
1155	1155	R-HSA-9669938	Signaling by KIT in disease R-HSA-9669938	37	4,37,2629	1128,2355,2421,2433,2539,2594	1128,2355,2376,2421,2433,2475,2502,2528,2539,2579,2594,2599,2610
1156	1156	R-HSA-8876384	Listeria monocytogenes entry into host cells R-HSA-8876384	433	4,11,433,2629	1335,1664	1335,1664
1157	1157	R-HSA-9671555	Signaling by PDGFR in disease R-HSA-9671555	37	4,37,2629	1463,1477,1952,2151,2498,2627	1463,1477,1952,2151,2361,2498,2504,2580,2612,2627
1158	1158	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD R-HSA-3560801	718	4,72,157,718,2629		
1159	1159	R-HSA-9687136	Aberrant regulation of mitotic exit in cancer due to RB1 defects R-HSA-9687136	782	4,752,782,2629		
1160	1160	R-HSA-190241	FGFR2 ligand binding and activation R-HSA-190241	421	0,32,347,421,2629	1450,1606	1450,1606
1161	1161	R-HSA-9603798	Class I peroxisomal membrane protein import R-HSA-9603798	129	129,2629		
1162	1162	R-HSA-9671793	Diseases of hemostasis R-HSA-9671793	4	4,2629	1263,1765	1263,1677,1765,1799,1814,1824,1907,2027,2100,2111,2113,2120,2121,2167,2171,2179,2206,2254,2327,2459,2520,2570,2575
1163	1163	R-HSA-8964038	LDL clearance R-HSA-8964038	761	18,409,761,2629		
1164	1164	R-HSA-5423646	Aflatoxin activation and detoxification R-HSA-5423646	82	1,82,2629		
1165	1165	R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex R-HSA-1362277	953	24,30,148,953,2629		
1166	1166	R-HSA-9840309	Glycosphingolipid biosynthesis R-HSA-9840309	540	1,17,251,540,2629		
1167	1167	R-HSA-174414	Processive synthesis on the C-strand of the telomere R-HSA-174414	823	24,166,232,609,823,2629	1235	1235
1168	1168	R-HSA-3000480	Scavenging by Class A Receptors R-HSA-3000480	291	20,291,2629		
1169	1169	R-HSA-2995383	Initiation of Nuclear Envelope (NE) Reformation R-HSA-2995383	405	24,30,40,77,78,405,2629		
1170	1170	R-HSA-9018678	Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678	17	1,17,2629	1258,1892,1908,2058,2314	1258,1771,1871,1892,1908,1972,2031,2035,2042,2058,2080,2125,2239,2255,2305,2314,2323,2347,2588,2613
1171	1171	R-HSA-5218921	VEGFR2 mediated cell proliferation R-HSA-5218921	296	0,32,254,296,2629		
1172	1172	R-HSA-8963898	Plasma lipoprotein assembly R-HSA-8963898	409	18,409,2629	1633,1717,2001	1633,1717,2001
1173	1173	R-HSA-416700	Other semaphorin interactions R-HSA-416700	477	8,29,31,477,2629		
1174	1174	R-HSA-110320	Translesion Synthesis by POLH R-HSA-110320	739	46,636,739,2629		
1175	1175	R-HSA-5576886	Phase 4 - resting membrane potential R-HSA-5576886	181	98,181,2629		
1176	1176	R-HSA-197264	Nicotinamide salvaging R-HSA-197264	872	1,107,187,872,2629		
1177	1177	R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382	1179	4,37,997,1179,2629		
1178	1178	R-HSA-8963889	Assembly of active LPL and LIPC lipase complexes R-HSA-8963889	816	18,409,816,2629		
1179	1179	R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815	997	4,37,997,2629	1177	1177
1180	1180	R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin R-HSA-422085	345	3,345,2629		
1181	1181	R-HSA-9703465	Signaling by FLT3 fusion proteins R-HSA-9703465	938	4,37,938,2629		
1182	1182	R-HSA-5625900	RHO GTPases activate CIT R-HSA-5625900	50	0,21,22,50,2629		
1183	1183	R-HSA-5627117	RHO GTPases Activate ROCKs R-HSA-5627117	50	0,21,22,50,2629		
1184	1184	R-HSA-8978934	Metabolism of cofactors R-HSA-8978934	107	1,107,2629	1589,1707,2486	1589,1707,2486
1185	1185	R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters R-HSA-442660	366	18,73,366,2629		
1186	1186	R-HSA-3928664	Ephrin signaling R-HSA-3928664	328	8,29,31,328,2629		
1187	1187	R-HSA-9818027	NFE2L2 regulating anti-oxidant/detoxification enzymes R-HSA-9818027	297	13,15,89,195,297,2629		
1188	1188	R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment R-HSA-168927	264	2,10,127,264,2629		
1189	1189	R-HSA-6804760	Regulation of TP53 Activity through Methylation R-HSA-6804760	132	5,7,9,45,132,2629		
1190	1190	R-HSA-888590	GABA synthesis, release, reuptake and degradation R-HSA-888590	605	41,69,605,2629	2095,2229,2247	2095,2229,2247
1191	1191	R-HSA-9694614	Attachment and Entry R-HSA-9694614	772	4,11,12,35,56,772,2629		
1192	1192	R-HSA-392851	Prostacyclin signalling through prostacyclin receptor R-HSA-392851	359	25,359,2629		
1193	1193	R-HSA-8851708	Signaling by FGFR2 IIIa TM R-HSA-8851708	846	4,37,488,685,846,2629		
1194	1194	R-HSA-163615	PKA activation R-HSA-163615	1129	0,23,28,51,53,333,578,621,719,770,795,803,1129,2629		
1195	1195	R-HSA-9022699	MECP2 regulates neuronal receptors and channels R-HSA-9022699	490	5,7,9,490,2629		
1196	1196	R-HSA-163210	Formation of ATP by chemiosmotic coupling R-HSA-163210	188	1,120,188,2629		
1197	1197	R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest R-HSA-6804114	624	5,7,9,45,624,2629		
1198	1198	R-HSA-210993	Tie2 Signaling R-HSA-210993	105	25,105,2629		
1199	1199	R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI) R-HSA-162710	321	3,6,321,2629		
1200	1200	R-HSA-1660514	Synthesis of PIPs at the Golgi membrane R-HSA-1660514	367	1,17,91,367,2629		
1201	1201	R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins R-HSA-2022377	345	3,345,2629		
1202	1202	R-HSA-5654704	SHC-mediated cascade:FGFR3 R-HSA-5654704	994	0,32,347,728,994,2629		
1203	1203	R-HSA-1482925	Acyl chain remodelling of PG R-HSA-1482925	185	1,17,91,185,2629		
1204	1204	R-HSA-5635838	Activation of SMO R-HSA-5635838	357	0,147,357,2629		
1205	1205	R-HSA-190242	FGFR1 ligand binding and activation R-HSA-190242	602	0,32,347,602,2629	1388,1714,2214	1388,1714,2214
1206	1206	R-HSA-1368082	RORA activates gene expression R-HSA-1368082	442	442,2629		
1207	1207	R-HSA-2243919	Crosslinking of collagen fibrils R-HSA-2243919	498	55,336,498,2629		
1208	1208	R-HSA-1912420	Pre-NOTCH Processing in Golgi R-HSA-1912420	208	0,74,208,2629		
1209	1209	R-HSA-8964315	G beta:gamma signalling through BTK R-HSA-8964315	863	0,23,28,863,2629		
1210	1210	R-HSA-209776	Metabolism of amine-derived hormones R-HSA-209776	44	1,44,2629	1615,2014,2043	1615,2014,2043,2212
1211	1211	R-HSA-159418	Recycling of bile acids and salts R-HSA-159418	656	1,17,140,656,2629		
1212	1212	R-HSA-181429	Serotonin Neurotransmitter Release Cycle R-HSA-181429	605	41,69,605,2629		
1213	1213	R-HSA-446353	Cell-extracellular matrix interactions R-HSA-446353	214	138,214,2629	1737,2081	1737,2081
1214	1214	R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants R-HSA-1839117	884	4,37,488,754,884,2629		
1215	1215	R-HSA-9830364	Formation of the nephric duct R-HSA-9830364	652	8,652,2629		
1216	1216	R-HSA-5654710	PI-3K cascade:FGFR3 R-HSA-5654710	994	0,32,347,728,994,2629		
1217	1217	R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK R-HSA-881907	88	0,23,28,88,2629	1654	1654
1218	1218	R-HSA-9037629	Lewis blood group biosynthesis R-HSA-9037629	1119	1,58,1119,2629		
1219	1219	R-HSA-1369062	ABC transporters in lipid homeostasis R-HSA-1369062	271	18,271,2629		
1220	1220	R-HSA-5603041	IRAK4 deficiency (TLR2/4) R-HSA-5603041	882	4,882,892,2629		
1221	1221	R-HSA-9758274	Regulation of NF-kappa B signaling R-HSA-9758274	672	2,10,16,34,127,144,154,222,224,226,233,234,247,249,253,264,268,277,280,299,302,303,672,2629		
1222	1222	R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle R-HSA-181430	605	41,69,605,2629		
1223	1223	R-HSA-73780	RNA Polymerase III Chain Elongation R-HSA-73780	713	5,713,2629		
1224	1224	R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2 R-HSA-5654221	903	0,32,347,421,903,2629		
1225	1225	R-HSA-5602498	MyD88 deficiency (TLR2/4) R-HSA-5602498	882	4,882,892,2629		
1226	1226	R-HSA-9819196	Zygotic genome activation (ZGA) R-HSA-9819196	186	8,186,2629		
1227	1227	R-HSA-2142845	Hyaluronan metabolism R-HSA-2142845	192	1,58,192,2629	1460,1990	1460,1990
1228	1228	R-HSA-1810476	RIP-mediated NFkB activation via ZBP1 R-HSA-1810476	1109	2,10,480,1109,2629		
1229	1229	R-HSA-8934593	Regulation of RUNX1 Expression and Activity R-HSA-8934593	76	5,7,9,76,2629		
1230	1230	R-HSA-5655862	Translesion synthesis by POLK R-HSA-5655862	739	46,636,739,2629		
1231	1231	R-HSA-8876725	Protein methylation R-HSA-8876725	6	3,6,2629		
1232	1232	R-HSA-9754189	Germ layer formation at gastrulation R-HSA-9754189	182	8,182,2629		
1233	1233	R-HSA-2033519	Activated point mutants of FGFR2 R-HSA-2033519	846	4,37,488,685,846,2629		
1234	1234	R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584	386	13,15,104,386,2629		
1235	1235	R-HSA-174437	Removal of the Flap Intermediate from the C-strand R-HSA-174437	1167	24,166,232,609,823,1167,2629		
1236	1236	R-HSA-9659787	Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787	782	4,752,782,2629	1257,2547	1257,2547
1237	1237	R-HSA-1502540	Signaling by Activin R-HSA-1502540	197	0,197,2629	2023	2023
1238	1238	R-HSA-9834899	Specification of the neural plate border R-HSA-9834899	182	8,182,2629		
1239	1239	R-HSA-180292	GAB1 signalosome R-HSA-180292	586	0,32,586,2629		
1240	1240	R-HSA-74259	Purine catabolism R-HSA-74259	808	1,293,808,2629	1807	1807
1241	1241	R-HSA-196757	Metabolism of folate and pterines R-HSA-196757	187	1,107,187,2629		
1242	1242	R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle R-HSA-264642	605	41,69,605,2629		
1243	1243	R-HSA-5083632	Defective C1GALT1C1 causes TNPS R-HSA-5083632	454	4,72,157,454,2629		
1244	1244	R-HSA-432142	Platelet sensitization by LDL R-HSA-432142	359	25,359,2629		
1245	1245	R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA R-HSA-450513	355	19,355,2629		
1246	1246	R-HSA-9617828	FOXO-mediated transcription of cell cycle genes R-HSA-9617828	469	5,7,9,469,2629		
1247	1247	R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway R-HSA-5676594	278	2,16,278,2629		
1248	1248	R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA R-HSA-450385	355	19,355,2629		
1249	1249	R-HSA-9823730	Formation of definitive endoderm R-HSA-9823730	182	8,182,2629		
1250	1250	R-HSA-1482922	Acyl chain remodelling of PI R-HSA-1482922	185	1,17,91,185,2629		
1251	1251	R-HSA-196299	Beta-catenin phosphorylation cascade R-HSA-196299	361	0,47,361,2629		
1252	1252	R-HSA-6788467	IL-6-type cytokine receptor ligand interactions R-HSA-6788467	1035	2,16,34,1035,2629		
1253	1253	R-HSA-416993	Trafficking of GluR2-containing AMPA receptors R-HSA-416993	885	41,69,93,867,885,2629		
1254	1254	R-HSA-936964	Activation of IRF3, IRF7 mediated by TBK1, IKBKE R-HSA-936964	249	2,10,127,154,247,249,2629		
1255	1255	R-HSA-9034015	Signaling by NTRK3 (TRKC) R-HSA-9034015	176	0,32,176,2629	1704,1879,2126,2127,2276	1704,1879,2126,2127,2276
1256	1256	R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA R-HSA-450604	355	19,355,2629		
1257	1257	R-HSA-9661069	Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069	1236	4,752,782,1236,2629		
1258	1258	R-HSA-9018677	Biosynthesis of DHA-derived SPMs R-HSA-9018677	1170	1,17,1170,2629	1771,2042,2080,2125,2239	1771,1871,2042,2080,2125,2239,2255,2613
1259	1259	R-HSA-164378	PKA activation in glucagon signalling R-HSA-164378	832	1,248,832,2629		
1260	1260	R-HSA-5656121	Translesion synthesis by POLI R-HSA-5656121	739	46,636,739,2629		
1261	1261	R-HSA-391160	Signal regulatory protein family interactions R-HSA-391160	138	138,2629		
1262	1262	R-HSA-1963642	PI3K events in ERBB2 signaling R-HSA-1963642	615	0,32,615,2629		
1263	1263	R-HSA-9651496	Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) R-HSA-9651496	1162	4,1162,2629	1677,1799,2121,2179,2206	1677,1799,1907,2113,2120,2121,2167,2171,2179,2206,2254,2327,2459,2520,2570,2575
1264	1264	R-HSA-844456	The NLRP3 inflammasome R-HSA-844456	1124	2,10,551,1124,2629		
1265	1265	R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation R-HSA-5684264	226,489	2,10,16,34,127,144,154,222,224,226,233,234,247,249,253,264,268,277,280,299,302,303,438,489,2629		
1266	1266	R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex R-HSA-937072	249	2,10,127,154,247,249,2629		
1267	1267	R-HSA-5083636	Defective GALNT12 causes CRCS1 R-HSA-5083636	454	4,72,157,454,2629		
1268	1268	R-HSA-1295596	Spry regulation of FGF signaling R-HSA-1295596	814,842,876,915	0,32,347,421,602,725,728,814,842,876,915,2629		
1269	1269	R-HSA-1834941	STING mediated induction of host immune responses R-HSA-1834941	480	2,10,480,2629	1431,2194	1431,2194
1270	1270	R-HSA-399956	CRMPs in Sema3A signaling R-HSA-399956	477	8,29,31,477,2629		
1271	1271	R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells R-HSA-210744	709	8,709,2629		
1272	1272	R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex R-HSA-204174	865	1,120,566,865,2629		
1273	1273	R-HSA-1433559	Regulation of KIT signaling R-HSA-1433559	681	0,32,681,2629		
1274	1274	R-HSA-3229121	Glycogen storage diseases R-HSA-3229121	821	4,72,821,2629	1643,2193,2273,2286,2291,2294,2442,2450,2569	1643,2193,2273,2286,2291,2294,2442,2450,2569
1275	1275	R-HSA-392517	Rap1 signalling R-HSA-392517	14	2,14,2629		
1276	1276	R-HSA-1660516	Synthesis of PIPs at the early endosome membrane R-HSA-1660516	367	1,17,91,367,2629		
1277	1277	R-HSA-4655427	SUMOylation of DNA methylation proteins R-HSA-4655427	117	3,6,110,117,2629		
1278	1278	R-HSA-140534	Caspase activation via Death Receptors in the presence of ligand R-HSA-140534	977	92,119,977,2629	1529,1560	1529,1560
1279	1279	R-HSA-175474	Assembly Of The HIV Virion R-HSA-175474	172	4,11,12,80,150,172,2629	1348,2548	1348,1387,2548
1280	1280	R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 R-HSA-1362300	953	24,30,148,953,2629		
1281	1281	R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219	877	0,32,347,602,877,2629		
1282	1282	R-HSA-75892	Platelet Adhesion to exposed collagen R-HSA-75892	25	25,2629		
1283	1283	R-HSA-193639	p75NTR signals via NF-kB R-HSA-193639	294	0,142,294,2629	1422,1446	1422,1446
1284	1284	R-HSA-8949664	Processing of SMDT1 R-HSA-8949664	1067	18,1067,2629		
1285	1285	R-HSA-110312	Translesion synthesis by REV1 R-HSA-110312	739	46,636,739,2629		
1286	1286	R-HSA-9820965	Respiratory syncytial virus (RSV) genome replication, transcription and translation R-HSA-9820965	205	4,11,12,205,2629	1416,2287,2479	1416,2287,2479
1287	1287	R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease R-HSA-429958	549	19,549,2629		
1288	1288	R-HSA-418457	cGMP effects R-HSA-418457	1081	25,359,1081,2629		
1289	1289	R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) R-HSA-2173791	317	0,197,317,2629		
1290	1290	R-HSA-399954	Sema3A PAK dependent Axon repulsion R-HSA-399954	477	8,29,31,477,2629		
1291	1291	R-HSA-139853	Elevation of cytosolic Ca2+ levels R-HSA-139853	947	25,359,947,2629		
1292	1292	R-HSA-9614657	FOXO-mediated transcription of cell death genes R-HSA-9614657	469	5,7,9,469,2629		
1293	1293	R-HSA-9703648	Signaling by FLT3 ITD and TKD mutants R-HSA-9703648	938	4,37,938,2629	1631	1631
1294	1294	R-HSA-205043	NRIF signals cell death from the nucleus R-HSA-205043	407	0,142,294,407,2629		
1295	1295	R-HSA-156711	Polo-like kinase mediated events R-HSA-156711	102	24,30,101,102,2629		
1296	1296	R-HSA-9735871	SARS-CoV-1 targets host intracellular signalling and regulatory pathways R-HSA-9735871	285	4,11,12,35,156,285,2629		
1297	1297	R-HSA-5083625	Defective GALNT3 causes HFTC R-HSA-5083625	454	4,72,157,454,2629		
1298	1298	R-HSA-8866427	VLDLR internalisation and degradation R-HSA-8866427	761	18,409,761,2629		
1299	1299	R-HSA-9665348	Signaling by ERBB2 ECD mutants R-HSA-9665348	986	4,37,986,2629		
1300	1300	R-HSA-418038	Nucleotide-like (purinergic) receptors R-HSA-418038	48	0,23,36,48,2629	1501,2093	1501,2093
1301	1301	R-HSA-1963640	GRB2 events in ERBB2 signaling R-HSA-1963640	615	0,32,615,2629		
1302	1302	R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression R-HSA-2032785	9	5,7,9,2629		
1303	1303	R-HSA-975577	N-Glycan antennae elongation R-HSA-975577	985	3,6,54,114,985,2629		
1304	1304	R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants R-HSA-2691232	1318	4,37,527,1318,2629		
1305	1305	R-HSA-5609975	Diseases associated with glycosylation precursor biosynthesis R-HSA-5609975	157	4,72,157,2629	2114,2149,2209,2316,2409,2458,2489,2516,2533,2557,2560,2573,2598,2607	2114,2149,2209,2316,2409,2458,2489,2516,2533,2557,2560,2573,2598,2607
1306	1306	R-HSA-5339716	Signaling by GSK3beta mutants R-HSA-5339716	817	4,37,817,2629		
1307	1307	R-HSA-1170546	Prolactin receptor signaling R-HSA-1170546	16	2,16,2629		
1308	1308	R-HSA-9694631	Maturation of nucleoprotein R-HSA-9694631	545	4,11,12,35,56,441,545,2629		
1309	1309	R-HSA-5576893	Phase 2 - plateau phase R-HSA-5576893	181	98,181,2629		
1310	1310	R-HSA-391903	Eicosanoid ligand-binding receptors R-HSA-391903	48	0,23,36,48,2629	1689,1927	1689,1927
1311	1311	R-HSA-5637810	Constitutive Signaling by EGFRvIII R-HSA-5637810	1336	4,37,997,1336,2629		
1312	1312	R-HSA-435354	Zinc transporters R-HSA-435354	1022	18,73,366,1022,2629	1622,2005	1622,2005
1313	1313	R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease R-HSA-430039	549	19,549,2629		
1314	1314	R-HSA-2022857	Keratan sulfate degradation R-HSA-2022857	780	1,58,192,780,2629		
1315	1315	R-HSA-6785631	ERBB2 Regulates Cell Motility R-HSA-6785631	615	0,32,615,2629		
1316	1316	R-HSA-5358751	CTNNB1 S45 mutants aren't phosphorylated R-HSA-5358751	1341	4,37,817,1341,2629		
1317	1317	R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation R-HSA-975163	280	2,10,127,253,268,277,280,2629		
1318	1318	R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer R-HSA-2691230	527	4,37,527,2629	1304	1304
1319	1319	R-HSA-211935	Fatty acids R-HSA-211935	476	1,82,263,476,2629		
1320	1320	R-HSA-111447	Activation of BAD and translocation to mitochondria  R-HSA-111447	902	92,119,556,902,2629		
1321	1321	R-HSA-1614558	Degradation of cysteine and homocysteine R-HSA-1614558	950	1,44,950,2629	1856	1856
1322	1322	R-HSA-5358747	CTNNB1 S33 mutants aren't phosphorylated R-HSA-5358747	1341	4,37,817,1341,2629		
1323	1323	R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists R-HSA-3772470	79	0,47,79,2629		
1324	1324	R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins  R-HSA-354194	966	0,25,71,736,966,2629		
1325	1325	R-HSA-71336	Pentose phosphate pathway R-HSA-71336	58	1,58,2629	2150	2150
1326	1326	R-HSA-918233	TRAF3-dependent IRF activation pathway R-HSA-918233	374	2,10,374,2629		
1327	1327	R-HSA-5358749	CTNNB1 S37 mutants aren't phosphorylated R-HSA-5358749	1341	4,37,817,1341,2629		
1328	1328	R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA R-HSA-3134975	480	2,10,480,2629	2384	2384
1329	1329	R-HSA-9648895	Response of EIF2AK1 (HRI) to heme deficiency R-HSA-9648895	15	13,15,2629		
1330	1330	R-HSA-549132	Organic cation/anion/zwitterion transport R-HSA-549132	366	18,73,366,2629	1590,1985	1590,1985
1331	1331	R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX) R-HSA-2162123	514	1,17,122,514,2629		
1332	1332	R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4 R-HSA-5654228	961	0,32,347,725,961,2629		
1333	1333	R-HSA-372708	p130Cas linkage to MAPK signaling for integrins R-HSA-372708	966	0,25,71,736,966,2629		
1334	1334	R-HSA-5358752	CTNNB1 T41 mutants aren't phosphorylated R-HSA-5358752	1341	4,37,817,1341,2629		
1335	1335	R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell R-HSA-8875360	1156	4,11,433,1156,2629		
1336	1336	R-HSA-5637812	Signaling by EGFRvIII in Cancer R-HSA-5637812	997	4,37,997,2629	1311	1311
1337	1337	R-HSA-4419969	Depolymerization of the Nuclear Lamina R-HSA-4419969	583	24,30,40,159,583,2629		
1338	1338	R-HSA-189483	Heme degradation R-HSA-189483	955	1,955,2629		
1339	1339	R-HSA-69183	Processive synthesis on the lagging strand R-HSA-69183	1131	24,30,112,130,203,850,1131,2629	1381	1381
1340	1340	R-HSA-9706369	Negative regulation of FLT3 R-HSA-9706369	756	2,16,756,2629		
1341	1341	R-HSA-4839743	Signaling by CTNNB1 phospho-site mutants R-HSA-4839743	817	4,37,817,2629	1316,1322,1327,1334	1316,1322,1327,1334
1342	1342	R-HSA-5099900	WNT5A-dependent internalization of FZD4 R-HSA-5099900	327	0,47,152,327,2629		
1343	1343	R-HSA-2214320	Anchoring fibril formation R-HSA-2214320	498	55,336,498,2629		
1344	1344	R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol R-HSA-193807	822	1,17,140,656,822,2629		
1345	1345	R-HSA-5358508	Mismatch Repair R-HSA-5358508	46	46,2629	1355,1403	1355,1403
1346	1346	R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors R-HSA-8866910	757	5,7,9,757,2629		
1347	1347	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS R-HSA-3656253	718	4,72,157,718,2629		
1348	1348	R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins R-HSA-174495	1279	4,11,12,80,150,172,1279,2629	1387	1387
1349	1349	R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759	132	5,7,9,45,132,2629		
1350	1350	R-HSA-71240	Tryptophan catabolism R-HSA-71240	44	1,44,2629		
1351	1351	R-HSA-8964539	Glutamate and glutamine metabolism R-HSA-8964539	44	1,44,2629		
1352	1352	R-HSA-5682910	LGI-ADAM interactions R-HSA-5682910	8	8,2629		
1353	1353	R-HSA-198323	AKT phosphorylates targets in the cytosol R-HSA-198323	70	0,53,70,2629		
1354	1354	R-HSA-8956320	Nucleotide biosynthesis R-HSA-8956320	293	1,293,2629	1576,2147	1576,2147
1355	1355	R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) R-HSA-5358606	1345	46,1345,2629		
1356	1356	R-HSA-9796292	Formation of axial mesoderm R-HSA-9796292	182	8,182,2629		
1357	1357	R-HSA-3656237	Defective EXT2 causes exostoses 2 R-HSA-3656237	718	4,72,157,718,2629		
1358	1358	R-HSA-4641265	Repression of WNT target genes R-HSA-4641265	361	0,47,361,2629		
1359	1359	R-HSA-200425	Carnitine metabolism R-HSA-200425	122	1,17,122,2629		
1360	1360	R-HSA-180336	SHC1 events in EGFR signaling R-HSA-180336	586	0,32,586,2629		
1361	1361	R-HSA-2024101	CS/DS degradation R-HSA-2024101	619	1,58,192,619,2629		
1362	1362	R-HSA-170670	Adenylate cyclase inhibitory pathway R-HSA-170670	578,694	0,23,28,41,51,69,93,333,505,578,679,694,2629		
1363	1363	R-HSA-189451	Heme biosynthesis R-HSA-189451	955	1,955,2629		
1364	1364	R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658	159	24,30,40,159,2629		
1365	1365	R-HSA-5660526	Response to metal ions R-HSA-5660526	13	13,2629	1578,2170	1578,2170
1366	1366	R-HSA-209952	Peptide hormone biosynthesis R-HSA-209952	345	3,345,2629	1483	1483
1367	1367	R-HSA-419408	Lysosphingolipid and LPA receptors R-HSA-419408	48	0,23,36,48,2629		
1368	1368	R-HSA-162594	Early Phase of HIV Life Cycle R-HSA-162594	150	4,11,12,80,150,2629	1641,2044,2419,2576	1641,1835,2044,2156,2176,2419,2493,2531,2576
1369	1369	R-HSA-4839735	Signaling by AXIN mutants R-HSA-4839735	817	4,37,817,2629	1374,2503	1374,2503
1370	1370	R-HSA-877312	Regulation of IFNG signaling R-HSA-877312	287	2,16,66,287,2629		
1371	1371	R-HSA-156581	Methylation R-HSA-156581	243	1,82,243,2629		
1372	1372	R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol R-HSA-1855183	634	1,634,2629		
1373	1373	R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases R-HSA-8849471	573	0,573,577,2629		
1374	1374	R-HSA-5467340	AXIN missense mutants destabilize the destruction complex R-HSA-5467340	1369	4,37,817,1369,2629		
1375	1375	R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol R-HSA-193775	822	1,17,140,656,822,2629		
1376	1376	R-HSA-5467337	APC truncation mutants have impaired AXIN binding R-HSA-5467337	1382	4,37,817,1382,2629		
1377	1377	R-HSA-9027284	Erythropoietin activates RAS R-HSA-9027284	1000	0,1000,2629		
1378	1378	R-HSA-5578768	Physiological factors R-HSA-5578768	181	98,181,2629		
1379	1379	R-HSA-4839748	Signaling by AMER1 mutants R-HSA-4839748	817	4,37,817,2629	1407,2514	1407,2514
1380	1380	R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion R-HSA-399955	477	8,29,31,477,2629		
1381	1381	R-HSA-69166	Removal of the Flap Intermediate R-HSA-69166	1339	24,30,112,130,203,850,1131,1339,2629		
1382	1382	R-HSA-4839744	Signaling by APC mutants R-HSA-4839744	817	4,37,817,2629	1376,2437	1376,2437
1383	1383	R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors R-HSA-622327	1391	41,69,93,1391,2629	1523,1808	1523,1808
1384	1384	R-HSA-69109	Leading Strand Synthesis R-HSA-69109	850	24,30,112,130,203,850,2629	1385	1385
1385	1385	R-HSA-69091	Polymerase switching R-HSA-69091	1131,1384	24,30,112,130,203,850,1131,1384,2629		
1386	1386	R-HSA-9694676	Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9694676	772	4,11,12,35,56,772,2629	2511	2511
1387	1387	R-HSA-174490	Membrane binding and targetting of GAG proteins R-HSA-174490	1348	4,11,12,80,150,172,1279,1348,2629		
1388	1388	R-HSA-190373	FGFR1c ligand binding and activation R-HSA-190373	1205	0,32,347,602,1205,2629		
1389	1389	R-HSA-418885	DCC mediated attractive signaling R-HSA-418885	616	8,29,31,616,2629		
1390	1390	R-HSA-177504	Retrograde neurotrophin signalling R-HSA-177504	225	0,32,176,225,2629		
1391	1391	R-HSA-181431	Acetylcholine binding and downstream events R-HSA-181431	93	41,69,93,2629	1383,1491	1383,1491,1523,1655,1808
1392	1392	R-HSA-169893	Prolonged ERK activation events R-HSA-169893	825	0,32,176,225,825,2629	1509,1816	1509,1816
1393	1393	R-HSA-70221	Glycogen breakdown (glycogenolysis) R-HSA-70221	1012	1,58,1012,2629		
1394	1394	R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain R-HSA-6803205	675	5,7,9,45,675,2629		
1395	1395	R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest R-HSA-6804116	624	5,7,9,45,624,2629		
1396	1396	R-HSA-202131	Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131	1	1,2629	1609,1996,2324	1609,1996,2324
1397	1397	R-HSA-8983432	Interleukin-15 signaling R-HSA-8983432	674	2,16,34,674,2629		
1398	1398	R-HSA-1250347	SHC1 events in ERBB4 signaling R-HSA-1250347	533	0,32,533,2629		
1399	1399	R-HSA-8941856	RUNX3 regulates NOTCH signaling R-HSA-8941856	298	5,7,9,298,2629		
1400	1400	R-HSA-3296469	Defects in cobalamin (B12) metabolism R-HSA-3296469	1093	4,72,1093,2629	2118,2196,2231,2249,2266,2289,2306,2340,2358,2455,2464,2554	2118,2196,2231,2249,2266,2289,2306,2340,2358,2455,2464,2554
1401	1401	R-HSA-75109	Triglyceride biosynthesis R-HSA-75109	751	1,17,751,2629		
1402	1402	R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation R-HSA-975144	280	2,10,127,253,268,277,280,2629		
1403	1403	R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) R-HSA-5358565	1345	46,1345,2629		
1404	1404	R-HSA-190322	FGFR4 ligand binding and activation R-HSA-190322	725	0,32,347,725,2629	2159	2159
1405	1405	R-HSA-3322077	Glycogen synthesis R-HSA-3322077	1012	1,58,1012,2629		
1406	1406	R-HSA-937039	IRAK1 recruits IKK complex R-HSA-937039	233,303	2,10,127,154,222,224,233,234,299,302,303,2629		
1407	1407	R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex R-HSA-5467348	1379	4,37,817,1379,2629		
1408	1408	R-HSA-190372	FGFR3c ligand binding and activation R-HSA-190372	1443	0,32,347,728,1443,2629		
1409	1409	R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling R-HSA-5658623	602	0,32,347,602,2629		
1410	1410	R-HSA-9768759	Regulation of NPAS4 gene expression R-HSA-9768759	824	5,7,9,824,2629	1652,1987	1652,1987
1411	1411	R-HSA-111461	Cytochrome c-mediated apoptotic response R-HSA-111461	1149	92,119,556,1149,2629	1535,1875	1535,1542,1875
1412	1412	R-HSA-2474795	Diseases associated with visual transduction R-HSA-2474795	1429	4,1429,2629	1451,2368	1451,2368,2494
1413	1413	R-HSA-174430	Telomere C-strand synthesis initiation R-HSA-174430	823	24,166,232,609,823,2629		
1414	1414	R-HSA-879415	Advanced glycosylation endproduct receptor signaling R-HSA-879415	10	2,10,2629		
1415	1415	R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511	1032	3,345,1032,2629		
1416	1416	R-HSA-9828806	Maturation of hRSV A proteins R-HSA-9828806	1286	4,11,12,205,1286,2629		
1417	1417	R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2 R-HSA-5140745	327	0,47,152,327,2629		
1418	1418	R-HSA-74217	Purine salvage R-HSA-74217	1068	1,293,1068,2629		
1419	1419	R-HSA-8847993	ERBB2 Activates PTK6 Signaling R-HSA-8847993	573,615	0,32,573,577,615,2629		
1420	1420	R-HSA-75205	Dissolution of Fibrin Clot R-HSA-75205	25	25,2629		
1421	1421	R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1 R-HSA-113501	1072	24,30,148,179,1072,2629		
1422	1422	R-HSA-209543	p75NTR recruits signalling complexes R-HSA-209543	1283	0,142,294,1283,2629		
1423	1423	R-HSA-68884	Mitotic Telophase/Cytokinesis R-HSA-68884	40	24,30,40,2629	1593	1593
1424	1424	R-HSA-1663150	The activation of arylsulfatases R-HSA-1663150	503	3,6,503,2629		
1425	1425	R-HSA-2046106	alpha-linolenic acid (ALA) metabolism R-HSA-2046106	1445	1,17,122,1445,2629		
1426	1426	R-HSA-1480926	O2/CO2 exchange in erythrocytes R-HSA-1480926	18	18,2629	1458,1639	1458,1639
1427	1427	R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3 R-HSA-5654227	994	0,32,347,728,994,2629		
1428	1428	R-HSA-9005891	Loss of function of MECP2 in Rett syndrome R-HSA-9005891	1449	4,1432,1433,1449,2629	1810,2099,2104,2558	1810,2099,2104,2558
1429	1429	R-HSA-9675143	Diseases of the neuronal system R-HSA-9675143	4	4,2629	1412	1412,1451,2368,2494
1430	1430	R-HSA-9679504	Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9679504	156	4,11,12,35,156,2629		
1431	1431	R-HSA-3270619	IRF3-mediated induction of type I IFN R-HSA-3270619	1269	2,10,480,1269,2629		
1432	1432	R-HSA-9697154	Disorders of Nervous System Development R-HSA-9697154	1433	4,1433,2629	1449	1428,1449,1810,2099,2104,2558
1433	1433	R-HSA-9675151	Disorders of Developmental Biology R-HSA-9675151	4	4,2629	1432	1428,1432,1449,1810,2099,2104,2558
1434	1434	R-HSA-1483213	Synthesis of PE R-HSA-1483213	185	1,17,91,185,2629		
1435	1435	R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex R-HSA-75035	318	24,62,126,318,2629		
1436	1436	R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 R-HSA-933543	374	2,10,374,2629		
1437	1437	R-HSA-9733458	Induction of Cell-Cell Fusion R-HSA-9733458	441	4,11,12,35,56,441,2629		
1438	1438	R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation R-HSA-2892247	874	8,874,2629		
1439	1439	R-HSA-9637687	Suppression of phagosomal maturation R-HSA-9637687	1054	4,11,433,967,1054,2629	1665,2124,2477	1665,2124,2477
1440	1440	R-HSA-428540	Activation of RAC1 R-HSA-428540	86	8,29,31,86,2629		
1441	1441	R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis R-HSA-1362409	1	1,2629	2200	2200
1442	1442	R-HSA-140342	Apoptosis induced DNA fragmentation R-HSA-140342	594	92,119,594,2629		
1443	1443	R-HSA-190239	FGFR3 ligand binding and activation R-HSA-190239	728	0,32,347,728,2629	1408,1796	1408,1796
1444	1444	R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803	922	0,32,615,922,2629		
1445	1445	R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism R-HSA-2046104	122	1,17,122,2629	1425,1722	1425,1722
1446	1446	R-HSA-209560	NF-kB is activated and signals survival R-HSA-209560	1283	0,142,294,1283,2629		
1447	1447	R-HSA-1679131	Trafficking and processing of endosomal TLR R-HSA-1679131	127	2,10,127,2629		
1448	1448	R-HSA-432047	Passive transport by Aquaporins R-HSA-432047	597	18,597,2629		
1449	1449	R-HSA-9005895	Pervasive developmental disorders R-HSA-9005895	1432	4,1432,1433,2629	1428	1428,1810,2099,2104,2558
1450	1450	R-HSA-190375	FGFR2c ligand binding and activation R-HSA-190375	1160	0,32,347,421,1160,2629		
1451	1451	R-HSA-2453864	Retinoid cycle disease events R-HSA-2453864	1412	4,1412,1429,2629	2494	2494
1452	1452	R-HSA-202670	ERKs are inactivated R-HSA-202670	1075	0,2,10,16,32,34,127,154,176,222,224,225,233,234,247,249,253,264,268,277,280,299,302,303,438,489,501,866,1075,2629		
1453	1453	R-HSA-171007	p38MAPK events R-HSA-171007	1137	0,32,176,225,825,1137,2629		
1454	1454	R-HSA-9690406	Transcriptional regulation of testis differentiation R-HSA-9690406	8	8,2629		
1455	1455	R-HSA-179812	GRB2 events in EGFR signaling R-HSA-179812	586	0,32,586,2629		
1456	1456	R-HSA-9831926	Nephron development R-HSA-9831926	652	8,652,2629		
1457	1457	R-HSA-2564830	Cytosolic iron-sulfur cluster assembly R-HSA-2564830	1	1,2629		
1458	1458	R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen R-HSA-1237044	1426	18,1426,2629		
1459	1459	R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling R-HSA-975110	277	2,10,127,253,268,277,2629		
1460	1460	R-HSA-2160916	Hyaluronan uptake and degradation R-HSA-2160916	1227	1,58,192,1227,2629		
1461	1461	R-HSA-190873	Gap junction degradation R-HSA-190873	627	20,27,603,627,2629	1548	1548
1462	1462	R-HSA-196108	Pregnenolone biosynthesis R-HSA-196108	791	1,17,140,791,2629		
1463	1463	R-HSA-9673767	Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767	1157	4,37,1157,2629		
1464	1464	R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones R-HSA-381033	322	13,15,322,2629	1621	1621
1465	1465	R-HSA-1433617	Regulation of signaling by NODAL R-HSA-1433617	1060	8,1060,2629		
1466	1466	R-HSA-9664420	Killing mechanisms R-HSA-9664420	84	4,11,84,85,2629	1468	1468
1467	1467	R-HSA-442720	CREB1 phosphorylation through the activation of Adenylate Cyclase R-HSA-442720	383	41,69,93,311,383,2629		
1468	1468	R-HSA-9673324	WNT5:FZD7-mediated leishmania damping R-HSA-9673324	1466	4,11,84,85,1466,2629		
1469	1469	R-HSA-9836573	Mitochondrial RNA degradation R-HSA-9836573	19	19,2629	1894	1894
1470	1470	R-HSA-1475029	Reversible hydration of carbon dioxide R-HSA-1475029	1	1,2629		
1471	1471	R-HSA-9027276	Erythropoietin activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276	1000	0,1000,2629		
1472	1472	R-HSA-210990	PECAM1 interactions R-HSA-210990	105	25,105,2629		
1473	1473	R-HSA-9634600	Regulation of glycolysis by fructose 2,6-bisphosphate metabolism R-HSA-9634600	420	1,58,308,420,2629		
1474	1474	R-HSA-174403	Glutathione synthesis and recycling R-HSA-174403	778	1,82,243,778,2629		
1475	1475	R-HSA-71064	Lysine catabolism R-HSA-71064	44	1,44,2629		
1476	1476	R-HSA-9020558	Interleukin-2 signaling R-HSA-9020558	674	2,16,34,674,2629		
1477	1477	R-HSA-9673770	Signaling by PDGFRA extracellular domain mutants R-HSA-9673770	1157	4,37,1157,2629		
1478	1478	R-HSA-5689877	Josephin domain DUBs R-HSA-5689877	57	3,6,57,2629		
1479	1479	R-HSA-1839130	Signaling by activated point mutants of FGFR3 R-HSA-1839130	1490	4,37,488,1077,1490,2629		
1480	1480	R-HSA-211979	Eicosanoids R-HSA-211979	476	1,82,263,476,2629		
1481	1481	R-HSA-390666	Serotonin receptors R-HSA-390666	706	0,23,36,48,706,2629		
1482	1482	R-HSA-9845614	Sphingolipid catabolism R-HSA-9845614	251	1,17,251,2629		
1483	1483	R-HSA-209822	Glycoprotein hormones R-HSA-209822	1366	3,345,1366,2629		
1484	1484	R-HSA-2197563	NOTCH2 intracellular domain regulates transcription R-HSA-2197563	843	0,74,843,2629		
1485	1485	R-HSA-9827857	Specification of primordial germ cells R-HSA-9827857	137	137,2629		
1486	1486	R-HSA-8868766	rRNA processing in the mitochondrion R-HSA-8868766	94	19,94,2629	1738	1738
1487	1487	R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane R-HSA-83936	696	18,73,696,2629		
1488	1488	R-HSA-418359	Reduction of cytosolic Ca++ levels R-HSA-418359	947	25,359,947,2629		
1489	1489	R-HSA-9755779	SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779	95	4,11,12,35,56,95,2629		
1490	1490	R-HSA-2033514	FGFR3 mutant receptor activation R-HSA-2033514	1077	4,37,488,1077,2629	1479,2508,2518	1479,2508,2518
1491	1491	R-HSA-622323	Presynaptic nicotinic acetylcholine receptors R-HSA-622323	1391	41,69,93,1391,2629	1655,1808	1655,1808
1492	1492	R-HSA-4755510	SUMOylation of immune response proteins R-HSA-4755510	117	3,6,110,117,2629		
1493	1493	R-HSA-176974	Unwinding of DNA R-HSA-176974	850	24,30,112,130,203,850,2629		
1494	1494	R-HSA-389359	CD28 dependent Vav1 pathway R-HSA-389359	829	2,14,414,829,2629		
1495	1495	R-HSA-9820865	Z-decay: degradation of maternal mRNAs by zygotically expressed factors R-HSA-9820865	186	8,186,2629		
1496	1496	R-HSA-211958	Miscellaneous substrates R-HSA-211958	476	1,82,263,476,2629		
1497	1497	R-HSA-5685939	HDR through MMEJ (alt-NHEJ) R-HSA-5685939	168	46,125,168,2629		
1498	1498	R-HSA-9700645	ALK mutants bind TKIs R-HSA-9700645	325	4,37,325,2629		
1499	1499	R-HSA-9013973	TICAM1-dependent activation of IRF3/IRF7 R-HSA-9013973	264	2,10,127,264,2629		
1500	1500	R-HSA-375281	Hormone ligand-binding receptors R-HSA-375281	48	0,23,36,48,2629		
1501	1501	R-HSA-417957	P2Y receptors R-HSA-417957	1300	0,23,36,48,1300,2629		
1502	1502	R-HSA-8851680	Butyrophilin (BTN) family interactions R-HSA-8851680	14	2,14,2629		
1503	1503	R-HSA-8984722	Interleukin-35 Signalling R-HSA-8984722	541	2,16,34,541,2629		
1504	1504	R-HSA-71384	Ethanol oxidation R-HSA-71384	263	1,82,263,2629		
1505	1505	R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases R-HSA-6803207	675	5,7,9,45,675,2629		
1506	1506	R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands R-HSA-6803211	675	5,7,9,45,675,2629		
1507	1507	R-HSA-430116	GP1b-IX-V activation signalling R-HSA-430116	71	25,71,2629		
1508	1508	R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins R-HSA-264870	749	92,119,594,749,2629		
1509	1509	R-HSA-170968	Frs2-mediated activation R-HSA-170968	1392	0,32,176,225,825,1392,2629		
1510	1510	R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors R-HSA-8866907	757	5,7,9,757,2629		
1511	1511	R-HSA-73621	Pyrimidine catabolism R-HSA-73621	808	1,293,808,2629		
1512	1512	R-HSA-196791	Vitamin D (calciferol) metabolism R-HSA-196791	140	1,17,140,2629		
1513	1513	R-HSA-1296346	Tandem pore domain potassium channels R-HSA-1296346	267	41,267,2629	2122,2141,2232,2265,2385,2386	2122,2141,2232,2265,2385,2386
1514	1514	R-HSA-9614399	Regulation of localization of FOXO transcription factors R-HSA-9614399	469	5,7,9,469,2629		
1515	1515	R-HSA-9818030	NFE2L2 regulating tumorigenic genes R-HSA-9818030	297	13,15,89,195,297,2629		
1516	1516	R-HSA-193048	Androgen biosynthesis R-HSA-193048	791	1,17,140,791,2629		
1517	1517	R-HSA-5655291	Signaling by FGFR4 in disease R-HSA-5655291	488	4,37,488,2629	2587	2587
1518	1518	R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor R-HSA-1234158	411	13,15,411,2629		
1519	1519	R-HSA-8875555	MET activates RAP1 and RAC1 R-HSA-8875555	724	0,32,389,724,2629		
1520	1520	R-HSA-390247	Beta-oxidation of very long chain fatty acids R-HSA-390247	918	1,17,122,918,2629		
1521	1521	R-HSA-2534343	Interaction With Cumulus Cells And The Zona Pellucida R-HSA-2534343	988	137,988,2629		
1522	1522	R-HSA-9020956	Interleukin-27 signaling R-HSA-9020956	541	2,16,34,541,2629		
1523	1523	R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors R-HSA-629594	1383	41,69,93,1383,1391,2629		
1524	1524	R-HSA-9755088	Ribavirin ADME R-HSA-9755088	244	244,2629		
1525	1525	R-HSA-9754560	SARS-CoV-2 modulates autophagy R-HSA-9754560	95	4,11,12,35,56,95,2629		
1526	1526	R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation R-HSA-5607763	281	2,10,162,281,2629		
1527	1527	R-HSA-879518	Transport of organic anions R-HSA-879518	696	18,73,696,2629		
1528	1528	R-HSA-2586552	Signaling by Leptin R-HSA-2586552	0	0,2629		
1529	1529	R-HSA-3371378	Regulation by c-FLIP R-HSA-3371378	1278	92,119,977,1278,2629		
1530	1530	R-HSA-211999	CYP2E1 reactions R-HSA-211999	1069	1,82,263,476,1069,2629		
1531	1531	R-HSA-71288	Creatine metabolism R-HSA-71288	44	1,44,2629		
1532	1532	R-HSA-5625970	RHO GTPases activate KTN1 R-HSA-5625970	50	0,21,22,50,2629		
1533	1533	R-HSA-9634285	Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285	986	4,37,986,2629		
1534	1534	R-HSA-9664873	Pexophagy R-HSA-9664873	372	146,170,372,2629		
1535	1535	R-HSA-111458	Formation of apoptosome R-HSA-111458	1411	92,119,556,1149,1411,2629	1542	1542
1536	1536	R-HSA-2468052	Establishment of Sister Chromatid Cohesion R-HSA-2468052	130	24,30,130,2629		
1537	1537	R-HSA-9701898	STAT3 nuclear events downstream of ALK signaling R-HSA-9701898	908	0,32,908,2629		
1538	1538	R-HSA-1839122	Signaling by activated point mutants of FGFR1 R-HSA-1839122	884	4,37,488,754,884,2629		
1539	1539	R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins R-HSA-159854	503	3,6,503,2629	1623,1627,1649	1623,1627,1649
1540	1540	R-HSA-5210891	Uptake and function of anthrax toxins R-HSA-5210891	909	4,11,433,909,2629		
1541	1541	R-HSA-112308	Presynaptic depolarization and calcium channel opening R-HSA-112308	69	41,69,2629		
1542	1542	R-HSA-9627069	Regulation of the apoptosome activity R-HSA-9627069	1535	92,119,556,1149,1411,1535,2629		
1543	1543	R-HSA-1660517	Synthesis of PIPs at the late endosome membrane R-HSA-1660517	367	1,17,91,367,2629		
1544	1544	R-HSA-189085	Digestion of dietary carbohydrate R-HSA-189085	1048	935,1048,2629		
1545	1545	R-HSA-446107	Type I hemidesmosome assembly R-HSA-446107	214	138,214,2629		
1546	1546	R-HSA-8963693	Aspartate and asparagine metabolism R-HSA-8963693	44	1,44,2629		
1547	1547	R-HSA-2514853	Condensation of Prometaphase Chromosomes R-HSA-2514853	99	24,30,40,99,2629		
1548	1548	R-HSA-196025	Formation of annular gap junctions R-HSA-196025	1461	20,27,603,627,1461,2629		
1549	1549	R-HSA-9013700	NOTCH4 Activation and Transmission of Signal to the Nucleus R-HSA-9013700	371	0,74,371,2629		
1550	1550	R-HSA-9708530	Regulation of BACH1 activity R-HSA-9708530	195	13,15,89,195,2629		
1551	1551	R-HSA-9823739	Formation of the anterior neural plate R-HSA-9823739	182	8,182,2629		
1552	1552	R-HSA-5218900	CASP8 activity is inhibited R-HSA-5218900	857	92,521,857,864,2629		
1553	1553	R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins R-HSA-351906	749	92,119,594,749,2629		
1554	1554	R-HSA-8934903	Receptor Mediated Mitophagy R-HSA-8934903	928	146,170,372,928,2629		
1555	1555	R-HSA-1059683	Interleukin-6 signaling R-HSA-1059683	1035	2,16,34,1035,2629		
1556	1556	R-HSA-2485179	Activation of the phototransduction cascade R-HSA-2485179	810	26,282,810,2629		
1557	1557	R-HSA-9645460	Alpha-protein kinase 1 signaling pathway R-HSA-9645460	10	2,10,2629		
1558	1558	R-HSA-73614	Pyrimidine salvage R-HSA-73614	1068	1,293,1068,2629		
1559	1559	R-HSA-196780	Biotin transport and metabolism R-HSA-196780	187	1,107,187,2629		
1560	1560	R-HSA-69416	Dimerization of procaspase-8 R-HSA-69416	1278	92,119,977,1278,2629		
1561	1561	R-HSA-9683610	Maturation of nucleoprotein R-HSA-9683610	934	4,11,12,35,156,934,2629		
1562	1562	R-HSA-112311	Neurotransmitter clearance R-HSA-112311	69	41,69,2629	1988,2144	1988,2078,2144,2248,2262
1563	1563	R-HSA-8851805	MET activates RAS signaling R-HSA-8851805	389	0,32,389,2629		
1564	1564	R-HSA-2206281	Mucopolysaccharidoses R-HSA-2206281	821	4,72,821,2629	2364,2413,2425,2472,2517,2545,2563,2584,2592,2618,2628	2364,2413,2425,2472,2517,2545,2563,2584,2592,2618,2628
1565	1565	R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids R-HSA-77286	767	1,17,122,767,2629	1909,1926,1935,1964,1970,2191,2218	1909,1926,1935,1964,1970,2191,2218
1566	1566	R-HSA-400451	Free fatty acids regulate insulin secretion R-HSA-400451	398	1,248,398,2629	1724,2137	1724,2137
1567	1567	R-HSA-9014325	TICAM1,TRAF6-dependent induction of TAK1 complex R-HSA-9014325	264	2,10,127,264,2629		
1568	1568	R-HSA-8963691	Phenylalanine and tyrosine metabolism R-HSA-8963691	44	1,44,2629	1877,2003	1877,2003
1569	1569	R-HSA-193692	Regulated proteolysis of p75NTR R-HSA-193692	294	0,142,294,2629		
1570	1570	R-HSA-1236977	Endosomal/Vacuolar pathway R-HSA-1236977	258	2,14,43,258,2629		
1571	1571	R-HSA-376172	DSCAM interactions R-HSA-376172	616	8,29,31,616,2629		
1572	1572	R-HSA-9028731	Activated NTRK2 signals through FRS2 and FRS3 R-HSA-9028731	999	0,32,176,999,2629		
1573	1573	R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs R-HSA-77588	913	19,913,2629		
1574	1574	R-HSA-425561	Sodium/Calcium exchangers R-HSA-425561	252	18,73,252,2629		
1575	1575	R-HSA-2022923	Dermatan sulfate biosynthesis R-HSA-2022923	619	1,58,192,619,2629		
1576	1576	R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis R-HSA-73817	1354	1,293,1354,2629		
1577	1577	R-HSA-9762292	Regulation of CDH11 function R-HSA-9762292	923	138,214,334,526,849,855,923,2629	1832	1832
1578	1578	R-HSA-5661231	Metallothioneins bind metals R-HSA-5661231	1365	13,1365,2629		
1579	1579	R-HSA-170660	Adenylate cyclase activating pathway R-HSA-170660	578	0,23,28,51,333,578,2629		
1580	1580	R-HSA-451306	Ionotropic activity of kainate receptors R-HSA-451306	894	41,69,93,894,2629	1634,2268	1634,2268
1581	1581	R-HSA-74182	Ketone body metabolism R-HSA-74182	17	1,17,2629	1731,2089	1731,2089
1582	1582	R-HSA-1462054	Alpha-defensins R-HSA-1462054	585	2,10,286,585,2629		
1583	1583	R-HSA-428542	Regulation of commissural axon pathfinding by SLIT and ROBO R-HSA-428542	86	8,29,31,86,2629		
1584	1584	R-HSA-9020958	Interleukin-21 signaling R-HSA-9020958	674	2,16,34,674,2629		
1585	1585	R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs R-HSA-111367	913	19,913,2629		
1586	1586	R-HSA-193697	p75NTR regulates axonogenesis R-HSA-193697	294	0,142,294,2629	1659,2085	1659,2085
1587	1587	R-HSA-399997	Acetylcholine regulates insulin secretion R-HSA-399997	398	1,248,398,2629		
1588	1588	R-HSA-9758881	Uptake of dietary cobalamins into enterocytes R-HSA-9758881	1084	1,107,187,1084,2629		
1589	1589	R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151	1184	1,107,1184,2629		
1590	1590	R-HSA-549127	Organic cation transport R-HSA-549127	1330	18,73,366,1330,2629		
1591	1591	R-HSA-1855167	Synthesis of pyrophosphates in the cytosol R-HSA-1855167	634	1,634,2629		
1592	1592	R-HSA-9762293	Regulation of CDH11 gene transcription R-HSA-9762293	923	138,214,334,526,849,855,923,2629		
1593	1593	R-HSA-2470946	Cohesin Loading onto Chromatin R-HSA-2470946	1423	24,30,40,1423,2629		
1594	1594	R-HSA-8875656	MET receptor recycling R-HSA-8875656	389	0,32,389,2629		
1595	1595	R-HSA-390450	Folding of actin by CCT/TriC R-HSA-390450	834	3,290,329,834,2629		
1596	1596	R-HSA-9832991	Formation of the posterior neural plate R-HSA-9832991	182	8,182,2629		
1597	1597	R-HSA-9759811	Regulation of CDH11 mRNA translation by microRNAs R-HSA-9759811	923	138,214,334,526,849,855,923,2629		
1598	1598	R-HSA-168799	Neurotoxicity of clostridium toxins R-HSA-168799	909	4,11,433,909,2629	1968,1994,2109,2116,2136,2172,2213,2420	1968,1994,2109,2116,2136,2172,2213,2420
1599	1599	R-HSA-198693	AKT phosphorylates targets in the nucleus R-HSA-198693	70	0,53,70,2629		
1600	1600	R-HSA-9706019	RHOBTB3 ATPase cycle R-HSA-9706019	21	0,21,2629		
1601	1601	R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway R-HSA-975578	985	3,6,54,114,985,2629		
1602	1602	R-HSA-419812	Calcitonin-like ligand receptors R-HSA-419812	319	0,23,36,319,2629		
1603	1603	R-HSA-1250342	PI3K events in ERBB4 signaling R-HSA-1250342	533	0,32,533,2629		
1604	1604	R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation R-HSA-2151209	313	61,313,2629		
1605	1605	R-HSA-8963901	Chylomicron remodeling R-HSA-8963901	816	18,409,816,2629		
1606	1606	R-HSA-190377	FGFR2b ligand binding and activation R-HSA-190377	1160	0,32,347,421,1160,2629		
1607	1607	R-HSA-418889	Caspase activation via Dependence Receptors in the absence of ligand R-HSA-418889	977	92,119,977,2629		
1608	1608	R-HSA-8877330	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) R-HSA-8877330	76	5,7,9,76,2629		
1609	1609	R-HSA-203615	eNOS activation R-HSA-203615	1396	1,1396,2629		
1610	1610	R-HSA-5687613	Diseases associated with surfactant metabolism R-HSA-5687613	72	4,72,2629	1706,1786,2349,2423,2444,2482,2611	1706,1786,2349,2423,2444,2482,2611
1611	1611	R-HSA-110056	MAPK3 (ERK1) activation R-HSA-110056	1066	0,49,63,1066,2629		
1612	1612	R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression R-HSA-164940	1116	4,11,12,80,180,937,1116,2629		
1613	1613	R-HSA-8951936	RUNX3 regulates p14-ARF R-HSA-8951936	298	5,7,9,298,2629		
1614	1614	R-HSA-425381	Bicarbonate transporters R-HSA-425381	252	18,73,252,2629		
1615	1615	R-HSA-209968	Thyroxine biosynthesis R-HSA-209968	1210	1,44,1210,2629	2212	2212
1616	1616	R-HSA-111932	CaMK IV-mediated phosphorylation of CREB R-HSA-111932	803	0,23,28,51,53,333,578,621,719,770,795,803,2629		
1617	1617	R-HSA-428643	Organic anion transporters R-HSA-428643	252	18,73,252,2629		
1618	1618	R-HSA-450341	Activation of the AP-1 family of transcription factors R-HSA-450341	866	2,10,16,34,127,154,222,224,233,234,247,249,253,264,268,277,280,299,302,303,438,489,866,2629		
1619	1619	R-HSA-70635	Urea cycle R-HSA-70635	44	1,44,2629		
1620	1620	R-HSA-3215018	Processing and activation of SUMO R-HSA-3215018	110	3,6,110,2629	1837,1882,1931	1837,1882,1931
1621	1621	R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes R-HSA-381183	1464	13,15,322,1464,2629		
1622	1622	R-HSA-442380	Zinc influx into cells by the SLC39 gene family R-HSA-442380	1312	18,73,366,1022,1312,2629		
1623	1623	R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins R-HSA-159782	1539	3,6,503,1539,2629		
1624	1624	R-HSA-75072	mRNA Editing R-HSA-75072	19	19,2629	1780,2348	1727,1780,2242,2312,2348
1625	1625	R-HSA-194002	Glucocorticoid biosynthesis R-HSA-194002	791	1,17,140,791,2629		
1626	1626	R-HSA-9617629	Regulation of FOXO transcriptional activity by acetylation R-HSA-9617629	469	5,7,9,469,2629		
1627	1627	R-HSA-159740	Gamma-carboxylation of protein precursors R-HSA-159740	1539	3,6,503,1539,2629		
1628	1628	R-HSA-418890	Role of second messengers in netrin-1 signaling R-HSA-418890	616	8,29,31,616,2629		
1629	1629	R-HSA-9757110	Prednisone ADME R-HSA-9757110	244	244,2629		
1630	1630	R-HSA-8964058	HDL remodeling R-HSA-8964058	816	18,409,816,2629		
1631	1631	R-HSA-9702518	STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518	1293	4,37,938,1293,2629		
1632	1632	R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation R-HSA-2892245	874	8,874,2629		
1633	1633	R-HSA-8963888	Chylomicron assembly R-HSA-8963888	1172	18,409,1172,2629		
1634	1634	R-HSA-451308	Activation of Ca-permeable Kainate Receptor R-HSA-451308	1580	41,69,93,894,1580,2629		
1635	1635	R-HSA-74749	Signal attenuation R-HSA-74749	575	0,32,373,575,2629		
1636	1636	R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors R-HSA-8866904	757	5,7,9,757,2629		
1637	1637	R-HSA-937042	IRAK2 mediated activation of TAK1 complex R-HSA-937042	233,303	2,10,127,154,222,224,233,234,299,302,303,2629		
1638	1638	R-HSA-2465910	MASTL Facilitates Mitotic Progression R-HSA-2465910	159	24,30,40,159,2629		
1639	1639	R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide R-HSA-1247673	1426	18,1426,2629		
1640	1640	R-HSA-389887	Beta-oxidation of pristanoyl-CoA R-HSA-389887	918	1,17,122,918,2629		
1641	1641	R-HSA-162592	Integration of provirus R-HSA-162592	1368	4,11,12,80,150,1368,2629	1835,2156,2176	1835,2156,2176
1642	1642	R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 R-HSA-8849469	573	0,573,577,2629		
1643	1643	R-HSA-3785653	Myoclonic epilepsy of Lafora R-HSA-3785653	1274	4,72,821,1274,2629		
1644	1644	R-HSA-2562578	TRIF-mediated programmed cell death R-HSA-2562578	249	2,10,127,154,247,249,2629		
1645	1645	R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids R-HSA-2142688	514	1,17,122,514,2629		
1646	1646	R-HSA-1253288	Downregulation of ERBB4 signaling R-HSA-1253288	533	0,32,533,2629		
1647	1647	R-HSA-427601	Multifunctional anion exchangers R-HSA-427601	252	18,73,252,2629		
1648	1648	R-HSA-198203	PI3K/AKT activation R-HSA-198203	225	0,32,176,225,2629		
1649	1649	R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus R-HSA-159763	1539	3,6,503,1539,2629		
1650	1650	R-HSA-447041	CHL1 interactions R-HSA-447041	202	8,29,31,202,2629		
1651	1651	R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) R-HSA-2142816	514	1,17,122,514,2629		
1652	1652	R-HSA-9768778	Regulation of NPAS4 mRNA translation R-HSA-9768778	1410	5,7,9,824,1410,2629		
1653	1653	R-HSA-8943723	Regulation of PTEN mRNA translation R-HSA-8943723	164	0,53,70,164,2629	1751	1751
1654	1654	R-HSA-2179392	EGFR Transactivation by Gastrin R-HSA-2179392	1217	0,23,28,88,1217,2629		
1655	1655	R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors R-HSA-629597	1491	41,69,93,1391,1491,2629		
1656	1656	R-HSA-390696	Adrenoceptors R-HSA-390696	706	0,23,36,48,706,2629		
1657	1657	R-HSA-1296052	Ca2+ activated K+ channels R-HSA-1296052	267	41,267,2629		
1658	1658	R-HSA-139915	Activation of PUMA and translocation to mitochondria R-HSA-139915	902	92,119,556,902,2629		
1659	1659	R-HSA-193634	Axonal growth inhibition (RHOA activation) R-HSA-193634	1586	0,142,294,1586,2629		
1660	1660	R-HSA-419771	Opsins R-HSA-419771	48	0,23,36,48,2629		
1661	1661	R-HSA-9613354	Lipophagy R-HSA-9613354	372	146,170,372,2629		
1662	1662	R-HSA-9662834	CD163 mediating an anti-inflammatory response R-HSA-9662834	174	4,11,84,85,174,175,2629		
1663	1663	R-HSA-8985947	Interleukin-9 signaling R-HSA-8985947	674	2,16,34,674,2629		
1664	1664	R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells R-HSA-8876493	1156	4,11,433,1156,2629		
1665	1665	R-HSA-9636383	Prevention of phagosomal-lysosomal fusion R-HSA-9636383	1439	4,11,433,967,1054,1439,2629		
1666	1666	R-HSA-2025928	Calcineurin activates NFAT R-HSA-2025928	380	2,14,128,380,2629		
1667	1667	R-HSA-448706	Interleukin-1 processing R-HSA-448706	144	2,16,34,144,2629		
1668	1668	R-HSA-5576890	Phase 3 - rapid repolarisation R-HSA-5576890	181	98,181,2629		
1669	1669	R-HSA-110357	Displacement of DNA glycosylase by APEX1 R-HSA-110357	750	46,340,750,2629		
1670	1670	R-HSA-1483115	Hydrolysis of LPC R-HSA-1483115	185	1,17,91,185,2629		
1671	1671	R-HSA-6811555	PI5P Regulates TP53 Acetylation R-HSA-6811555	897	5,7,9,45,132,897,2629		
1672	1672	R-HSA-167590	Nef Mediated CD4 Down-regulation R-HSA-167590	1116	4,11,12,80,180,937,1116,2629		
1673	1673	R-HSA-156587	Amino Acid conjugation R-HSA-156587	243	1,82,243,2629	1697	1697,1716,1919,2282
1674	1674	R-HSA-8983711	OAS antiviral response R-HSA-8983711	145	2,16,66,145,2629		
1675	1675	R-HSA-212718	EGFR interacts with phospholipase C-gamma R-HSA-212718	586	0,32,586,2629		
1676	1676	R-HSA-426486	Small interfering RNA (siRNA) biogenesis R-HSA-426486	165	5,165,2629		
1677	1677	R-HSA-9668250	Defective factor IX causes hemophilia B R-HSA-9668250	1263	4,1162,1263,2629	1907,2167,2327,2575	1907,2167,2327,2575
1678	1678	R-HSA-727802	Transport of nucleotide sugars R-HSA-727802	696	18,73,696,2629		
1679	1679	R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins R-HSA-5666185	50	0,21,22,50,2629		
1680	1680	R-HSA-9683673	Maturation of protein 3a R-HSA-9683673	934	4,11,12,35,156,934,2629		
1681	1681	R-HSA-9026519	Activated NTRK2 signals through RAS R-HSA-9026519	999	0,32,176,999,2629		
1682	1682	R-HSA-9840373	Cellular response to mitochondrial stress R-HSA-9840373	15	13,15,2629		
1683	1683	R-HSA-9020933	Interleukin-23 signaling R-HSA-9020933	541	2,16,34,541,2629		
1684	1684	R-HSA-9010642	ROBO receptors bind AKAP5 R-HSA-9010642	86	8,29,31,86,2629		
1685	1685	R-HSA-6787450	tRNA modification in the mitochondrion R-HSA-6787450	235	19,235,2629		
1686	1686	R-HSA-977347	Serine biosynthesis R-HSA-977347	44	1,44,2629		
1687	1687	R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation R-HSA-113507	1072	24,30,148,179,1072,2629		
1688	1688	R-HSA-9623433	NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis R-HSA-9623433	649	0,59,649,2629		
1689	1689	R-HSA-391908	Prostanoid ligand receptors R-HSA-391908	1310	0,23,36,48,1310,2629		
1690	1690	R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members R-HSA-111453	556	92,119,556,2629		
1691	1691	R-HSA-8948747	Regulation of PTEN localization R-HSA-8948747	164	0,53,70,164,2629		
1692	1692	R-HSA-1300642	Sperm Motility And Taxes R-HSA-1300642	988	137,988,2629		
1693	1693	R-HSA-9754706	Atorvastatin ADME R-HSA-9754706	244	244,2629		
1694	1694	R-HSA-2161522	Abacavir ADME R-HSA-2161522	244	244,2629	1957,2105	1957,2105
1695	1695	R-HSA-9694719	Maturation of protein 3a R-HSA-9694719	545	4,11,12,35,56,441,545,2629		
1696	1696	R-HSA-2428933	SHC-related events triggered by IGF1R R-HSA-2428933	588	0,32,580,588,2629		
1697	1697	R-HSA-159424	Conjugation of carboxylic acids R-HSA-159424	1673	1,82,243,1673,2629	1716,1919,2282	1716,1919,2282
1698	1698	R-HSA-8874211	CREB3 factors activate genes R-HSA-8874211	322	13,15,322,2629		
1699	1699	R-HSA-425986	Sodium/Proton exchangers R-HSA-425986	252	18,73,252,2629		
1700	1700	R-HSA-112411	MAPK1 (ERK2) activation R-HSA-112411	1066	0,49,63,1066,2629		
1701	1701	R-HSA-9029558	NR1H2 & NR1H3 regulate gene expression linked to lipogenesis R-HSA-9029558	649	0,59,649,2629		
1702	1702	R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se R-HSA-2408508	209	1,44,209,2629		
1703	1703	R-HSA-8951671	RUNX3 regulates YAP1-mediated transcription R-HSA-8951671	298	5,7,9,298,2629		
1704	1704	R-HSA-9034864	Activated NTRK3 signals through RAS R-HSA-9034864	1255	0,32,176,1255,2629		
1705	1705	R-HSA-8939242	RUNX1 regulates transcription of genes involved in differentiation of keratinocytes R-HSA-8939242	76	5,7,9,76,2629		
1706	1706	R-HSA-5688849	Defective CSF2RB causes SMDP5 R-HSA-5688849	1610	4,72,1610,2629		
1707	1707	R-HSA-2142789	Ubiquinol biosynthesis R-HSA-2142789	1184	1,107,1184,2629		
1708	1708	R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine R-HSA-446210	487	3,6,54,390,487,2629		
1709	1709	R-HSA-9726840	SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840	1767	4,37,375,1767,2629		
1710	1710	R-HSA-73942	DNA Damage Reversal R-HSA-73942	46	46,2629	1813,2454	1813,2097,2454,2620
1711	1711	R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins R-HSA-8850843	808	1,293,808,2629		
1712	1712	R-HSA-194313	VEGF ligand-receptor interactions R-HSA-194313	254	0,32,254,2629	1746	1746
1713	1713	R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands R-HSA-444473	103	0,23,36,48,103,2629		
1714	1714	R-HSA-190370	FGFR1b ligand binding and activation R-HSA-190370	1205	0,32,347,602,1205,2629		
1715	1715	R-HSA-3323169	Defects in biotin (Btn) metabolism R-HSA-3323169	1093	4,72,1093,2629	1818,2399	1818,2399
1716	1716	R-HSA-177128	Conjugation of salicylate with glycine R-HSA-177128	1697	1,82,243,1673,1697,2629		
1717	1717	R-HSA-8963896	HDL assembly R-HSA-8963896	1172	18,409,1172,2629		
1718	1718	R-HSA-1483148	Synthesis of PG R-HSA-1483148	185	1,17,91,185,2629		
1719	1719	R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) R-HSA-2142670	514	1,17,122,514,2629		
1720	1720	R-HSA-428890	Role of ABL in ROBO-SLIT signaling R-HSA-428890	86	8,29,31,86,2629		
1721	1721	R-HSA-68952	DNA replication initiation R-HSA-68952	203	24,30,112,130,203,2629		
1722	1722	R-HSA-2046105	Linoleic acid (LA) metabolism R-HSA-2046105	1445	1,17,122,1445,2629		
1723	1723	R-HSA-5632681	Ligand-receptor interactions R-HSA-5632681	357	0,147,357,2629		
1724	1724	R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion R-HSA-434316	1566	1,248,398,1566,2629		
1725	1725	R-HSA-5362798	Release of Hh-Np from the secreting cell R-HSA-5362798	474	0,147,474,2629		
1726	1726	R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells R-HSA-210747	709	8,709,2629		
1727	1727	R-HSA-75094	Formation of the Editosome R-HSA-75094	1780	19,1624,1780,2629		
1728	1728	R-HSA-72731	Recycling of eIF2:GDP R-HSA-72731	204	3,60,204,206,2629		
1729	1729	R-HSA-9022702	MECP2 regulates transcription of neuronal ligands R-HSA-9022702	490	5,7,9,490,2629		
1730	1730	R-HSA-5340588	Signaling by RNF43 mutants R-HSA-5340588	817	4,37,817,2629		
1731	1731	R-HSA-77111	Synthesis of Ketone Bodies R-HSA-77111	1581	1,17,1581,2629		
1732	1732	R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters R-HSA-4411364	331	0,47,79,331,2629		
1733	1733	R-HSA-8951430	RUNX3 regulates WNT signaling R-HSA-8951430	298	5,7,9,298,2629		
1734	1734	R-HSA-9818749	Regulation of NFE2L2 gene expression R-HSA-9818749	297	13,15,89,195,297,2629		
1735	1735	R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors R-HSA-389397	103	0,23,36,48,103,2629		
1736	1736	R-HSA-9845576	Glycosphingolipid transport R-HSA-9845576	18	18,2629		
1737	1737	R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components R-HSA-446388	1213	138,214,1213,2629		
1738	1738	R-HSA-6793080	rRNA modification in the mitochondrion R-HSA-6793080	1486	19,94,1486,2629		
1739	1739	R-HSA-428543	Inactivation of CDC42 and RAC1 R-HSA-428543	86	8,29,31,86,2629		
1740	1740	R-HSA-201688	WNT mediated activation of DVL R-HSA-201688	79	0,47,79,2629		
1741	1741	R-HSA-5358493	Synthesis of diphthamide-EEF2 R-HSA-5358493	503	3,6,503,2629		
1742	1742	R-HSA-3656225	Defective CHST6 causes MCDC1 R-HSA-3656225	718	4,72,157,718,2629		
1743	1743	R-HSA-75158	TRAIL  signaling R-HSA-75158	142	0,142,2629		
1744	1744	R-HSA-164944	Nef and signal transduction R-HSA-164944	937	4,11,12,80,180,937,2629		
1745	1745	R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) R-HSA-3656244	718	4,72,157,718,2629		
1746	1746	R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399	1712	0,32,254,1712,2629		
1747	1747	R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15 R-HSA-3656243	718	4,72,157,718,2629		
1748	1748	R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair R-HSA-110362	1002	46,340,750,1002,2629		
1749	1749	R-HSA-3595172	Defective CHST3 causes SEDCJD R-HSA-3595172	718	4,72,157,718,2629		
1750	1750	R-HSA-9818032	NFE2L2 regulating MDR associated enzymes R-HSA-9818032	297	13,15,89,195,297,2629		
1751	1751	R-HSA-8948700	Competing endogenous RNAs (ceRNAs) regulate PTEN translation R-HSA-8948700	1653	0,53,70,164,1653,2629		
1752	1752	R-HSA-111469	SMAC, XIAP-regulated apoptotic response R-HSA-111469	1149	92,119,556,1149,2629	1812,1850	1812,1850
1753	1753	R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer R-HSA-5638302	997	4,37,997,2629	1785	1785
1754	1754	R-HSA-8941332	RUNX2 regulates genes involved in cell migration R-HSA-8941332	207	5,7,9,207,2629		
1755	1755	R-HSA-68689	CDC6 association with the ORC:origin complex R-HSA-68689	158	112,133,158,2629		
1756	1756	R-HSA-3595177	Defective CHSY1 causes TPBS R-HSA-3595177	718	4,72,157,718,2629		
1757	1757	R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity R-HSA-163680	248	1,248,2629		
1758	1758	R-HSA-418886	Netrin mediated repulsion signals R-HSA-418886	616	8,29,31,616,2629		
1759	1759	R-HSA-444821	Relaxin receptors R-HSA-444821	103	0,23,36,48,103,2629		
1760	1760	R-HSA-174577	Activation of C3 and C5 R-HSA-174577	223	2,10,223,2629		
1761	1761	R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer R-HSA-3304351	37	4,37,2629	1795,1846,2166,2185	1795,1846,1867,1885,2017,2163,2166,2175,2185,2190,2253
1762	1762	R-HSA-70921	Histidine catabolism R-HSA-70921	44	1,44,2629		
1763	1763	R-HSA-9732724	IFNG signaling activates MAPKs R-HSA-9732724	287	2,16,66,287,2629		
1764	1764	R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type R-HSA-3595174	718	4,72,157,718,2629		
1765	1765	R-HSA-9823587	Defects of platelet adhesion to exposed collagen R-HSA-9823587	1162	4,1162,2629	1814,1824,2027,2100,2111	1814,1824,2027,2100,2111
1766	1766	R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA R-HSA-450520	355	19,355,2629		
1767	1767	R-HSA-9660537	Signaling by MRAS-complex mutants R-HSA-9660537	375	4,37,375,2629	1709,1775	1709,1775
1768	1768	R-HSA-9761174	Formation of intermediate mesoderm R-HSA-9761174	182	8,182,2629		
1769	1769	R-HSA-9017802	Noncanonical activation of NOTCH3 R-HSA-9017802	1018	0,74,625,1018,2629		
1770	1770	R-HSA-9818028	NFE2L2 regulates pentose phosphate pathway genes R-HSA-9818028	297	13,15,89,195,297,2629		
1771	1771	R-HSA-9018682	Biosynthesis of maresins R-HSA-9018682	1258	1,17,1170,1258,2629	1871	1871
1772	1772	R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration R-HSA-416550	1041	8,29,31,477,1041,2629		
1773	1773	R-HSA-804914	Transport of fatty acids R-HSA-804914	696	18,73,696,2629		
1774	1774	R-HSA-9715370	Miro GTPase Cycle R-HSA-9715370	21	0,21,2629	1823,1963	1823,1963
1775	1775	R-HSA-9726842	Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842	1767	4,37,375,1767,2629		
1776	1776	R-HSA-9758890	Transport of RCbl within the body R-HSA-9758890	1084	1,107,187,1084,2629		
1777	1777	R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes) R-HSA-1236973	258	2,14,43,258,2629		
1778	1778	R-HSA-9012546	Interleukin-18 signaling R-HSA-9012546	144	2,16,34,144,2629		
1779	1779	R-HSA-166662	Lectin pathway of complement activation R-HSA-166662	436	2,10,223,384,436,2629	2011	2011
1780	1780	R-HSA-72200	mRNA Editing: C to U Conversion R-HSA-72200	1624	19,1624,2629	1727	1727
1781	1781	R-HSA-166665	Terminal pathway of complement R-HSA-166665	223	2,10,223,2629		
1782	1782	R-HSA-196836	Vitamin C (ascorbate) metabolism R-HSA-196836	187	1,107,187,2629		
1783	1783	R-HSA-442729	CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde R-HSA-442729	383	41,69,93,311,383,2629		
1784	1784	R-HSA-163765	ChREBP activates metabolic gene expression R-HSA-163765	248	1,248,2629		
1785	1785	R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR R-HSA-5638303	1753	4,37,997,1753,2629		
1786	1786	R-HSA-5688890	Defective CSF2RA causes SMDP4 R-HSA-5688890	1610	4,72,1610,2629		
1787	1787	R-HSA-9619229	Activation of RAC1 downstream of NMDARs R-HSA-9619229	383	41,69,93,311,383,2629		
1788	1788	R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway R-HSA-5649702	750	46,340,750,2629		
1789	1789	R-HSA-8941855	RUNX3 regulates CDKN1A transcription R-HSA-8941855	298	5,7,9,298,2629		
1790	1790	R-HSA-9652817	Signaling by MAPK mutants R-HSA-9652817	375	4,37,375,2629		
1791	1791	R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription R-HSA-5635851	357	0,147,357,2629		
1792	1792	R-HSA-1482883	Acyl chain remodeling of DAG and TAG R-HSA-1482883	185	1,17,91,185,2629		
1793	1793	R-HSA-9758919	Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919	182	8,182,2629		
1794	1794	R-HSA-8848584	Wax and plasmalogen biosynthesis R-HSA-8848584	17	1,17,2629	2103,2202	2103,2202
1795	1795	R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer R-HSA-3304349	1761	4,37,1761,2629	1885,2190	1885,2190
1796	1796	R-HSA-190371	FGFR3b ligand binding and activation R-HSA-190371	1443	0,32,347,728,1443,2629		
1797	1797	R-HSA-196783	Coenzyme A biosynthesis R-HSA-196783	1134	1,107,187,1134,2629		
1798	1798	R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660826	1847	4,37,527,1847,2629		
1799	1799	R-HSA-9662001	Defective factor VIII causes hemophilia A R-HSA-9662001	1263	4,1162,1263,2629	2113,2120,2171,2254,2459,2520,2570	2113,2120,2171,2254,2459,2520,2570
1800	1800	R-HSA-9664535	LTC4-CYSLTR mediated IL4 production R-HSA-9664535	174	4,11,84,85,174,175,2629		
1801	1801	R-HSA-6814848	Glycerophospholipid catabolism R-HSA-6814848	367	1,17,91,367,2629		
1802	1802	R-HSA-192456	Digestion of dietary lipid R-HSA-192456	1048	935,1048,2629		
1803	1803	R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767	583	24,30,40,159,583,2629		
1804	1804	R-HSA-6785470	tRNA processing in the mitochondrion R-HSA-6785470	235	19,235,2629		
1805	1805	R-HSA-9028335	Activated NTRK2 signals through PI3K R-HSA-9028335	999	0,32,176,999,2629		
1806	1806	R-HSA-447043	Neurofascin interactions R-HSA-447043	202	8,29,31,202,2629		
1807	1807	R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins R-HSA-2393930	1240	1,293,808,1240,2629		
1808	1808	R-HSA-629587	Highly sodium permeable postsynaptic acetylcholine nicotinic receptors R-HSA-629587	1383,1491	41,69,93,1383,1391,1491,2629		
1809	1809	R-HSA-426496	Post-transcriptional silencing by small RNAs R-HSA-426496	165	5,165,2629		
1810	1810	R-HSA-9022537	Loss of MECP2 binding ability to the NCoR/SMRT complex R-HSA-9022537	1428	4,1428,1432,1433,1449,2629		
1811	1811	R-HSA-162791	Attachment of GPI anchor to uPAR R-HSA-162791	321	3,6,321,2629		
1812	1812	R-HSA-111464	SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes  R-HSA-111464	1752	92,119,556,1149,1752,2629		
1813	1813	R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases R-HSA-73943	1710	46,1710,2629	2097,2620	2097,2620
1814	1814	R-HSA-9845620	Enhanced binding of GP1BA variant to VWF multimer:collagen  R-HSA-9845620	1765	4,1162,1765,2629		
1815	1815	R-HSA-9637628	Modulation by Mtb of host immune system R-HSA-9637628	967	4,11,433,967,2629		
1816	1816	R-HSA-170984	ARMS-mediated activation R-HSA-170984	1392	0,32,176,225,825,1392,2629		
1817	1817	R-HSA-199920	CREB phosphorylation R-HSA-199920	501,866	0,2,10,16,32,34,127,154,176,222,224,225,233,234,247,249,253,264,268,277,280,299,302,303,438,489,501,866,2629		
1818	1818	R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency R-HSA-3371599	1715	4,72,1093,1715,2629		
1819	1819	R-HSA-5652084	Fructose metabolism R-HSA-5652084	58	1,58,2629	1928,2274	1928,2274
1820	1820	R-HSA-447038	NrCAM interactions R-HSA-447038	202	8,29,31,202,2629		
1821	1821	R-HSA-111457	Release of apoptotic factors from the mitochondria R-HSA-111457	1149	92,119,556,1149,2629		
1822	1822	R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors R-HSA-163767	248	1,248,2629		
1823	1823	R-HSA-9013419	RHOT2 GTPase cycle R-HSA-9013419	1774	0,21,1774,2629		
1824	1824	R-HSA-9846298	Defective binding of VWF variant to GPIb:IX:V R-HSA-9846298	1765	4,1162,1765,2629		
1825	1825	R-HSA-9693928	Defective RIPK1-mediated regulated necrosis R-HSA-9693928	266	4,266,2629	2047	2047
1826	1826	R-HSA-9764302	Regulation of CDH19 Expression and Function R-HSA-9764302	855	138,214,334,526,849,855,2629		
1827	1827	R-HSA-9027283	Erythropoietin activates STAT5 R-HSA-9027283	1000	0,1000,2629		
1828	1828	R-HSA-9032500	Activated NTRK2 signals through FYN R-HSA-9032500	999	0,32,176,999,2629	1950	1950
1829	1829	R-HSA-9706377	FLT3 signaling by CBL mutants R-HSA-9706377	938	4,37,938,2629		
1830	1830	R-HSA-8939246	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246	76	5,7,9,76,2629		
1831	1831	R-HSA-112412	SOS-mediated signalling R-HSA-112412	632	0,32,373,575,580,588,600,632,2629		
1832	1832	R-HSA-9833576	CDH11 homotypic and heterotypic interactions R-HSA-9833576	1577	138,214,334,526,849,855,923,1577,2629		
1833	1833	R-HSA-9759218	Cobalamin (Cbl) metabolism R-HSA-9759218	1084	1,107,187,1084,2629		
1834	1834	R-HSA-9027277	Erythropoietin activates Phospholipase C gamma (PLCG) R-HSA-9027277	1000	0,1000,2629		
1835	1835	R-HSA-164843	2-LTR circle formation R-HSA-164843	1641	4,11,12,80,150,1368,1641,2629		
1836	1836	R-HSA-9645135	STAT5 Activation R-HSA-9645135	756	2,16,756,2629		
1837	1837	R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9) R-HSA-3065678	1620	3,6,110,1620,2629		
1838	1838	R-HSA-9014826	Interleukin-36 pathway R-HSA-9014826	144	2,16,34,144,2629		
1839	1839	R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants R-HSA-6802953	375	4,37,375,2629		
1840	1840	R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives R-HSA-2142712	514	1,17,122,514,2629		
1841	1841	R-HSA-182218	Nef Mediated CD8 Down-regulation R-HSA-182218	1116	4,11,12,80,180,937,1116,2629		
1842	1842	R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production  R-HSA-3134963	480	2,10,480,2629		
1843	1843	R-HSA-5603029	IkBA variant leads to EDA-ID R-HSA-5603029	882	4,882,892,2629		
1844	1844	R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels R-HSA-5576894	181	98,181,2629		
1845	1845	R-HSA-196843	Vitamin B2 (riboflavin) metabolism R-HSA-196843	187	1,107,187,2629		
1846	1846	R-HSA-3656534	Loss of Function of TGFBR1 in Cancer R-HSA-3656534	1761	4,37,1761,2629	1867,2017	1867,2017
1847	1847	R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660825	527	4,37,527,2629	1798	1798
1848	1848	R-HSA-2187335	The retinoid cycle in cones (daylight vision) R-HSA-2187335	282	26,282,2629		
1849	1849	R-HSA-426117	Cation-coupled Chloride cotransporters R-HSA-426117	252	18,73,252,2629		
1850	1850	R-HSA-111463	SMAC (DIABLO) binds to IAPs  R-HSA-111463	1752	92,119,556,1149,1752,2629		
1851	1851	R-HSA-420597	Nectin/Necl  trans heterodimerization R-HSA-420597	526	138,214,334,526,2629		
1852	1852	R-HSA-9033500	TYSND1 cleaves peroxisomal proteins R-HSA-9033500	486	129,486,2629		
1853	1853	R-HSA-9635465	Suppression of apoptosis R-HSA-9635465	1054	4,11,433,967,1054,2629		
1854	1854	R-HSA-444257	RSK activation R-HSA-444257	951	41,69,93,311,383,951,2629		
1855	1855	R-HSA-187015	Activation of TRKA receptors R-HSA-187015	225	0,32,176,225,2629	1961,2336	1961,2336
1856	1856	R-HSA-1614517	Sulfide oxidation to sulfate R-HSA-1614517	1321	1,44,950,1321,2629		
1857	1857	R-HSA-5693548	Sensing of DNA Double Strand Breaks R-HSA-5693548	395	46,125,395,2629		
1858	1858	R-HSA-5336415	Uptake and function of diphtheria toxin R-HSA-5336415	909	4,11,433,909,2629		
1859	1859	R-HSA-193144	Estrogen biosynthesis R-HSA-193144	791	1,17,140,791,2629		
1860	1860	R-HSA-193993	Mineralocorticoid biosynthesis R-HSA-193993	791	1,17,140,791,2629		
1861	1861	R-HSA-6806942	MET Receptor Activation R-HSA-6806942	389	0,32,389,2629		
1862	1862	R-HSA-8964041	LDL remodeling R-HSA-8964041	816	18,409,816,2629		
1863	1863	R-HSA-8939245	RUNX1 regulates transcription of genes involved in BCR signaling R-HSA-8939245	76	5,7,9,76,2629		
1864	1864	R-HSA-1482798	Acyl chain remodeling of CL R-HSA-1482798	185	1,17,91,185,2629		
1865	1865	R-HSA-1237112	Methionine salvage pathway R-HSA-1237112	950	1,44,950,2629		
1866	1866	R-HSA-433692	Proton-coupled monocarboxylate transport R-HSA-433692	366	18,73,366,2629		
1867	1867	R-HSA-3656532	TGFBR1 KD Mutants in Cancer R-HSA-3656532	1846	4,37,1761,1846,2629		
1868	1868	R-HSA-5660668	CLEC7A/inflammasome pathway R-HSA-5660668	281	2,10,162,281,2629		
1869	1869	R-HSA-446199	Synthesis of Dolichyl-phosphate R-HSA-446199	487	3,6,54,390,487,2629		
1870	1870	R-HSA-6798163	Choline catabolism R-HSA-6798163	44	1,44,2629		
1871	1871	R-HSA-9027307	Biosynthesis of maresin-like SPMs R-HSA-9027307	1771	1,17,1170,1258,1771,2629		
1872	1872	R-HSA-9706374	FLT3 signaling through SRC family kinases R-HSA-9706374	756	2,16,756,2629		
1873	1873	R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe) R-HSA-6782861	688	19,235,688,2629		
1874	1874	R-HSA-3000484	Scavenging by Class F Receptors R-HSA-3000484	291	20,291,2629		
1875	1875	R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage R-HSA-111459	1411	92,119,556,1149,1411,2629		
1876	1876	R-HSA-1566977	Fibronectin matrix formation R-HSA-1566977	55	55,2629		
1877	1877	R-HSA-8964208	Phenylalanine metabolism R-HSA-8964208	1568	1,44,1568,2629		
1878	1878	R-HSA-6787639	GDP-fucose biosynthesis R-HSA-6787639	487	3,6,54,390,487,2629		
1879	1879	R-HSA-9603381	Activated NTRK3 signals through PI3K R-HSA-9603381	1255	0,32,176,1255,2629		
1880	1880	R-HSA-8931987	RUNX1 regulates estrogen receptor mediated transcription R-HSA-8931987	76	5,7,9,76,2629		
1881	1881	R-HSA-6799990	Metal sequestration by antimicrobial proteins R-HSA-6799990	286	2,10,286,2629		
1882	1882	R-HSA-3065679	SUMO is proteolytically processed R-HSA-3065679	1620	3,6,110,1620,2629		
1883	1883	R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives R-HSA-2142770	514	1,17,122,514,2629		
1884	1884	R-HSA-8964572	Lipid particle organization R-HSA-8964572	17	1,17,2629		
1885	1885	R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer R-HSA-3304356	1795	4,37,1761,1795,2629		
1886	1886	R-HSA-388479	Vasopressin-like receptors R-HSA-388479	103	0,23,36,48,103,2629		
1887	1887	R-HSA-8851907	MET activates PI3K/AKT signaling R-HSA-8851907	389	0,32,389,2629		
1888	1888	R-HSA-947581	Molybdenum cofactor biosynthesis R-HSA-947581	187	1,107,187,2629		
1889	1889	R-HSA-389599	Alpha-oxidation of phytanate R-HSA-389599	918	1,17,122,918,2629		
1890	1890	R-HSA-9730628	Sensory perception of salty taste R-HSA-9730628	650	26,650,2629		
1891	1891	R-HSA-8857538	PTK6 promotes HIF1A stabilization R-HSA-8857538	573	0,573,577,2629		
1892	1892	R-HSA-9018679	Biosynthesis of EPA-derived SPMs R-HSA-9018679	1170	1,17,1170,2629	1972,2035	1972,2035
1893	1893	R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration R-HSA-8949275	298	5,7,9,298,2629		
1894	1894	R-HSA-9837092	FASTK family proteins regulate processing and stability of mitochondrial RNAs R-HSA-9837092	1469	19,1469,2629		
1895	1895	R-HSA-8964046	VLDL clearance R-HSA-8964046	761	18,409,761,2629		
1896	1896	R-HSA-8937144	Aryl hydrocarbon receptor signalling R-HSA-8937144	263	1,82,263,2629		
1897	1897	R-HSA-1300645	Acrosome Reaction and Sperm:Oocyte Membrane Binding R-HSA-1300645	988	137,988,2629		
1898	1898	R-HSA-211916	Vitamins R-HSA-211916	476	1,82,263,476,2629		
1899	1899	R-HSA-166187	Mitochondrial Uncoupling R-HSA-166187	188	1,120,188,2629	1976,1991,2378	1976,1991,2378
1900	1900	R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids R-HSA-77288	767	1,17,122,767,2629		
1901	1901	R-HSA-9634635	Estrogen-stimulated signaling through PRKCZ R-HSA-9634635	410	0,59,83,410,2629		
1902	1902	R-HSA-5626978	TNFR1-mediated ceramide production R-HSA-5626978	544	0,142,544,2629		
1903	1903	R-HSA-5339717	Signaling by LRP5 mutants  R-HSA-5339717	817	4,37,817,2629		
1904	1904	R-HSA-8939256	RUNX1 regulates transcription of genes involved in WNT signaling R-HSA-8939256	76	5,7,9,76,2629		
1905	1905	R-HSA-5674499	Negative feedback regulation of MAPK pathway R-HSA-5674499	678	0,49,63,65,678,2629		
1906	1906	R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum R-HSA-1912399	208	0,74,208,2629		
1907	1907	R-HSA-9673221	Defective F9 activation R-HSA-9673221	1677	4,1162,1263,1677,2629		
1908	1908	R-HSA-2142700	Synthesis of Lipoxins (LX) R-HSA-2142700	1170	1,17,1170,2629		
1909	1909	R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA R-HSA-77346	1565	1,17,122,767,1565,2629		
1910	1910	R-HSA-205025	NADE modulates death signalling R-HSA-205025	407	0,142,294,407,2629		
1911	1911	R-HSA-9013957	TLR3-mediated TICAM1-dependent programmed cell death R-HSA-9013957	264	2,10,127,264,2629		
1912	1912	R-HSA-176417	Phosphorylation of Emi1 R-HSA-176417	378	24,30,348,350,378,2629		
1913	1913	R-HSA-8849470	PTK6 Regulates Cell Cycle R-HSA-8849470	573	0,573,577,2629		
1914	1914	R-HSA-193670	p75NTR negatively regulates cell cycle via SC1 R-HSA-193670	294	0,142,294,2629		
1915	1915	R-HSA-3000471	Scavenging by Class B Receptors R-HSA-3000471	291	20,291,2629		
1916	1916	R-HSA-174362	Transport and synthesis of PAPS R-HSA-174362	192,1044	1,58,82,192,243,1044,2629		
1917	1917	R-HSA-9032845	Activated NTRK2 signals through CDK5 R-HSA-9032845	999	0,32,176,999,2629		
1918	1918	R-HSA-5676934	Protein repair R-HSA-5676934	3	3,2629		
1919	1919	R-HSA-177135	Conjugation of benzoate with glycine R-HSA-177135	1697	1,82,243,1673,1697,2629		
1920	1920	R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing R-HSA-8849468	573	0,573,577,2629		
1921	1921	R-HSA-69478	G2/M DNA replication checkpoint R-HSA-69478	126	24,62,126,2629		
1922	1922	R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi R-HSA-964739	114	3,6,54,114,2629	2184	2184
1923	1923	R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells R-HSA-210746	709	8,709,2629		
1924	1924	R-HSA-8963676	Intestinal absorption R-HSA-8963676	935	935,2629	2075,2615	2075,2615
1925	1925	R-HSA-112303	Electric Transmission Across Gap Junctions R-HSA-112303	2004	41,2004,2629		
1926	1926	R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA R-HSA-77352	1565	1,17,122,767,1565,2629		
1927	1927	R-HSA-391906	Leukotriene receptors R-HSA-391906	1310	0,23,36,48,1310,2629		
1928	1928	R-HSA-70350	Fructose catabolism R-HSA-70350	1819	1,58,1819,2629		
1929	1929	R-HSA-173736	Alternative complement activation R-HSA-173736	384	2,10,223,384,2629		
1930	1930	R-HSA-8935964	RUNX1 regulates expression of components of tight junctions R-HSA-8935964	76	5,7,9,76,2629		
1931	1931	R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1) R-HSA-3065676	1620	3,6,110,1620,2629		
1932	1932	R-HSA-427652	Sodium-coupled phosphate cotransporters R-HSA-427652	252	18,73,252,2629	2203	2203
1933	1933	R-HSA-71032	Propionyl-CoA catabolism R-HSA-71032	767	1,17,122,767,2629		
1934	1934	R-HSA-9031525	NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake  R-HSA-9031525	649	0,59,649,2629		
1935	1935	R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA R-HSA-77350	1565	1,17,122,767,1565,2629		
1936	1936	R-HSA-444209	Free fatty acid receptors R-HSA-444209	48	0,23,36,48,2629		
1937	1937	R-HSA-1606341	IRF3 mediated activation of type 1 IFN R-HSA-1606341	1109	2,10,480,1109,2629		
1938	1938	R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors R-HSA-163358	248	1,248,2629		
1939	1939	R-HSA-380095	Tachykinin receptors bind tachykinins R-HSA-380095	103	0,23,36,48,103,2629		
1940	1940	R-HSA-9818035	NFE2L2 regulating ER-stress associated genes R-HSA-9818035	297	13,15,89,195,297,2629		
1941	1941	R-HSA-196819	Vitamin B1 (thiamin) metabolism R-HSA-196819	187	1,107,187,2629		
1942	1942	R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors R-HSA-8866911	757	5,7,9,757,2629		
1943	1943	R-HSA-8964011	HDL clearance R-HSA-8964011	761	18,409,761,2629		
1944	1944	R-HSA-9705677	SARS-CoV-2 targets PDZ proteins in cell-cell junction R-HSA-9705677	95	4,11,12,35,56,95,2629		
1945	1945	R-HSA-8865999	MET activates PTPN11 R-HSA-8865999	389	0,32,389,2629		
1946	1946	R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection R-HSA-180689	180	4,11,12,80,180,2629		
1947	1947	R-HSA-8964026	Chylomicron clearance R-HSA-8964026	761	18,409,761,2629		
1948	1948	R-HSA-9793528	Ciprofloxacin ADME R-HSA-9793528	244	244,2629		
1949	1949	R-HSA-5083630	Defective LFNG causes SCDO3 R-HSA-5083630	454	4,72,157,454,2629		
1950	1950	R-HSA-9032759	NTRK2 activates RAC1 R-HSA-9032759	1828	0,32,176,999,1828,2629		
1951	1951	R-HSA-9632974	NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis  R-HSA-9632974	649	0,59,649,2629		
1952	1952	R-HSA-9673768	Signaling by membrane-tethered fusions of PDGFRA or PDGFRB R-HSA-9673768	1157	4,37,1157,2629		
1953	1953	R-HSA-9707587	Regulation of HMOX1 expression and activity R-HSA-9707587	478	13,15,89,478,2629		
1954	1954	R-HSA-390648	Muscarinic acetylcholine receptors R-HSA-390648	706	0,23,36,48,706,2629		
1955	1955	R-HSA-1169092	Activation of RAS in B cells R-HSA-1169092	380	2,14,128,380,2629		
1956	1956	R-HSA-446205	Synthesis of GDP-mannose R-HSA-446205	487	3,6,54,390,487,2629		
1957	1957	R-HSA-2161517	Abacavir transmembrane transport R-HSA-2161517	1694	244,1694,2629		
1958	1958	R-HSA-5662702	Melanin biosynthesis R-HSA-5662702	44	1,44,2629		
1959	1959	R-HSA-8849473	PTK6 Expression R-HSA-8849473	573	0,573,577,2629		
1960	1960	R-HSA-9022707	MECP2 regulates transcription factors R-HSA-9022707	490	5,7,9,490,2629		
1961	1961	R-HSA-187024	NGF-independant TRKA activation R-HSA-187024	1855	0,32,176,225,1855,2629		
1962	1962	R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer R-HSA-2644605	527	4,37,527,2629	1969	1969
1963	1963	R-HSA-9013425	RHOT1 GTPase cycle R-HSA-9013425	1774	0,21,1774,2629		
1964	1964	R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA R-HSA-77348	1565	1,17,122,767,1565,2629		
1965	1965	R-HSA-75157	FasL/ CD95L signaling R-HSA-75157	142	0,142,2629		
1966	1966	R-HSA-5661270	Formation of xylulose-5-phosphate R-HSA-5661270	58	1,58,2629		
1967	1967	R-HSA-8875513	MET interacts with TNS proteins R-HSA-8875513	724	0,32,389,724,2629		
1968	1968	R-HSA-5250955	Toxicity of botulinum toxin type D (botD) R-HSA-5250955	1598	4,11,433,909,1598,2629		
1969	1969	R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling R-HSA-2644607	1962	4,37,527,1962,2629		
1970	1970	R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA R-HSA-77310	1565	1,17,122,767,1565,2629		
1971	1971	R-HSA-1483226	Synthesis of PI R-HSA-1483226	185	1,17,91,185,2629		
1972	1972	R-HSA-9018896	Biosynthesis of E-series 18(S)-resolvins R-HSA-9018896	1892	1,17,1170,1892,2629		
1973	1973	R-HSA-390651	Dopamine receptors R-HSA-390651	706	0,23,36,48,706,2629		
1974	1974	R-HSA-74713	IRS activation R-HSA-74713	575	0,32,373,575,2629		
1975	1975	R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation R-HSA-140834	731	25,731,2629		
1976	1976	R-HSA-167826	The fatty acid cycling model R-HSA-167826	1899	1,120,188,1899,2629		
1977	1977	R-HSA-9818026	NFE2L2 regulating inflammation associated genes R-HSA-9818026	297	13,15,89,195,297,2629		
1978	1978	R-HSA-1306955	GRB7 events in ERBB2 signaling R-HSA-1306955	615	0,32,615,2629		
1979	1979	R-HSA-8952158	RUNX3 regulates BCL2L11 (BIM) transcription R-HSA-8952158	298	5,7,9,298,2629		
1980	1980	R-HSA-5624138	Trafficking of myristoylated proteins to the cilium R-HSA-5624138	607	61,100,607,2629		
1981	1981	R-HSA-9667769	Acetylcholine inhibits contraction of outer hair cells R-HSA-9667769	568	26,400,568,2629		
1982	1982	R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production R-HSA-3134973	480	2,10,480,2629		
1983	1983	R-HSA-8866376	Reelin signalling pathway R-HSA-8866376	31	8,29,31,2629		
1984	1984	R-HSA-8852405	Signaling by MST1 R-HSA-8852405	32	0,32,2629		
1985	1985	R-HSA-561048	Organic anion transport R-HSA-561048	1330	18,73,366,1330,2629		
1986	1986	R-HSA-9683686	Maturation of spike protein R-HSA-9683686	934	4,11,12,35,156,934,2629		
1987	1987	R-HSA-9768777	Regulation of NPAS4 gene transcription R-HSA-9768777	1410	5,7,9,824,1410,2629		
1988	1988	R-HSA-379401	Dopamine clearance from the synaptic cleft R-HSA-379401	1562	41,69,1562,2629	2078,2262	2078,2262
1989	1989	R-HSA-9031528	NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose R-HSA-9031528	649	0,59,649,2629		
1990	1990	R-HSA-2142850	Hyaluronan biosynthesis and export R-HSA-2142850	1227	1,58,192,1227,2629		
1991	1991	R-HSA-167827	The proton buffering model R-HSA-167827	1899	1,120,188,1899,2629		
1992	1992	R-HSA-1483248	Synthesis of PIPs at the ER membrane R-HSA-1483248	367	1,17,91,367,2629		
1993	1993	R-HSA-187706	Signalling to p38 via RIT and RIN R-HSA-187706	825	0,32,176,225,825,2629		
1994	1994	R-HSA-5250981	Toxicity of botulinum toxin type F (botF) R-HSA-5250981	1598	4,11,433,909,1598,2629		
1995	1995	R-HSA-114516	Disinhibition of SNARE formation R-HSA-114516	178	25,71,178,2629		
1996	1996	R-HSA-203641	NOSTRIN mediated eNOS trafficking R-HSA-203641	1396	1,1396,2629		
1997	1997	R-HSA-68911	G2 Phase R-HSA-68911	101	24,30,101,2629		
1998	1998	R-HSA-111448	Activation of NOXA and translocation to mitochondria R-HSA-111448	902	92,119,556,902,2629		
1999	1999	R-HSA-8941284	RUNX2 regulates chondrocyte maturation R-HSA-8941284	875	5,7,9,207,875,2629		
2000	2000	R-HSA-426048	Arachidonate production from DAG R-HSA-426048	957	0,23,25,28,71,88,957,2629		
2001	2001	R-HSA-8866423	VLDL assembly R-HSA-8866423	1172	18,409,1172,2629		
2002	2002	R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters R-HSA-433137	366	18,73,366,2629		
2003	2003	R-HSA-8963684	Tyrosine catabolism R-HSA-8963684	1568	1,44,1568,2629		
2004	2004	R-HSA-112307	Transmission across Electrical Synapses  R-HSA-112307	41	41,2629	1925	1925
2005	2005	R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family R-HSA-435368	1312	18,73,366,1022,1312,2629		
2006	2006	R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation R-HSA-8869496	757	5,7,9,757,2629		
2007	2007	R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins R-HSA-5368598	79	0,47,79,2629		
2008	2008	R-HSA-5423599	Diseases of Mismatch Repair (MMR) R-HSA-5423599	611	4,611,2629	2186,2236,2258,2280,2333	2186,2236,2258,2280,2333
2009	2009	R-HSA-8939247	RUNX1 regulates transcription of genes involved in interleukin signaling R-HSA-8939247	76	5,7,9,76,2629		
2010	2010	R-HSA-9605308	Diseases of Base Excision Repair R-HSA-9605308	611	4,611,2629	2391,2490,2524,2540,2585	2391,2404,2414,2416,2474,2490,2524,2537,2540,2583,2585,2589
2011	2011	R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface R-HSA-2855086	1779	2,10,223,384,436,1779,2629		
2012	2012	R-HSA-9754119	Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119	644	24,30,148,640,644,2629		
2013	2013	R-HSA-9758920	Formation of lateral plate mesoderm R-HSA-9758920	182	8,182,2629		
2014	2014	R-HSA-209931	Serotonin and melatonin biosynthesis R-HSA-209931	1210	1,44,1210,2629		
2015	2015	R-HSA-6803544	Ion influx/efflux at host-pathogen interface R-HSA-6803544	286	2,10,286,2629		
2016	2016	R-HSA-9682706	Replication of the SARS-CoV-1 genome R-HSA-9682706	2026	4,11,12,35,156,2026,2629		
2017	2017	R-HSA-3656535	TGFBR1 LBD Mutants in Cancer R-HSA-3656535	1846	4,37,1761,1846,2629		
2018	2018	R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression R-HSA-1368071	442	442,2629		
2019	2019	R-HSA-1296061	HCN channels R-HSA-1296061	267	41,267,2629		
2020	2020	R-HSA-5658034	HHAT G278V doesn't palmitoylate Hh-Np R-HSA-5658034	520	4,37,520,2629		
2021	2021	R-HSA-9652169	Signaling by MAP2K mutants R-HSA-9652169	375	4,37,375,2629		
2022	2022	R-HSA-1369007	Mitochondrial ABC transporters R-HSA-1369007	271	18,271,2629		
2023	2023	R-HSA-2473224	Antagonism of Activin by Follistatin R-HSA-2473224	1237	0,197,1237,2629		
2024	2024	R-HSA-9665247	Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247	2076	4,37,986,2076,2629		
2025	2025	R-HSA-427975	Proton/oligopeptide cotransporters R-HSA-427975	252	18,73,252,2629		
2026	2026	R-HSA-9679514	SARS-CoV-1 Genome Replication and Transcription R-HSA-9679514	156	4,11,12,35,156,2629	2016	2016
2027	2027	R-HSA-9845621	Defective VWF cleavage by ADAMTS13 variant R-HSA-9845621	1765	4,1162,1765,2629		
2028	2028	R-HSA-9026527	Activated NTRK2 signals through PLCG1 R-HSA-9026527	999	0,32,176,999,2629		
2029	2029	R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway R-HSA-110381	750	46,340,750,2629	2243	2243
2030	2030	R-HSA-167060	NGF processing R-HSA-167060	2053	0,32,176,2053,2629		
2031	2031	R-HSA-9025094	Biosynthesis of DPAn-3 SPMs R-HSA-9025094	2058	1,17,1170,2058,2629	2305,2323,2588	2305,2323,2588
2032	2032	R-HSA-6783984	Glycine degradation R-HSA-6783984	873	1,44,873,2629		
2033	2033	R-HSA-8849474	PTK6 Activates STAT3 R-HSA-8849474	573	0,573,577,2629		
2034	2034	R-HSA-9665251	Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251	2076	4,37,986,2076,2629		
2035	2035	R-HSA-9023661	Biosynthesis of E-series 18(R)-resolvins R-HSA-9023661	1892	1,17,1170,1892,2629		
2036	2036	R-HSA-5579026	Defective CYP11A1 causes AICSR R-HSA-5579026	812	4,72,812,2629		
2037	2037	R-HSA-71262	Carnitine synthesis R-HSA-71262	44	1,44,2629		
2038	2038	R-HSA-8985586	SLIT2:ROBO1 increases RHOA activity R-HSA-8985586	86	8,29,31,86,2629		
2039	2039	R-HSA-140179	Amine Oxidase reactions R-HSA-140179	263	1,82,263,2629	2304,2337	2304,2337
2040	2040	R-HSA-9665245	Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245	2076	4,37,986,2076,2629		
2041	2041	R-HSA-70370	Galactose catabolism R-HSA-70370	58	1,58,2629		
2042	2042	R-HSA-9018676	Biosynthesis of D-series resolvins R-HSA-9018676	1258	1,17,1170,1258,2629		
2043	2043	R-HSA-209905	Catecholamine biosynthesis R-HSA-209905	1210	1,44,1210,2629		
2044	2044	R-HSA-173107	Binding and entry of HIV virion R-HSA-173107	1368	4,11,12,80,150,1368,2629		
2045	2045	R-HSA-9694493	Maturation of protein E R-HSA-9694493	545	4,11,12,35,56,441,545,2629		
2046	2046	R-HSA-5603037	IRAK4 deficiency (TLR5) R-HSA-5603037	882	4,882,892,2629		
2047	2047	R-HSA-9686347	Microbial modulation of RIPK1-mediated regulated necrosis R-HSA-9686347	1825	4,266,1825,2629		
2048	2048	R-HSA-9007892	Interleukin-38 signaling R-HSA-9007892	144	2,16,34,144,2629		
2049	2049	R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors R-HSA-8866906	757	5,7,9,757,2629		
2050	2050	R-HSA-111957	Cam-PDE 1 activation R-HSA-111957	803	0,23,28,51,53,333,578,621,719,770,795,803,2629		
2051	2051	R-HSA-399710	Activation of AMPA receptors R-HSA-399710	867	41,69,93,867,2629		
2052	2052	R-HSA-9851151	MDK and PTN in ALK signaling R-HSA-9851151	908	0,32,908,2629		
2053	2053	R-HSA-9036866	Expression and Processing of Neurotrophins R-HSA-9036866	176	0,32,176,2629	2030	2030
2054	2054	R-HSA-9678110	Attachment and Entry R-HSA-9678110	156	4,11,12,35,156,2629		
2055	2055	R-HSA-9665737	Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737	986	4,37,986,2629		
2056	2056	R-HSA-211163	AKT-mediated inactivation of FOXO1A R-HSA-211163	1107	8,709,1107,2629		
2057	2057	R-HSA-9665233	Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233	2076	4,37,986,2076,2629		
2058	2058	R-HSA-9018683	Biosynthesis of DPA-derived SPMs R-HSA-9018683	1170	1,17,1170,2629	2031,2347	2031,2305,2323,2347,2588
2059	2059	R-HSA-9683683	Maturation of protein E R-HSA-9683683	934	4,11,12,35,156,934,2629		
2060	2060	R-HSA-9665246	Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246	2076	4,37,986,2076,2629		
2061	2061	R-HSA-9694682	SARS-CoV-2 Genome Replication and Transcription R-HSA-9694682	772	4,11,12,35,56,772,2629	2067	2067
2062	2062	R-HSA-194306	Neurophilin interactions with VEGF and VEGFR R-HSA-194306	254	0,32,254,2629		
2063	2063	R-HSA-8941333	RUNX2 regulates genes involved in differentiation of myeloid cells R-HSA-8941333	207	5,7,9,207,2629		
2064	2064	R-HSA-5221030	TET1,2,3 and TDG demethylate DNA R-HSA-5221030	111	5,111,2629		
2065	2065	R-HSA-1296053	Classical Kir channels R-HSA-1296053	797	41,267,797,2629		
2066	2066	R-HSA-390650	Histamine receptors R-HSA-390650	706	0,23,36,48,706,2629		
2067	2067	R-HSA-9694686	Replication of the SARS-CoV-2 genome R-HSA-9694686	2061	4,11,12,35,56,772,2061,2629		
2068	2068	R-HSA-9665249	Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249	2076	4,37,986,2076,2629		
2069	2069	R-HSA-9735804	Diseases of nucleotide metabolism R-HSA-9735804	72	4,72,2629	2220,2550	2220,2373,2390,2398,2550,2591
2070	2070	R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21  R-HSA-69895	2084	24,62,459,465,466,2084,2629		
2071	2071	R-HSA-8847453	Synthesis of PIPs in the nucleus R-HSA-8847453	367	1,17,91,367,2629		
2072	2072	R-HSA-9652282	Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282	615	0,32,615,2629		
2073	2073	R-HSA-9665250	Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250	2076	4,37,986,2076,2629		
2074	2074	R-HSA-9665244	Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244	2076	4,37,986,2076,2629		
2075	2075	R-HSA-8981373	Intestinal hexose absorption R-HSA-8981373	1924	935,1924,2629		
2076	2076	R-HSA-9665230	Drug resistance in ERBB2 KD mutants R-HSA-9665230	986	4,37,986,2629	2024,2034,2040,2057,2060,2068,2073,2074	2024,2034,2040,2057,2060,2068,2073,2074
2077	2077	R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism R-HSA-210455	2106	41,69,2106,2629		
2078	2078	R-HSA-379397	Enzymatic degradation of dopamine by COMT R-HSA-379397	1988	41,69,1562,1988,2629		
2079	2079	R-HSA-1251932	PLCG1 events in ERBB2 signaling R-HSA-1251932	615	0,32,615,2629		
2080	2080	R-HSA-9018681	Biosynthesis of protectins R-HSA-9018681	1258	1,17,1170,1258,2629		
2081	2081	R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions R-HSA-446343	1213	138,214,1213,2629		
2082	2082	R-HSA-6807047	Cholesterol biosynthesis via desmosterol R-HSA-6807047	971	1,17,140,971,2629		
2083	2083	R-HSA-8853383	Lysosomal oligosaccharide catabolism R-HSA-8853383	58	1,58,2629		
2084	2084	R-HSA-69560	Transcriptional activation of p53 responsive genes   R-HSA-69560	465	24,62,459,465,466,2629	2070	2070
2085	2085	R-HSA-209563	Axonal growth stimulation R-HSA-209563	1586	0,142,294,1586,2629		
2086	2086	R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes R-HSA-69200	369	24,30,148,179,369,2629		
2087	2087	R-HSA-204626	Hypusine synthesis from eIF5A-lysine R-HSA-204626	503	3,6,503,2629		
2088	2088	R-HSA-165158	Activation of AKT2 R-HSA-165158	664	0,32,373,575,580,588,600,632,664,2629		
2089	2089	R-HSA-77108	Utilization of Ketone Bodies R-HSA-77108	1581	1,17,1581,2629		
2090	2090	R-HSA-8874177	ATF6B (ATF6-beta) activates chaperones R-HSA-8874177	322	13,15,322,2629		
2091	2091	R-HSA-75944	Transcription from mitochondrial promoters R-HSA-75944	5	5,2629	2208,2366	2208,2366
2092	2092	R-HSA-8985801	Regulation of cortical dendrite branching R-HSA-8985801	86	8,29,31,86,2629		
2093	2093	R-HSA-417973	Adenosine P1 receptors R-HSA-417973	1300	0,23,36,48,1300,2629		
2094	2094	R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria R-HSA-75108	556	92,119,556,2629		
2095	2095	R-HSA-888593	Reuptake of GABA R-HSA-888593	1190	41,69,605,1190,2629		
2096	2096	R-HSA-3000497	Scavenging by Class H Receptors R-HSA-3000497	291	20,291,2629		
2097	2097	R-HSA-112126	ALKBH3 mediated reversal of alkylation damage R-HSA-112126	1813	46,1710,1813,2629		
2098	2098	R-HSA-1296025	ATP sensitive Potassium channels R-HSA-1296025	797	41,267,797,2629		
2099	2099	R-HSA-9022535	Loss of phosphorylation of MECP2 at T308 R-HSA-9022535	1428	4,1428,1432,1433,1449,2629		
2100	2100	R-HSA-9845619	Enhanced cleavage of VWF variant by ADAMTS13 R-HSA-9845619	1765	4,1162,1765,2629		
2101	2101	R-HSA-8849175	Threonine catabolism R-HSA-8849175	44	1,44,2629		
2102	2102	R-HSA-1855191	Synthesis of IPs in the nucleus R-HSA-1855191	634	1,634,2629		
2103	2103	R-HSA-9640463	Wax biosynthesis R-HSA-9640463	1794	1,17,1794,2629		
2104	2104	R-HSA-9022538	Loss of MECP2 binding ability to 5mC-DNA R-HSA-9022538	1428	4,1428,1432,1433,1449,2629		
2105	2105	R-HSA-2161541	Abacavir metabolism R-HSA-2161541	1694	244,1694,2629		
2106	2106	R-HSA-112313	Neurotransmitter uptake and metabolism In glial cells R-HSA-112313	69	41,69,2629	2077	2077
2107	2107	R-HSA-6807062	Cholesterol biosynthesis via lathosterol R-HSA-6807062	971	1,17,140,971,2629		
2108	2108	R-HSA-8941237	Invadopodia formation R-HSA-8941237	55	55,2629		
2109	2109	R-HSA-5250968	Toxicity of botulinum toxin type A (botA) R-HSA-5250968	1598	4,11,433,909,1598,2629		
2110	2110	R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se R-HSA-2408550	209	1,44,209,2629		
2111	2111	R-HSA-9845622	Defective VWF binding to collagen type I  R-HSA-9845622	1765	4,1162,1765,2629		
2112	2112	R-HSA-8951911	RUNX3 regulates RUNX1-mediated transcription R-HSA-8951911	298	5,7,9,298,2629		
2113	2113	R-HSA-9672396	Defective cofactor function of FVIIIa variant R-HSA-9672396	1799	4,1162,1263,1799,2629		
2114	2114	R-HSA-4719360	Defective DPM3 causes DPM3-CDG R-HSA-4719360	1305	4,72,157,1305,2629		
2115	2115	R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor R-HSA-392023	736	25,71,736,2629		
2116	2116	R-HSA-5250971	Toxicity of botulinum toxin type C (botC) R-HSA-5250971	1598	4,11,433,909,1598,2629		
2117	2117	R-HSA-139910	Activation of BMF and translocation to mitochondria R-HSA-139910	902	92,119,556,902,2629		
2118	2118	R-HSA-3359462	Defective AMN causes MGA1 R-HSA-3359462	1400	4,72,1093,1400,2629		
2119	2119	R-HSA-5619099	Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-5619099	284	4,121,284,2629		
2120	2120	R-HSA-9674519	Defective F8 sulfation at Y1699 R-HSA-9674519	1799	4,1162,1263,1799,2629		
2121	2121	R-HSA-9672383	Defective factor IX causes thrombophilia R-HSA-9672383	1263	4,1162,1263,2629		
2122	2122	R-HSA-1299503	TWIK related potassium channel (TREK) R-HSA-1299503	1513	41,267,1513,2629		
2123	2123	R-HSA-9630747	Diseases of Cellular Senescence R-HSA-9630747	2204	4,2204,2629	2133,2139,2521,2600	2133,2139,2145,2181,2284,2339,2521,2600
2124	2124	R-HSA-9636249	Inhibition of nitric oxide production R-HSA-9636249	1439	4,11,433,967,1054,1439,2629		
2125	2125	R-HSA-9020265	Biosynthesis of aspirin-triggered D-series resolvins R-HSA-9020265	1258	1,17,1170,1258,2629		
2126	2126	R-HSA-9034793	Activated NTRK3 signals through PLCG1 R-HSA-9034793	1255	0,32,176,1255,2629		
2127	2127	R-HSA-9603505	NTRK3 as a dependence receptor R-HSA-9603505	1255	0,32,176,1255,2629		
2128	2128	R-HSA-5339700	Signaling by TCF7L2 mutants R-HSA-5339700	817	4,37,817,2629		
2129	2129	R-HSA-9649913	RAS GTPase cycle mutants R-HSA-9649913	660	4,37,375,660,2629	2189,2192	2189,2192
2130	2130	R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate R-HSA-880009	566	1,120,566,2629		
2131	2131	R-HSA-351200	Interconversion of polyamines R-HSA-351200	525	1,44,525,2629		
2132	2132	R-HSA-71737	Pyrophosphate hydrolysis R-HSA-71737	1	1,2629		
2133	2133	R-HSA-9630750	Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750	2123	4,2123,2204,2629	2181,2339	2181,2339
2134	2134	R-HSA-167021	PLC-gamma1 signalling R-HSA-167021	225	0,32,176,225,2629		
2135	2135	R-HSA-191650	Regulation of gap junction activity R-HSA-191650	603	20,27,603,2629		
2136	2136	R-HSA-5250958	Toxicity of botulinum toxin type B (botB) R-HSA-5250958	1598	4,11,433,909,1598,2629		
2137	2137	R-HSA-434313	Intracellular metabolism of fatty acids regulates insulin secretion R-HSA-434313	1566	1,248,398,1566,2629		
2138	2138	R-HSA-3296197	Hydroxycarboxylic acid-binding receptors R-HSA-3296197	48	0,23,36,48,2629		
2139	2139	R-HSA-9632693	Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693	2123	4,2123,2204,2629	2145,2284	2145,2284
2140	2140	R-HSA-190827	Transport of connexins along the secretory pathway R-HSA-190827	747	20,27,603,627,747,2629		
2141	2141	R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) R-HSA-1299308	1513	41,267,1513,2629		
2142	2142	R-HSA-173599	Formation of the active cofactor, UDP-glucuronate R-HSA-173599	1020	1,82,243,1020,2629		
2143	2143	R-HSA-5602571	TRAF3 deficiency - HSE R-HSA-5602571	882	4,882,892,2629		
2144	2144	R-HSA-380615	Serotonin clearance from the synaptic cleft R-HSA-380615	1562	41,69,1562,2629	2248	2248
2145	2145	R-HSA-9632700	Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700	2139	4,2123,2139,2204,2629		
2146	2146	R-HSA-165181	Inhibition of TSC complex formation by PKB R-HSA-165181	712	0,712,2629		
2147	2147	R-HSA-500753	Pyrimidine biosynthesis R-HSA-500753	1354	1,293,1354,2629		
2148	2148	R-HSA-9692913	SARS-CoV-1-mediated effects on programmed cell death R-HSA-9692913	285	4,11,12,35,156,285,2629		
2149	2149	R-HSA-4719377	Defective DPM2 causes DPM2-CDG R-HSA-4719377	1305	4,72,157,1305,2629		
2150	2150	R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis R-HSA-73843	1325	1,58,1325,2629		
2151	2151	R-HSA-9673766	Signaling by cytosolic PDGFRA and PDGFRB fusion proteins R-HSA-9673766	1157	4,37,1157,2629		
2152	2152	R-HSA-198745	Signalling to STAT3 R-HSA-198745	225	0,32,176,225,2629		
2153	2153	R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions R-HSA-8853336	884	4,37,488,754,884,2629		
2154	2154	R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA R-HSA-428359	19	19,2629		
2155	2155	R-HSA-8981607	Intracellular oxygen transport R-HSA-8981607	18	18,2629		
2156	2156	R-HSA-175567	Integration of viral DNA into host genomic DNA R-HSA-175567	1641	4,11,12,80,150,1368,1641,2629		
2157	2157	R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes R-HSA-170145	1008	24,30,101,102,1008,2629		
2158	2158	R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E R-HSA-5624958	607	61,100,607,2629		
2159	2159	R-HSA-1307965	betaKlotho-mediated ligand binding R-HSA-1307965	1404	0,32,347,725,1404,2629		
2160	2160	R-HSA-5653890	Lactose synthesis R-HSA-5653890	58	1,58,2629		
2161	2161	R-HSA-162699	Synthesis of dolichyl-phosphate mannose R-HSA-162699	321,487	3,6,54,321,390,487,2629		
2162	2162	R-HSA-9708296	tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis R-HSA-9708296	165	5,165,2629		
2163	2163	R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer R-HSA-3645790	2185	4,37,1761,2185,2629		
2164	2164	R-HSA-190704	Oligomerization of connexins into connexons R-HSA-190704	747	20,27,603,627,747,2629		
2165	2165	R-HSA-6806664	Metabolism of vitamin K R-HSA-6806664	628	1,107,628,2629		
2166	2166	R-HSA-3304347	Loss of Function of SMAD4 in Cancer R-HSA-3304347	1761	4,37,1761,2629	2175	2175
2167	2167	R-HSA-9673202	Defective F9 variant does not activate FX R-HSA-9673202	1677	4,1162,1263,1677,2629		
2168	2168	R-HSA-844455	The NLRP1 inflammasome R-HSA-844455	1124	2,10,551,1124,2629		
2169	2169	R-HSA-8875791	MET activates STAT3 R-HSA-8875791	389	0,32,389,2629		
2170	2170	R-HSA-5660489	MTF1 activates gene expression R-HSA-5660489	1365	13,1365,2629		
2171	2171	R-HSA-9672391	Defective F8 cleavage by thrombin R-HSA-9672391	1799	4,1162,1263,1799,2629		
2172	2172	R-HSA-5250989	Toxicity of botulinum toxin type G (botG) R-HSA-5250989	1598	4,11,433,909,1598,2629		
2173	2173	R-HSA-9022927	MECP2 regulates transcription of genes involved in GABA signaling R-HSA-9022927	490	5,7,9,490,2629		
2174	2174	R-HSA-844615	The AIM2 inflammasome R-HSA-844615	1124	2,10,551,1124,2629		
2175	2175	R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer R-HSA-3311021	2166	4,37,1761,2166,2629		
2176	2176	R-HSA-177539	Autointegration results in viral DNA circles R-HSA-177539	1641	4,11,12,80,150,1368,1641,2629		
2177	2177	R-HSA-8849472	PTK6 Down-Regulation R-HSA-8849472	573	0,573,577,2629		
2178	2178	R-HSA-352238	Breakdown of the nuclear lamina R-HSA-352238	749	92,119,594,749,2629		
2179	2179	R-HSA-9657689	Defective SERPING1 causes hereditary angioedema R-HSA-9657689	1263	4,1162,1263,2629		
2180	2180	R-HSA-70688	Proline catabolism R-HSA-70688	44	1,44,2629		
2181	2181	R-HSA-9630794	Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794	2133	4,2123,2133,2204,2629		
2182	2182	R-HSA-1296067	Potassium transport channels R-HSA-1296067	797	41,267,797,2629		
2183	2183	R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 R-HSA-5083633	454	4,72,157,454,2629		
2184	2184	R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 R-HSA-964827	1922	3,6,54,114,1922,2629		
2185	2185	R-HSA-3642278	Loss of Function of TGFBR2 in Cancer R-HSA-3642278	1761	4,37,1761,2629	2163,2253	2163,2253
2186	2186	R-HSA-5632928	Defective Mismatch Repair Associated With MSH2 R-HSA-5632928	2008	4,611,2008,2629		
2187	2187	R-HSA-964975	Vitamin B6 activation to pyridoxal phosphate R-HSA-964975	187	1,107,187,2629		
2188	2188	R-HSA-217271	FMO oxidises nucleophiles R-HSA-217271	263	1,82,263,2629		
2189	2189	R-HSA-9753512	Signaling by RAS GTPase mutants R-HSA-9753512	2129	4,37,375,660,2129,2629		
2190	2190	R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer R-HSA-3315487	1795	4,37,1761,1795,2629		
2191	2191	R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA R-HSA-77285	1565	1,17,122,767,1565,2629		
2192	2192	R-HSA-9753510	Signaling by RAS GAP mutants R-HSA-9753510	2129	4,37,375,660,2129,2629		
2193	2193	R-HSA-3878781	Glycogen storage disease type IV (GBE1) R-HSA-3878781	1274	4,72,821,1274,2629		
2194	2194	R-HSA-3249367	STAT6-mediated induction of chemokines R-HSA-3249367	1269	2,10,480,1269,2629		
2195	2195	R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 R-HSA-5083629	454	4,72,157,454,2629		
2196	2196	R-HSA-3359463	Defective CUBN causes MGA1 R-HSA-3359463	1400	4,72,1093,1400,2629		
2197	2197	R-HSA-111446	Activation of BIM and translocation to mitochondria  R-HSA-111446	902	92,119,556,902,2629		
2198	2198	R-HSA-429593	Inositol transporters R-HSA-429593	366	18,73,366,2629		
2199	2199	R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) R-HSA-5603027	882	4,882,892,2629		
2200	2200	R-HSA-2395516	Electron transport from NADPH to Ferredoxin R-HSA-2395516	1441	1,1441,2629		
2201	2201	R-HSA-193681	Ceramide signalling R-HSA-193681	294	0,142,294,2629		
2202	2202	R-HSA-75896	Plasmalogen biosynthesis R-HSA-75896	1794	1,17,1794,2629		
2203	2203	R-HSA-427589	Type II Na+/Pi cotransporters R-HSA-427589	1932	18,73,252,1932,2629		
2204	2204	R-HSA-9675132	Diseases of cellular response to stress R-HSA-9675132	4	4,2629	2123	2123,2133,2139,2145,2181,2284,2339,2521,2600
2205	2205	R-HSA-444411	Rhesus glycoproteins mediate ammonium transport. R-HSA-444411	366	18,73,366,2629		
2206	2206	R-HSA-9657688	Defective factor XII causes hereditary angioedema R-HSA-9657688	1263	4,1162,1263,2629		
2207	2207	R-HSA-9793242	SUMOylation of nuclear envelope proteins R-HSA-9793242	117	3,6,110,117,2629		
2208	2208	R-HSA-163282	Mitochondrial transcription initiation R-HSA-163282	2091	5,2091,2629		
2209	2209	R-HSA-4717374	Defective DPM1 causes DPM1-CDG R-HSA-4717374	1305	4,72,157,1305,2629		
2210	2210	R-HSA-9014843	Interleukin-33 signaling R-HSA-9014843	144	2,16,34,144,2629		
2211	2211	R-HSA-5627083	RHO GTPases regulate CFTR trafficking R-HSA-5627083	50	0,21,22,50,2629		
2212	2212	R-HSA-350864	Regulation of thyroid hormone activity R-HSA-350864	1615	1,44,1210,1615,2629		
2213	2213	R-HSA-5250992	Toxicity of botulinum toxin type E (botE) R-HSA-5250992	1598	4,11,433,909,1598,2629		
2214	2214	R-HSA-190374	FGFR1c and Klotho ligand binding and activation R-HSA-190374	1205	0,32,347,602,1205,2629		
2215	2215	R-HSA-9818025	NFE2L2 regulating TCA cycle genes R-HSA-9818025	297	13,15,89,195,297,2629		
2216	2216	R-HSA-4341670	Defective NEU1 causes sialidosis R-HSA-4341670	1141	4,72,157,1141,2629		
2217	2217	R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization R-HSA-180897	762	4,11,12,80,180,762,2629		
2218	2218	R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA R-HSA-77305	1565	1,17,122,767,1565,2629		
2219	2219	R-HSA-5602636	IKBKB deficiency causes SCID R-HSA-5602636	882	4,882,892,2629		
2220	2220	R-HSA-9734207	Nucleotide salvage defects R-HSA-9734207	2069	4,72,2069,2629	2373,2390,2398	2373,2390,2398
2221	2221	R-HSA-373756	SDK interactions R-HSA-373756	334	138,214,334,2629		
2222	2222	R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1 R-HSA-211994	984	1,82,263,476,984,2629		
2223	2223	R-HSA-5659898	Intestinal saccharidase deficiencies R-HSA-5659898	821	4,72,821,2629		
2224	2224	R-HSA-9729555	Sensory perception of sour taste R-HSA-9729555	650	26,650,2629		
2225	2225	R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins R-HSA-432030	597	18,597,2629		
2226	2226	R-HSA-198765	Signalling to ERK5 R-HSA-198765	225	0,32,176,225,2629		
2227	2227	R-HSA-166020	Transfer of LPS from LBP carrier to CD14 R-HSA-166020	154	2,10,127,154,2629		
2228	2228	R-HSA-9036092	Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-9036092	284	4,121,284,2629		
2229	2229	R-HSA-916853	Degradation of GABA R-HSA-916853	1190	41,69,605,1190,2629		
2230	2230	R-HSA-111452	Activation and oligomerization of BAK protein R-HSA-111452	556	92,119,556,2629		
2231	2231	R-HSA-3359467	Defective MTRR causes HMAE R-HSA-3359467	1400	4,72,1093,1400,2629		
2232	2232	R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK) R-HSA-1299361	1513	41,267,1513,2629		
2233	2233	R-HSA-428559	Proton-coupled neutral amino acid transporters R-HSA-428559	252	18,73,252,2629		
2234	2234	R-HSA-165160	PDE3B signalling R-HSA-165160	2302	0,32,373,575,580,588,600,632,664,2302,2629		
2235	2235	R-HSA-176034	Interactions of Tat with host cellular proteins R-HSA-176034	180	4,11,12,80,180,2629		
2236	2236	R-HSA-5545483	Defective Mismatch Repair Associated With MLH1 R-HSA-5545483	2008	4,611,2008,2629		
2237	2237	R-HSA-9673013	Diseases of Telomere Maintenance R-HSA-9673013	752	4,752,2629	2251	2251,2256,2296,2297
2238	2238	R-HSA-9663199	Defective DNA double strand break response due to BRCA1 loss of function R-HSA-9663199	723	4,611,723,2629		
2239	2239	R-HSA-9026395	Biosynthesis of DHA-derived sulfido conjugates R-HSA-9026395	1258	1,17,1170,1258,2629	2255,2613	2255,2613
2240	2240	R-HSA-5602566	TICAM1 deficiency - HSE R-HSA-5602566	882	4,882,892,2629		
2241	2241	R-HSA-5619113	Defective SLC3A1 causes cystinuria (CSNU) R-HSA-5619113	284	4,121,284,2629		
2242	2242	R-HSA-77042	Formation of editosomes by ADAR proteins R-HSA-77042	2348	19,1624,2348,2629		
2243	2243	R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway R-HSA-73930	2029	46,340,750,2029,2629		
2244	2244	R-HSA-114294	Activation, translocation and oligomerization of BAX R-HSA-114294	556	92,119,556,2629		
2245	2245	R-HSA-5682113	Defective ABCA1 causes TGD R-HSA-5682113	393	4,121,393,2629		
2246	2246	R-HSA-156582	Acetylation R-HSA-156582	243	1,82,243,2629		
2247	2247	R-HSA-888568	GABA synthesis R-HSA-888568	1190	41,69,605,1190,2629		
2248	2248	R-HSA-380612	Metabolism of serotonin R-HSA-380612	2144	41,69,1562,2144,2629		
2249	2249	R-HSA-3359475	Defective MMAA causes MMA, cblA type R-HSA-3359475	1400	4,72,1093,1400,2629		
2250	2250	R-HSA-5633231	Defective ALG14 causes ALG14-CMS R-HSA-5633231	1141	4,72,157,1141,2629		
2251	2251	R-HSA-9006821	Alternative Lengthening of Telomeres (ALT) R-HSA-9006821	2237	4,752,2237,2629	2296	2256,2296,2297
2252	2252	R-HSA-5683177	Defective ABCC8 can cause hypo- and hyper-glycemias R-HSA-5683177	393	4,121,393,2629		
2253	2253	R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer R-HSA-3642279	2185	4,37,1761,2185,2629		
2254	2254	R-HSA-9672393	Defective F8 binding to von Willebrand factor R-HSA-9672393	1799	4,1162,1263,1799,2629		
2255	2255	R-HSA-9026762	Biosynthesis of maresin conjugates in tissue regeneration (MCTR) R-HSA-9026762	2239	1,17,1170,1258,2239,2629		
2256	2256	R-HSA-9670615	Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations R-HSA-9670615	2296	4,752,2237,2251,2296,2629		
2257	2257	R-HSA-8964540	Alanine metabolism R-HSA-8964540	44	1,44,2629		
2258	2258	R-HSA-5632987	Defective Mismatch Repair Associated With PMS2 R-HSA-5632987	2008	4,611,2008,2629		
2259	2259	R-HSA-205017	NFG and proNGF binds to p75NTR R-HSA-205017	294	0,142,294,2629		
2260	2260	R-HSA-1483101	Synthesis of PS R-HSA-1483101	185	1,17,91,185,2629		
2261	2261	R-HSA-9820962	Assembly and release of respiratory syncytial virus (RSV) virions R-HSA-9820962	205	4,11,12,205,2629		
2262	2262	R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase R-HSA-379398	1988	41,69,1562,1988,2629		
2263	2263	R-HSA-9024909	BDNF activates NTRK2 (TRKB) signaling R-HSA-9024909	999	0,32,176,999,2629		
2264	2264	R-HSA-5679090	Defective ABCG8 causes GBD4 and sitosterolemia R-HSA-5679090	393	4,121,393,2629		
2265	2265	R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK) R-HSA-1299316	1513	41,267,1513,2629		
2266	2266	R-HSA-3359469	Defective MTR causes HMAG R-HSA-3359469	1400	4,72,1093,1400,2629		
2267	2267	R-HSA-8854521	Interaction between PHLDA1 and AURKA R-HSA-8854521	102	24,30,101,102,2629		
2268	2268	R-HSA-451307	Activation of Na-permeable kainate receptors R-HSA-451307	1580	41,69,93,894,1580,2629		
2269	2269	R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate R-HSA-163754	248	1,248,2629		
2270	2270	R-HSA-9636667	Manipulation of host energy metabolism R-HSA-9636667	1054	4,11,433,967,1054,2629		
2271	2271	R-HSA-9759774	Diseases of mitochondrial beta oxidation R-HSA-9759774	72	4,72,2629	2278	2278,2300
2272	2272	R-HSA-351143	Agmatine biosynthesis R-HSA-351143	525	1,44,525,2629		
2273	2273	R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2) R-HSA-3858516	1274	4,72,821,1274,2629		
2274	2274	R-HSA-5652227	Fructose biosynthesis R-HSA-5652227	1819	1,58,1819,2629		
2275	2275	R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression R-HSA-164939	1116	4,11,12,80,180,937,1116,2629		
2276	2276	R-HSA-9034013	NTF3 activates NTRK3 signaling R-HSA-9034013	1255	0,32,176,1255,2629		
2277	2277	R-HSA-8941413	Events associated with phagocytolytic activity of PMN cells R-HSA-8941413	777	2,10,777,2629		
2278	2278	R-HSA-9759785	Diseases of propionyl-CoA catabolism R-HSA-9759785	2271	4,72,2271,2629	2300	2300
2279	2279	R-HSA-9026357	NTF4 activates NTRK2 (TRKB) signaling R-HSA-9026357	999	0,32,176,999,2629		
2280	2280	R-HSA-5632968	Defective Mismatch Repair Associated With MSH6 R-HSA-5632968	2008	4,611,2008,2629		
2281	2281	R-HSA-844623	The IPAF inflammasome R-HSA-844623	1124	2,10,551,1124,2629		
2282	2282	R-HSA-177162	Conjugation of phenylacetate with glutamine R-HSA-177162	1697	1,82,243,1673,1697,2629		
2283	2283	R-HSA-111995	phospho-PLA2 pathway R-HSA-111995	770	0,23,28,51,333,578,621,770,2629		
2284	2284	R-HSA-9632697	Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697	2139	4,2123,2139,2204,2629		
2285	2285	R-HSA-9636569	Suppression of autophagy R-HSA-9636569	1054	4,11,433,967,1054,2629		
2286	2286	R-HSA-3814836	Glycogen storage disease type XV (GYG1) R-HSA-3814836	1274	4,72,821,1274,2629		
2287	2287	R-HSA-9834752	Respiratory syncytial virus genome replication R-HSA-9834752	1286	4,11,12,205,1286,2629		
2288	2288	R-HSA-5678420	Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome R-HSA-5678420	393	4,121,393,2629		
2289	2289	R-HSA-5683329	Defective ABCD4 causes MAHCJ R-HSA-5683329	393,1400	4,72,121,393,1093,1400,2629		
2290	2290	R-HSA-6804754	Regulation of TP53 Expression R-HSA-6804754	766	5,7,9,45,132,766,2629		
2291	2291	R-HSA-5357609	Glycogen storage disease type II (GAA) R-HSA-5357609	1274	4,72,821,1274,2629		
2292	2292	R-HSA-5619049	Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) R-HSA-5619049	284	4,121,284,2629		
2293	2293	R-HSA-9734091	Drug-mediated inhibition of MET activation R-HSA-9734091	1121	0,32,389,1121,2629		
2294	2294	R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1) R-HSA-3828062	1274	4,72,821,1274,2629		
2295	2295	R-HSA-5602415	UNC93B1 deficiency - HSE R-HSA-5602415	882	4,882,892,2629		
2296	2296	R-HSA-9670621	Defective Inhibition of DNA Recombination at Telomere R-HSA-9670621	2251	4,752,2237,2251,2629	2256,2297	2256,2297
2297	2297	R-HSA-9670613	Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations R-HSA-9670613	2296	4,752,2237,2251,2296,2629		
2298	2298	R-HSA-480985	Synthesis of dolichyl-phosphate-glucose R-HSA-480985	487	3,6,54,390,487,2629		
2299	2299	R-HSA-5578999	Defective GCLC causes HAGGSD R-HSA-5578999	812	4,72,812,2629		
2300	2300	R-HSA-3359478	Defective MUT causes MMAM R-HSA-3359478	2278	4,72,2271,2278,2629		
2301	2301	R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis R-HSA-168275	134	4,11,12,134,2629		
2302	2302	R-HSA-109703	PKB-mediated events R-HSA-109703	664	0,32,373,575,580,588,600,632,664,2629	2234	2234
2303	2303	R-HSA-1614603	Cysteine formation from homocysteine R-HSA-1614603	950	1,44,950,2629		
2304	2304	R-HSA-141334	PAOs oxidise polyamines to amines R-HSA-141334	2039	1,82,263,2039,2629		
2305	2305	R-HSA-9026290	Biosynthesis of DPAn-3-derived maresins R-HSA-9026290	2031	1,17,1170,2031,2058,2629		
2306	2306	R-HSA-3359473	Defective MMADHC causes MMAHCD R-HSA-3359473	1400	4,72,1093,1400,2629		
2307	2307	R-HSA-168277	Influenza Virus Induced Apoptosis R-HSA-168277	134	4,11,12,134,2629		
2308	2308	R-HSA-5619070	Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) R-HSA-5619070	284	4,121,284,2629		
2309	2309	R-HSA-5660862	Defective SLC7A7 causes lysinuric protein intolerance (LPI) R-HSA-5660862	284	4,121,284,2629		
2310	2310	R-HSA-68881	Mitotic Metaphase/Anaphase Transition R-HSA-68881	77	24,30,40,77,2629		
2311	2311	R-HSA-1483152	Hydrolysis of LPE R-HSA-1483152	185	1,17,91,185,2629		
2312	2312	R-HSA-75102	C6 deamination of adenosine R-HSA-75102	2348	19,1624,2348,2629		
2313	2313	R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 R-HSA-5083628	454	4,72,157,454,2629		
2314	2314	R-HSA-9027604	Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives R-HSA-9027604	1170	1,17,1170,2629		
2315	2315	R-HSA-5660883	Defective SLC7A9 causes cystinuria (CSNU) R-HSA-5660883	284	4,121,284,2629		
2316	2316	R-HSA-4755609	Defective DHDDS causes RP59 R-HSA-4755609	1305	4,72,157,1305,2629		
2317	2317	R-HSA-168268	Virus Assembly and Release R-HSA-168268	134	4,11,12,134,2629	2345	2345
2318	2318	R-HSA-9699150	Defective DNA double strand break response due to BARD1 loss of function R-HSA-9699150	723	4,611,723,2629		
2319	2319	R-HSA-5083627	Defective LARGE causes MDDGA6 and MDDGB6 R-HSA-5083627	454	4,72,157,454,2629		
2320	2320	R-HSA-9709275	Impaired BRCA2 translocation to the nucleus R-HSA-9709275	722	4,611,722,723,2629		
2321	2321	R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10 R-HSA-211728	587	92,119,587,2629		
2322	2322	R-HSA-6791465	Pentose phosphate pathway disease R-HSA-6791465	821	4,72,821,2629	2471,2487,2572,2590	2471,2487,2572,2590
2323	2323	R-HSA-9026286	Biosynthesis of DPAn-3-derived protectins and resolvins R-HSA-9026286	2031	1,17,1170,2031,2058,2629		
2324	2324	R-HSA-203754	NOSIP mediated eNOS trafficking R-HSA-203754	1396	1,1396,2629		
2325	2325	R-HSA-9033807	ABO blood group biosynthesis R-HSA-9033807	1119	1,58,1119,2629		
2326	2326	R-HSA-211736	Stimulation of the cell death response by PAK-2p34 R-HSA-211736	594	92,119,594,2629		
2327	2327	R-HSA-9673240	Defective gamma-carboxylation of F9 R-HSA-9673240	1677	4,1162,1263,1677,2629		
2328	2328	R-HSA-9645722	Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function R-HSA-9645722	1014	4,266,1014,2629		
2329	2329	R-HSA-8942233	Intestinal infectious diseases R-HSA-8942233	909	4,11,433,909,2629		
2330	2330	R-HSA-5545619	XAV939 stabilizes AXIN R-HSA-5545619	817	4,37,817,2629		
2331	2331	R-HSA-9025046	NTF3 activates NTRK2 (TRKB) signaling R-HSA-9025046	999	0,32,176,999,2629		
2332	2332	R-HSA-5579031	Defective ACTH causes obesity and POMCD R-HSA-5579031	72	4,72,2629		
2333	2333	R-HSA-5632927	Defective Mismatch Repair Associated With MSH3 R-HSA-5632927	2008	4,611,2008,2629		
2334	2334	R-HSA-192905	vRNP Assembly R-HSA-192905	169	4,11,12,134,169,2629		
2335	2335	R-HSA-5655799	Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) R-HSA-5655799	284	4,121,284,2629		
2336	2336	R-HSA-187042	TRKA activation by NGF R-HSA-187042	1855	0,32,176,225,1855,2629		
2337	2337	R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB R-HSA-141333	2039	1,82,263,2039,2629		
2338	2338	R-HSA-9037628	Rhesus blood group biosynthesis R-HSA-9037628	1119	1,58,1119,2629		
2339	2339	R-HSA-9630791	Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791	2133	4,2123,2133,2204,2629		
2340	2340	R-HSA-3359485	Defective CD320 causes MMATC R-HSA-3359485	1400	4,72,1093,1400,2629		
2341	2341	R-HSA-9763198	Impaired BRCA2 binding to SEM1 (DSS1) R-HSA-9763198	722	4,611,722,723,2629		
2342	2342	R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing R-HSA-168315	717	4,11,12,134,717,2629		
2343	2343	R-HSA-5679096	Defective ABCG5 causes sitosterolemia R-HSA-5679096	393	4,121,393,2629		
2344	2344	R-HSA-5619060	Defective CP causes aceruloplasminemia (ACERULOP) R-HSA-5619060	284	4,121,284,2629		
2345	2345	R-HSA-168316	Assembly of Viral Components at the Budding Site R-HSA-168316	2317	4,11,12,134,2317,2629		
2346	2346	R-HSA-5602680	MyD88 deficiency (TLR5) R-HSA-5602680	882	4,882,892,2629		
2347	2347	R-HSA-9025106	Biosynthesis of DPAn-6 SPMs R-HSA-9025106	2058	1,17,1170,2058,2629		
2348	2348	R-HSA-75064	mRNA Editing: A to I Conversion R-HSA-75064	1624	19,1624,2629	2242,2312	2242,2312
2349	2349	R-HSA-5688031	Defective pro-SFTPB causes SMDP1 and RDS R-HSA-5688031	1610	4,72,1610,2629		
2350	2350	R-HSA-5579030	Defective CYP19A1 causes AEXS R-HSA-5579030	812	4,72,812,2629		
2351	2351	R-HSA-9723905	Loss of function of TP53 in cancer due to loss of tetramerization ability R-HSA-9723905	2452	4,266,1014,2452,2629		
2352	2352	R-HSA-5619104	Defective SLC12A1 causes Bartter syndrome 1 (BS1) R-HSA-5619104	284	4,121,284,2629		
2353	2353	R-HSA-5619098	Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS) R-HSA-5619098	284	4,121,284,2629		
2354	2354	R-HSA-9035968	Defective GGT1 in aflatoxin detoxification causes GLUTH R-HSA-9035968	812	4,72,812,2629		
2355	2355	R-HSA-9669935	Signaling by juxtamembrane domain KIT mutants R-HSA-9669935	1155	4,37,1155,2629		
2356	2356	R-HSA-9717319	brigatinib-resistant ALK mutants R-HSA-9717319	2422	4,37,325,2422,2629		
2357	2357	R-HSA-9717326	crizotinib-resistant ALK mutants R-HSA-9717326	2422	4,37,325,2422,2629		
2358	2358	R-HSA-3359454	Defective TCN2 causes TCN2 deficiency R-HSA-3359454	1400	4,72,1093,1400,2629		
2359	2359	R-HSA-5679001	Defective ABCC2 causes DJS R-HSA-5679001	393	4,121,393,2629		
2360	2360	R-HSA-4724289	Defective ALG6 causes CDG-1c R-HSA-4724289	1141	4,72,157,1141,2629		
2361	2361	R-HSA-9674396	Imatinib-resistant PDGFR mutants R-HSA-9674396	2498	4,37,1157,2498,2629		
2362	2362	R-HSA-5579011	Defective CYP2U1 causes SPG56 R-HSA-5579011	812	4,72,812,2629		
2363	2363	R-HSA-5683371	Defective ABCB6 causes MCOPCB7 R-HSA-5683371	393	4,121,393,2629		
2364	2364	R-HSA-2206302	MPS I - Hurler syndrome R-HSA-2206302	1564	4,72,821,1564,2629		
2365	2365	R-HSA-5619054	Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) R-HSA-5619054	284	4,121,284,2629		
2366	2366	R-HSA-163316	Mitochondrial transcription termination R-HSA-163316	2091	5,2091,2629		
2367	2367	R-HSA-9702998	linifanib-resistant FLT3 mutants R-HSA-9702998	2578	4,37,938,2578,2629		
2368	2368	R-HSA-6809583	Retinoid metabolism disease events R-HSA-6809583	1412	4,1412,1429,2629		
2369	2369	R-HSA-5579032	Defective TBXAS1 causes GHDD R-HSA-5579032	812	4,72,812,2629		
2370	2370	R-HSA-5619047	Defective SLC2A9 causes hypouricemia renal 2 (RHUC2) R-HSA-5619047	284	4,121,284,2629		
2371	2371	R-HSA-5678520	Defective ABCB11 causes PFIC2 and BRIC2 R-HSA-5678520	393	4,121,393,2629		
2372	2372	R-HSA-5682294	Defective ABCA12 causes ARCI4B R-HSA-5682294	393	4,121,393,2629		
2373	2373	R-HSA-9734195	Defective APRT disrupts adenine salvage R-HSA-9734195	2220	4,72,2069,2220,2629		
2374	2374	R-HSA-9703009	tamatinib-resistant FLT3 mutants R-HSA-9703009	2578	4,37,938,2578,2629		
2375	2375	R-HSA-5690338	Defective ABCC6 causes PXE R-HSA-5690338	393	4,121,393,2629		
2376	2376	R-HSA-9669926	Nilotinib-resistant KIT mutants R-HSA-9669926	2433	4,37,1155,2433,2629		
2377	2377	R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619058	284	4,121,284,2629		
2378	2378	R-HSA-9673163	Oleoyl-phe metabolism R-HSA-9673163	1899	1,120,188,1899,2629		
2379	2379	R-HSA-5579012	Defective MAOA causes BRUNS R-HSA-5579012	812	4,72,812,2629		
2380	2380	R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX) R-HSA-2142696	514	1,17,122,514,2629		
2381	2381	R-HSA-5659735	Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5659735	284	4,121,284,2629		
2382	2382	R-HSA-5619072	Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M) R-HSA-5619072	284	4,121,284,2629		
2383	2383	R-HSA-5678771	Defective ABCB4 causes PFIC3, ICP3 and GBD1 R-HSA-5678771	393	4,121,393,2629		
2384	2384	R-HSA-3248023	Regulation by TREX1 R-HSA-3248023	1328	2,10,480,1328,2629		
2385	2385	R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK) R-HSA-1299344	1513	41,267,1513,2629		
2386	2386	R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK) R-HSA-1299287	1513	41,267,1513,2629		
2387	2387	R-HSA-4720489	Defective ALG12 causes CDG-1g R-HSA-4720489	1141	4,72,157,1141,2629		
2388	2388	R-HSA-5683678	Defective ABCA3 causes SMDP3 R-HSA-5683678	393	4,121,393,2629		
2389	2389	R-HSA-5619043	Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) R-HSA-5619043	284	4,121,284,2629		
2390	2390	R-HSA-9734735	Defective ADA disrupts (deoxy)adenosine deamination R-HSA-9734735	2220	4,72,2069,2220,2629		
2391	2391	R-HSA-9605310	Defective Base Excision Repair Associated with MUTYH R-HSA-9605310	2010	4,611,2010,2629	2414,2416	2414,2416
2392	2392	R-HSA-5663020	Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5663020	284	4,121,284,2629		
2393	2393	R-HSA-9717329	lorlatinib-resistant ALK mutants R-HSA-9717329	2422	4,37,325,2422,2629		
2394	2394	R-HSA-2160456	Phenylketonuria R-HSA-2160456	72	4,72,2629		
2395	2395	R-HSA-5578998	Defective OPLAH causes OPLAHD R-HSA-5578998	812	4,72,812,2629		
2396	2396	R-HSA-5658208	Defective SLC5A2 causes renal glucosuria (GLYS1) R-HSA-5658208	284	4,121,284,2629		
2397	2397	R-HSA-5619039	Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) R-HSA-5619039	284	4,121,284,2629		
2398	2398	R-HSA-9734281	Defective HPRT1 disrupts guanine and hypoxanthine salvage R-HSA-9734281	2220	4,72,2069,2220,2629		
2399	2399	R-HSA-3371598	Defective BTD causes biotidinase deficiency R-HSA-3371598	1715	4,72,1093,1715,2629		
2400	2400	R-HSA-5619088	Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ) R-HSA-5619088	284	4,121,284,2629		
2401	2401	R-HSA-1839120	Signaling by FGFR1 amplification mutants R-HSA-1839120	884	4,37,488,754,884,2629		
2402	2402	R-HSA-5340573	LGK974 inhibits PORCN R-HSA-5340573	817	4,37,817,2629		
2403	2403	R-HSA-5619062	Defective SLC1A3 causes episodic ataxia 6 (EA6) R-HSA-5619062	284	4,121,284,2629		
2404	2404	R-HSA-9656256	Defective OGG1 Substrate Processing R-HSA-9656256	2585	4,611,2010,2585,2629		
2405	2405	R-HSA-5579007	Defective ACY1 causes encephalopathy R-HSA-5579007	812	4,72,812,2629		
2406	2406	R-HSA-5659729	Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5659729	284	4,121,284,2629		
2407	2407	R-HSA-5619046	Defective SLC26A4 causes Pendred syndrome (PDS) R-HSA-5619046	284	4,121,284,2629		
2408	2408	R-HSA-5619042	Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) R-HSA-5619042	284	4,121,284,2629		
2409	2409	R-HSA-4755583	Defective DOLK causes DOLK-CDG R-HSA-4755583	1305	4,72,157,1305,2629		
2410	2410	R-HSA-5619108	Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS) R-HSA-5619108	284	4,121,284,2629		
2411	2411	R-HSA-4793954	Defective MOGS causes CDG-2b R-HSA-4793954	1141	4,72,157,1141,2629		
2412	2412	R-HSA-4724325	Defective ALG8 causes CDG-1h R-HSA-4724325	1141	4,72,157,1141,2629		
2413	2413	R-HSA-2206290	MPS IV - Morquio syndrome A R-HSA-2206290	1564	4,72,821,1564,2629		
2414	2414	R-HSA-9608290	Defective MUTYH substrate processing R-HSA-9608290	2391	4,611,2010,2391,2629		
2415	2415	R-HSA-9702577	semaxanib-resistant FLT3 mutants R-HSA-9702577	2578	4,37,938,2578,2629		
2416	2416	R-HSA-9608287	Defective MUTYH substrate binding R-HSA-9608287	2391	4,611,2010,2391,2629		
2417	2417	R-HSA-5619071	Defective SLC22A12 causes renal hypouricemia 1 (RHUC1) R-HSA-5619071	284	4,121,284,2629		
2418	2418	R-HSA-5602410	TLR3 deficiency - HSE R-HSA-5602410	882	4,882,892,2629		
2419	2419	R-HSA-162589	Reverse Transcription of HIV RNA R-HSA-162589	1368	4,11,12,80,150,1368,2629	2493,2531	2493,2531
2420	2420	R-HSA-5250982	Toxicity of tetanus toxin (tetX) R-HSA-5250982	1598	4,11,433,909,1598,2629		
2421	2421	R-HSA-9680187	Signaling by extracellular domain mutants of KIT R-HSA-9680187	1155	4,37,1155,2629		
2422	2422	R-HSA-9700649	Drug resistance of ALK mutants R-HSA-9700649	325	4,37,325,2629	2356,2357,2393,2438,2492,2562,2621	2356,2357,2393,2438,2492,2562,2621
2423	2423	R-HSA-5688354	Defective pro-SFTPC causes SMDP2 and RDS R-HSA-5688354	1610	4,72,1610,2629		
2424	2424	R-HSA-9702581	crenolanib-resistant FLT3 mutants R-HSA-9702581	2578	4,37,938,2578,2629		
2425	2425	R-HSA-2206307	MPS IIIA - Sanfilippo syndrome A R-HSA-2206307	1564	4,72,821,1564,2629		
2426	2426	R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus R-HSA-168330	841	4,11,12,134,841,2629		
2427	2427	R-HSA-5619040	Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1) R-HSA-5619040	284	4,121,284,2629		
2428	2428	R-HSA-5619109	Defective SLC6A2 causes orthostatic intolerance (OI) R-HSA-5619109	284	4,121,284,2629		
2429	2429	R-HSA-5660686	Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5660686	284	4,121,284,2629		
2430	2430	R-HSA-5619078	Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C) R-HSA-5619078	284	4,121,284,2629		
2431	2431	R-HSA-3656248	Defective HEXB causes GM2G2 R-HSA-3656248	718	4,72,157,718,2629		
2432	2432	R-HSA-5619056	Defective HK1 causes hexokinase deficiency (HK deficiency) R-HSA-5619056	284	4,121,284,2629		
2433	2433	R-HSA-9669937	Drug resistance of KIT mutants R-HSA-9669937	1155	4,37,1155,2629	2376,2475,2502,2528,2579,2599,2610	2376,2475,2502,2528,2579,2599,2610
2434	2434	R-HSA-4687000	Defective MPDU1 causes CDG-1f R-HSA-4687000	1141	4,72,157,1141,2629		
2435	2435	R-HSA-5619085	Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1) R-HSA-5619085	284	4,121,284,2629		
2436	2436	R-HSA-9702509	FLT3 mutants bind TKIs R-HSA-9702509	938	4,37,938,2629		
2437	2437	R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated R-HSA-5467333	1382	4,37,817,1382,2629		
2438	2438	R-HSA-9717264	ASP-3026-resistant ALK mutants R-HSA-9717264	2422	4,37,325,2422,2629		
2439	2439	R-HSA-5684045	Defective ABCD1 causes ALD R-HSA-5684045	393	4,121,393,2629		
2440	2440	R-HSA-5619089	Defective SLC6A5 causes hyperekplexia 3 (HKPX3) R-HSA-5619089	284	4,121,284,2629		
2441	2441	R-HSA-5579024	Defective MAT1A causes MATD R-HSA-5579024	812	4,72,812,2629		
2442	2442	R-HSA-3274531	Glycogen storage disease type Ia (G6PC) R-HSA-3274531	1274	4,72,821,1274,2629		
2443	2443	R-HSA-5579028	Defective CYP17A1 causes AH5 R-HSA-5579028	812	4,72,812,2629		
2444	2444	R-HSA-5687583	Defective SLC34A2 causes PALM R-HSA-5687583	1610	4,72,1610,2629		
2445	2445	R-HSA-3560796	Defective PAPSS2 causes SEMD-PA R-HSA-3560796	718	4,72,157,718,2629		
2446	2446	R-HSA-4793950	Defective MAN1B1 causes MRT15 R-HSA-4793950	1141	4,72,157,1141,2629		
2447	2447	R-HSA-9702569	KW2449-resistant FLT3 mutants R-HSA-9702569	2578	4,37,938,2578,2629		
2448	2448	R-HSA-9635644	Inhibition of membrane repair R-HSA-9635644	1054	4,11,433,967,1054,2629		
2449	2449	R-HSA-5579016	Defective UGT1A4 causes hyperbilirubinemia R-HSA-5579016	812	4,72,812,2629		
2450	2450	R-HSA-3229133	Glycogen storage disease type Ib (SLC37A4) R-HSA-3229133	1274	4,72,821,1274,2629		
2451	2451	R-HSA-9636003	NEIL3-mediated resolution of ICLs R-HSA-9636003	493	46,340,493,2629		
2452	2452	R-HSA-9723907	Loss of Function of TP53 in Cancer R-HSA-9723907	1014	4,266,1014,2629	2351	2351
2453	2453	R-HSA-5619095	Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2) R-HSA-5619095	284	4,121,284,2629		
2454	2454	R-HSA-5657655	MGMT-mediated DNA damage reversal R-HSA-5657655	1710	46,1710,2629		
2455	2455	R-HSA-3359471	Defective MMAB causes MMA, cblB type R-HSA-3359471	1400	4,72,1093,1400,2629		
2456	2456	R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH R-HSA-5263617	209	1,44,209,2629		
2457	2457	R-HSA-2023837	Signaling by FGFR2 amplification mutants R-HSA-2023837	846	4,37,488,685,846,2629		
2458	2458	R-HSA-4085023	Defective GFPT1 causes CMSTA1 R-HSA-4085023	1305	4,72,157,1305,2629		
2459	2459	R-HSA-9672387	Defective F8 accelerates dissociation of the A2 domain R-HSA-9672387	1799	4,1162,1263,1799,2629		
2460	2460	R-HSA-9702624	sorafenib-resistant FLT3 mutants R-HSA-9702624	2578	4,37,938,2578,2629		
2461	2461	R-HSA-5579019	Defective FMO3 causes TMAU R-HSA-5579019	812	4,72,812,2629		
2462	2462	R-HSA-5619044	Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5619044	284	4,121,284,2629		
2463	2463	R-HSA-5578997	Defective AHCY causes HMAHCHD R-HSA-5578997	812	4,72,812,2629		
2464	2464	R-HSA-3359457	Defective CBLIF causes IFD R-HSA-3359457	1400	4,72,1093,1400,2629		
2465	2465	R-HSA-5619076	Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25) R-HSA-5619076	284	4,121,284,2629		
2466	2466	R-HSA-5579017	Defective CYP11B1 causes AH4 R-HSA-5579017	812	4,72,812,2629		
2467	2467	R-HSA-5579006	Defective GSS causes GSS deficiency R-HSA-5579006	812	4,72,812,2629		
2468	2468	R-HSA-1483196	PI and PC transport between ER and Golgi membranes R-HSA-1483196	185,367	1,17,91,185,367,2629		
2469	2469	R-HSA-9702596	lestaurtinib-resistant FLT3 mutants R-HSA-9702596	2578	4,37,938,2578,2629		
2470	2470	R-HSA-5578996	Defective CYP27A1 causes CTX R-HSA-5578996	812	4,72,812,2629		
2471	2471	R-HSA-5659996	RPIA deficiency: failed conversion of R5P to RU5P R-HSA-5659996	2322	4,72,821,2322,2629		
2472	2472	R-HSA-2206308	MPS IV - Morquio syndrome B R-HSA-2206308	1564	4,72,821,1564,2629		
2473	2473	R-HSA-5619035	Defective SLC17A5 causes Salla disease (SD) and ISSD R-HSA-5619035	284	4,121,284,2629		
2474	2474	R-HSA-9630222	Defective NTHL1 substrate binding R-HSA-9630222	2524	4,611,2010,2524,2629		
2475	2475	R-HSA-9669917	Imatinib-resistant KIT mutants R-HSA-9669917	2433	4,37,1155,2433,2629		
2476	2476	R-HSA-5619052	Defective SLC9A9 causes autism 16 (AUTS16) R-HSA-5619052	284	4,121,284,2629		
2477	2477	R-HSA-9636467	Blockage of phagosome acidification R-HSA-9636467	1439	4,11,433,967,1054,1439,2629		
2478	2478	R-HSA-5619041	Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG) R-HSA-5619041	284	4,121,284,2629		
2479	2479	R-HSA-9828642	Respiratory syncytial virus genome transcription R-HSA-9828642	1286	4,11,12,205,1286,2629		
2480	2480	R-HSA-5619068	Defective SLC2A10 causes arterial tortuosity syndrome (ATS) R-HSA-5619068	284	4,121,284,2629		
2481	2481	R-HSA-169131	Inhibition of PKR R-HSA-169131	717	4,11,12,134,717,2629		
2482	2482	R-HSA-5688399	Defective ABCA3 causes SMDP3 R-HSA-5688399	1610	4,72,1610,2629		
2483	2483	R-HSA-9692912	SARS-CoV-1 targets PDZ proteins in cell-cell junction R-HSA-9692912	285	4,11,12,35,156,285,2629		
2484	2484	R-HSA-5579009	Defective CYP11B2 causes CMO-1 deficiency R-HSA-5579009	812	4,72,812,2629		
2485	2485	R-HSA-9702614	ponatinib-resistant FLT3 mutants R-HSA-9702614	2578	4,37,938,2578,2629		
2486	2486	R-HSA-389542	NADPH regeneration R-HSA-389542	1184	1,107,1184,2629		
2487	2487	R-HSA-6791055	TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P R-HSA-6791055	2322	4,72,821,2322,2629		
2488	2488	R-HSA-4720454	Defective ALG9 causes CDG-1l R-HSA-4720454	1141	4,72,157,1141,2629		
2489	2489	R-HSA-5609974	Defective PGM1 causes PGM1-CDG R-HSA-5609974	1305	4,72,157,1305,2629		
2490	2490	R-HSA-9629232	Defective Base Excision Repair Associated with NEIL3 R-HSA-9629232	2010	4,611,2010,2629		
2491	2491	R-HSA-140180	COX reactions R-HSA-140180	263	1,82,263,2629		
2492	2492	R-HSA-9717316	alectinib-resistant ALK mutants R-HSA-9717316	2422	4,37,325,2422,2629		
2493	2493	R-HSA-164516	Minus-strand DNA synthesis R-HSA-164516	2419	4,11,12,80,150,1368,2419,2629		
2494	2494	R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation R-HSA-2466712	1052,1451	4,26,282,1052,1412,1429,1451,2629		
2495	2495	R-HSA-1222449	Mtb iron assimilation by chelation R-HSA-1222449	2593	4,11,433,967,2593,2629		
2496	2496	R-HSA-5619055	Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI) R-HSA-5619055	284	4,121,284,2629		
2497	2497	R-HSA-5579000	Defective CYP1B1 causes Glaucoma R-HSA-5579000	812	4,72,812,2629		
2498	2498	R-HSA-9674415	Drug resistance of PDGFR mutants R-HSA-9674415	1157	4,37,1157,2629	2361,2504,2580,2612	2361,2504,2580,2612
2499	2499	R-HSA-5579002	Defective UGT1A1 causes hyperbilirubinemia R-HSA-5579002	812	4,72,812,2629		
2500	2500	R-HSA-5619050	Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) R-HSA-5619050	284	4,121,284,2629		
2501	2501	R-HSA-5657562	Essential fructosuria R-HSA-5657562	821	4,72,821,2629		
2502	2502	R-HSA-9669934	Sunitinib-resistant KIT mutants R-HSA-9669934	2433	4,37,1155,2433,2629		
2503	2503	R-HSA-5467345	Deletions in the AXIN1 gene destabilize the destruction complex R-HSA-5467345	1369	4,37,817,1369,2629		
2504	2504	R-HSA-9674404	Sorafenib-resistant PDGFR mutants R-HSA-9674404	2498	4,37,1157,2498,2629		
2505	2505	R-HSA-5579005	Defective CYP4F22 causes ARCI5 R-HSA-5579005	812	4,72,812,2629		
2506	2506	R-HSA-5619053	Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP) R-HSA-5619053	284	4,121,284,2629		
2507	2507	R-HSA-5619036	Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6) R-HSA-5619036	284	4,121,284,2629		
2508	2508	R-HSA-8853334	Signaling by FGFR3 fusions in cancer R-HSA-8853334	1490	4,37,488,1077,1490,2629		
2509	2509	R-HSA-5578995	Defective TPMT causes TPMT deficiency R-HSA-5578995	812	4,72,812,2629		
2510	2510	R-HSA-5579014	Defective CYP27B1 causes VDDR1A R-HSA-5579014	812	4,72,812,2629		
2511	2511	R-HSA-9694301	Maturation of replicase proteins R-HSA-9694301	1386	4,11,12,35,56,772,1386,2629		
2512	2512	R-HSA-5658471	Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5658471	284	4,121,284,2629		
2513	2513	R-HSA-5579013	Defective CYP7B1 causes SPG5A and CBAS3 R-HSA-5579013	812	4,72,812,2629		
2514	2514	R-HSA-5467343	Deletions in the AMER1 gene destabilize the destruction complex R-HSA-5467343	1379	4,37,817,1379,2629		
2515	2515	R-HSA-4570571	Defective RFT1 causes CDG-1n R-HSA-4570571	1141	4,72,157,1141,2629		
2516	2516	R-HSA-5609978	Defective GALT can cause GALCT R-HSA-5609978	1305	4,72,157,1305,2629		
2517	2517	R-HSA-2206280	MPS IX - Natowicz syndrome R-HSA-2206280	1564	4,72,821,1564,2629		
2518	2518	R-HSA-2033515	t(4;14) translocations of FGFR3 R-HSA-2033515	1490	4,37,488,1077,1490,2629		
2519	2519	R-HSA-9702636	tandutinib-resistant FLT3 mutants R-HSA-9702636	2578	4,37,938,2578,2629		
2520	2520	R-HSA-9672395	Defective F8 binding to the cell membrane R-HSA-9672395	1799	4,1162,1263,1799,2629		
2521	2521	R-HSA-9646303	Evasion of Oncogene Induced Senescence Due to p14ARF Defects R-HSA-9646303	2123	4,2123,2204,2629		
2522	2522	R-HSA-9702600	midostaurin-resistant FLT3 mutants R-HSA-9702600	2578	4,37,938,2578,2629		
2523	2523	R-HSA-5619096	Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1) R-HSA-5619096	284	4,121,284,2629		
2524	2524	R-HSA-9616333	Defective Base Excision Repair Associated with NTHL1 R-HSA-9616333	2010	4,611,2010,2629	2474,2583	2474,2583
2525	2525	R-HSA-4549356	Defective DPAGT1 causes CDG-1j, CMSTA2 R-HSA-4549356	1141	4,72,157,1141,2629		
2526	2526	R-HSA-5619037	Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5619037	284	4,121,284,2629		
2527	2527	R-HSA-5619094	Variant SLC6A14 may confer susceptibility towards obesity R-HSA-5619094	284	4,121,284,2629		
2528	2528	R-HSA-9669929	Regorafenib-resistant KIT mutants R-HSA-9669929	2433	4,37,1155,2433,2629		
2529	2529	R-HSA-5619066	Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1) R-HSA-5619066	284	4,121,284,2629		
2530	2530	R-HSA-9702605	pexidartinib-resistant FLT3 mutants R-HSA-9702605	2578	4,37,938,2578,2629		
2531	2531	R-HSA-164525	Plus-strand DNA synthesis R-HSA-164525	2419	4,11,12,80,150,1368,2419,2629		
2532	2532	R-HSA-192814	vRNA Synthesis R-HSA-192814	169	4,11,12,134,169,2629		
2533	2533	R-HSA-4043916	Defective MPI causes MPI-CDG R-HSA-4043916	1305	4,72,157,1305,2629		
2534	2534	R-HSA-5619101	Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5619101	284	4,121,284,2629		
2535	2535	R-HSA-5579027	Defective CYP27B1 causes VDDR1B R-HSA-5579027	812	4,72,812,2629		
2536	2536	R-HSA-5619048	Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1) R-HSA-5619048	284	4,121,284,2629		
2537	2537	R-HSA-9656255	Defective OGG1 Substrate Binding R-HSA-9656255	2585	4,611,2010,2585,2629		
2538	2538	R-HSA-4549349	Defective ALG2 causes CDG-1i R-HSA-4549349	1141	4,72,157,1141,2629		
2539	2539	R-HSA-9669933	Signaling by kinase domain mutants of KIT R-HSA-9669933	1155	4,37,1155,2629		
2540	2540	R-HSA-9616334	Defective Base Excision Repair Associated with NEIL1 R-HSA-9616334	2010	4,611,2010,2629		
2541	2541	R-HSA-5579020	Defective SLC35D1 causes SCHBCKD R-HSA-5579020	812	4,72,812,2629		
2542	2542	R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619110	284	4,121,284,2629		
2543	2543	R-HSA-9702620	quizartinib-resistant FLT3 mutants R-HSA-9702620	2578	4,37,938,2578,2629		
2544	2544	R-HSA-5656364	Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) R-HSA-5656364	284	4,121,284,2629		
2545	2545	R-HSA-2206305	MPS IIID - Sanfilippo syndrome D R-HSA-2206305	1564	4,72,821,1564,2629		
2546	2546	R-HSA-5660724	Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5660724	284	4,121,284,2629		
2547	2547	R-HSA-9661070	Defective translocation of RB1 mutants to the nucleus R-HSA-9661070	1236	4,752,782,1236,2629		
2548	2548	R-HSA-171286	Synthesis and processing of ENV and VPU R-HSA-171286	1279	4,11,12,80,150,172,1279,2629		
2549	2549	R-HSA-5619092	Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH) R-HSA-5619092	284	4,121,284,2629		
2550	2550	R-HSA-9735786	Nucleotide catabolism defects R-HSA-9735786	2069	4,72,2069,2629	2591	2591
2551	2551	R-HSA-1855231	Synthesis of IPs in the ER lumen R-HSA-1855231	634	1,634,2629		
2552	2552	R-HSA-4793953	Defective B4GALT1 causes CDG-2d R-HSA-4793953	1141	4,72,157,1141,2629		
2553	2553	R-HSA-3656234	Defective HEXA causes GM2G1 R-HSA-3656234	718	4,72,157,718,2629		
2554	2554	R-HSA-3359474	Defective MMACHC causes MAHCC R-HSA-3359474	1400	4,72,1093,1400,2629		
2555	2555	R-HSA-1483076	Synthesis of CL R-HSA-1483076	185	1,17,91,185,2629		
2556	2556	R-HSA-5619067	Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) R-HSA-5619067	284	4,121,284,2629		
2557	2557	R-HSA-4085011	Defective GNE causes sialuria, NK and IBM2 R-HSA-4085011	1305	4,72,157,1305,2629		
2558	2558	R-HSA-9022534	Loss of MECP2 binding ability to 5hmC-DNA R-HSA-9022534	1428	4,1428,1432,1433,1449,2629		
2559	2559	R-HSA-2408552	Methylation of MeSeH for excretion R-HSA-2408552	209	1,44,209,2629		
2560	2560	R-HSA-4043911	Defective PMM2 causes PMM2-CDG R-HSA-4043911	1305	4,72,157,1305,2629		
2561	2561	R-HSA-8877627	Vitamin E R-HSA-8877627	628	1,107,628,2629		
2562	2562	R-HSA-9717301	NVP-TAE684-resistant ALK mutants R-HSA-9717301	2422	4,37,325,2422,2629		
2563	2563	R-HSA-2206291	MPS IIIC - Sanfilippo syndrome C R-HSA-2206291	1564	4,72,821,1564,2629		
2564	2564	R-HSA-4551295	Defective ALG11 causes CDG-1p R-HSA-4551295	1141	4,72,157,1141,2629		
2565	2565	R-HSA-5579015	Defective CYP26B1 causes RHFCA R-HSA-5579015	812	4,72,812,2629		
2566	2566	R-HSA-3560792	Defective SLC26A2 causes chondrodysplasias R-HSA-3560792	284,718	4,72,121,157,284,718,2629		
2567	2567	R-HSA-5619061	Defective SLC33A1 causes spastic paraplegia 42 (SPG42) R-HSA-5619061	284	4,121,284,2629		
2568	2568	R-HSA-5619097	Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) R-HSA-5619097	284	4,121,284,2629		
2569	2569	R-HSA-3282872	Severe congenital neutropenia type 4 (G6PC3) R-HSA-3282872	1274	4,72,821,1274,2629		
2570	2570	R-HSA-9672397	Defective F8 secretion R-HSA-9672397	1799	4,1162,1263,1799,2629		
2571	2571	R-HSA-5674404	PTEN Loss of Function in Cancer R-HSA-5674404	261	4,37,261,2629		
2572	2572	R-HSA-6791461	RPIA deficiency: failed conversion of RU5P to R5P R-HSA-6791461	2322	4,72,821,2322,2629		
2573	2573	R-HSA-5609976	Defective GALK1 causes GALCT2 R-HSA-5609976	1305	4,72,157,1305,2629		
2574	2574	R-HSA-4793952	Defective MGAT2 causes CDG-2a R-HSA-4793952	1141	4,72,157,1141,2629		
2575	2575	R-HSA-9673218	Defective F9 secretion R-HSA-9673218	1677	4,1162,1263,1677,2629		
2576	2576	R-HSA-162585	Uncoating of the HIV Virion R-HSA-162585	1368	4,11,12,80,150,1368,2629		
2577	2577	R-HSA-5657560	Hereditary fructose intolerance R-HSA-5657560	821	4,72,821,2629		
2578	2578	R-HSA-9702506	Drug resistance of FLT3 mutants R-HSA-9702506	938	4,37,938,2629	2367,2374,2415,2424,2447,2460,2469,2485,2519,2522,2530,2543,2597,2616	2367,2374,2415,2424,2447,2460,2469,2485,2519,2522,2530,2543,2597,2616
2579	2579	R-HSA-9669936	Sorafenib-resistant KIT mutants R-HSA-9669936	2433	4,37,1155,2433,2629		
2580	2580	R-HSA-9674401	Sunitinib-resistant PDGFR mutants R-HSA-9674401	2498	4,37,1157,2498,2629		
2581	2581	R-HSA-5619114	Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5619114	284	4,121,284,2629		
2582	2582	R-HSA-5619083	Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS) R-HSA-5619083	284	4,121,284,2629		
2583	2583	R-HSA-9630221	Defective NTHL1 substrate processing R-HSA-9630221	2524	4,611,2010,2524,2629		
2584	2584	R-HSA-2206296	MPS II - Hunter syndrome R-HSA-2206296	1564	4,72,821,1564,2629		
2585	2585	R-HSA-9656249	Defective Base Excision Repair Associated with OGG1 R-HSA-9656249	2010	4,611,2010,2629	2404,2537,2589	2404,2537,2589
2586	2586	R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 R-HSA-211957	1069	1,82,263,476,1069,2629		
2587	2587	R-HSA-1839128	FGFR4 mutant receptor activation R-HSA-1839128	1517	4,37,488,1517,2629		
2588	2588	R-HSA-9026403	Biosynthesis of DPAn-3-derived 13-series resolvins R-HSA-9026403	2031	1,17,1170,2031,2058,2629		
2589	2589	R-HSA-9657050	Defective OGG1 Localization R-HSA-9657050	2585	4,611,2010,2585,2629		
2590	2590	R-HSA-6791462	TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P R-HSA-6791462	2322	4,72,821,2322,2629		
2591	2591	R-HSA-9735763	Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine R-HSA-9735763	2550	4,72,2069,2550,2629		
2592	2592	R-HSA-2206292	MPS VII - Sly syndrome R-HSA-2206292	1564	4,72,821,1564,2629		
2593	2593	R-HSA-1222499	Latent infection - Other responses of Mtb to phagocytosis R-HSA-1222499	967	4,11,433,967,2629	2495	2495
2594	2594	R-HSA-9669921	KIT mutants bind TKIs R-HSA-9669921	1155	4,37,1155,2629		
2595	2595	R-HSA-8853333	Signaling by FGFR2 fusions R-HSA-8853333	846	4,37,488,685,846,2629		
2596	2596	R-HSA-5579021	Defective CYP21A2 causes AH3 R-HSA-5579021	812	4,72,812,2629		
2597	2597	R-HSA-9702590	gilteritinib-resistant FLT3 mutants R-HSA-9702590	2578	4,37,938,2578,2629		
2598	2598	R-HSA-5609977	Defective GALE causes EDG R-HSA-5609977	1305	4,72,157,1305,2629		
2599	2599	R-HSA-9669914	Dasatinib-resistant KIT mutants R-HSA-9669914	2433	4,37,1155,2433,2629		
2600	2600	R-HSA-9646304	Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects R-HSA-9646304	2123	4,2123,2204,2629		
2601	2601	R-HSA-5619087	Defective SLC12A3 causes Gitelman syndrome (GS) R-HSA-5619087	284	4,121,284,2629		
2602	2602	R-HSA-5619073	Defective GCK causes maturity-onset diabetes of the young 2 (MODY2) R-HSA-5619073	284	4,121,284,2629		
2603	2603	R-HSA-5619081	Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5619081	284	4,121,284,2629		
2604	2604	R-HSA-5579004	Defective CYP26C1 causes FFDD4 R-HSA-5579004	812	4,72,812,2629		
2605	2605	R-HSA-5662853	Essential pentosuria R-HSA-5662853	821	4,72,821,2629		
2606	2606	R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate R-HSA-2978092	72	4,72,2629		
2607	2607	R-HSA-4755579	Defective SRD5A3 causes SRD5A3-CDG, KHRZ R-HSA-4755579	1305	4,72,157,1305,2629		
2608	2608	R-HSA-5619045	Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) R-HSA-5619045	284	4,121,284,2629		
2609	2609	R-HSA-5619111	Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) R-HSA-5619111	284	4,121,284,2629		
2610	2610	R-HSA-9669924	Masitinib-resistant KIT mutants R-HSA-9669924	2433	4,37,1155,2433,2629		
2611	2611	R-HSA-5687868	Defective SFTPA2 causes IPF R-HSA-5687868	1610	4,72,1610,2629		
2612	2612	R-HSA-9674403	Regorafenib-resistant PDGFR mutants R-HSA-9674403	2498	4,37,1157,2498,2629		
2613	2613	R-HSA-9026766	Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR) R-HSA-9026766	2239	1,17,1170,1258,2239,2629		
2614	2614	R-HSA-5619079	Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5619079	284	4,121,284,2629		
2615	2615	R-HSA-8963678	Intestinal lipid absorption R-HSA-8963678	1924	935,1924,2629		
2616	2616	R-HSA-9702632	sunitinib-resistant FLT3 mutants R-HSA-9702632	2578	4,37,938,2578,2629		
2617	2617	R-HSA-4549380	Defective ALG1 causes CDG-1k R-HSA-4549380	1141	4,72,157,1141,2629		
2618	2618	R-HSA-2206282	MPS IIIB - Sanfilippo syndrome B R-HSA-2206282	1564	4,72,821,1564,2629		
2619	2619	R-HSA-4720475	Defective ALG3 causes CDG-1d R-HSA-4720475	1141	4,72,157,1141,2629		
2620	2620	R-HSA-112122	ALKBH2 mediated reversal of alkylation damage R-HSA-112122	1813	46,1710,1813,2629		
2621	2621	R-HSA-9717323	ceritinib-resistant ALK mutants R-HSA-9717323	2422	4,37,325,2422,2629		
2622	2622	R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway R-HSA-975574	985	3,6,54,114,985,2629		
2623	2623	R-HSA-5579010	Defective CYP24A1 causes HCAI R-HSA-5579010	812	4,72,812,2629		
2624	2624	R-HSA-5579022	Defective GGT1 causes GLUTH R-HSA-5579022	812	4,72,812,2629		
2625	2625	R-HSA-5619077	Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D) R-HSA-5619077	284	4,121,284,2629		
2626	2626	R-HSA-5619063	Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS) R-HSA-5619063	284	4,121,284,2629		
2627	2627	R-HSA-9674428	PDGFR mutants bind TKIs R-HSA-9674428	1157	4,37,1157,2629		
2628	2628	R-HSA-2206285	MPS VI - Maroteaux-Lamy syndrome R-HSA-2206285	1564	4,72,821,1564,2629		
2629	2629	R-HSA-Reactome Pathway	Reactome R-HSA-Reactome Pathway			0,1,2,3,4,5,8,13,18,19,20,24,25,26,41,46,55,61,68,92,98,112,129,137,138,146,244,442,935	0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,306,307,308,309,310,311,312,313,314,315,316,317,318,319,320,321,322,323,324,325,326,327,328,329,330,331,332,333,334,335,336,337,338,339,340,341,342,343,344,345,346,347,348,349,350,351,352,353,354,355,356,357,358,359,360,361,362,363,364,365,366,367,368,369,370,371,372,373,374,375,376,377,378,379,380,381,382,383,384,385,386,387,388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,430,431,432,433,434,435,436,437,438,439,440,441,442,443,444,445,446,447,448,449,450,451,452,453,454,455,456,457,458,459,460,461,462,463,464,465,466,467,468,469,470,471,472,473,474,475,476,477,478,479,480,481,482,483,484,485,486,487,488,489,490,491,492,493,494,495,496,497,498,499,500,501,502,503,504,505,506,507,508,509,510,511,512,513,514,515,516,517,518,519,520,521,522,523,524,525,526,527,528,529,530,531,532,533,534,535,536,537,538,539,540,541,542,543,544,545,546,547,548,549,550,551,552,553,554,555,556,557,558,559,560,561,562,563,564,565,566,567,568,569,570,571,572,573,574,575,576,577,578,579,580,581,582,583,584,585,586,587,588,589,590,591,592,593,594,595,596,597,598,599,600,601,602,603,604,605,606,607,608,609,610,611,612,613,614,615,616,617,618,619,620,621,622,623,624,625,626,627,628,629,630,631,632,633,634,635,636,637,638,639,640,641,642,643,644,645,646,647,648,649,650,651,652,653,654,655,656,657,658,659,660,661,662,663,664,665,666,667,668,669,670,671,672,673,674,675,676,677,678,679,680,681,682,683,684,685,686,687,688,689,690,691,692,693,694,695,696,697,698,699,700,701,702,703,704,705,706,707,708,709,710,711,712,713,714,715,716,717,718,719,720,721,722,723,724,725,726,727,728,729,730,731,732,733,734,735,736,737,738,739,740,741,742,743,744,745,746,747,748,749,750,751,752,753,754,755,756,757,758,759,760,761,762,763,764,765,766,767,768,769,770,771,772,773,774,775,776,777,778,779,780,781,782,783,784,785,786,787,788,789,790,791,792,793,794,795,796,797,798,799,800,801,802,803,804,805,806,807,808,809,810,811,812,813,814,815,816,817,818,819,820,821,822,823,824,825,826,827,828,829,830,831,832,833,834,835,836,837,838,839,840,841,842,843,844,845,846,847,848,849,850,851,852,853,854,855,856,857,858,859,860,861,862,863,864,865,866,867,868,869,870,871,872,873,874,875,876,877,878,879,880,881,882,883,884,885,886,887,888,889,890,891,892,893,894,895,896,897,898,899,900,901,902,903,904,905,906,907,908,909,910,911,912,913,914,915,916,917,918,919,920,921,922,923,924,925,926,927,928,929,930,931,932,933,934,935,936,937,938,939,940,941,942,943,944,945,946,947,948,949,950,951,952,953,954,955,956,957,958,959,960,961,962,963,964,965,966,967,968,969,970,971,972,973,974,975,976,977,978,979,980,981,982,983,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079,1080,1081,1082,1083,1084,1085,1086,1087,1088,1089,1090,1091,1092,1093,1094,1095,1096,1097,1098,1099,1100,1101,1102,1103,1104,1105,1106,1107,1108,1109,1110,1111,1112,1113,1114,1115,1116,1117,1118,1119,1120,1121,1122,1123,1124,1125,1126,1127,1128,1129,1130,1131,1132,1133,1134,1135,1136,1137,1138,1139,1140,1141,1142,1143,1144,1145,1146,1147,1148,1149,1150,1151,1152,1153,1154,1155,1156,1157,1158,1159,1160,1161,1162,1163,1164,1165,1166,1167,1168,1169,1170,1171,1172,1173,1174,1175,1176,1177,1178,1179,1180,1181,1182,1183,1184,1185,1186,1187,1188,1189,1190,1191,1192,1193,1194,1195,1196,1197,1198,1199,1200,1201,1202,1203,1204,1205,1206,1207,1208,1209,1210,1211,1212,1213,1214,1215,1216,1217,1218,1219,1220,1221,1222,1223,1224,1225,1226,1227,1228,1229,1230,1231,1232,1233,1234,1235,1236,1237,1238,1239,1240,1241,1242,1243,1244,1245,1246,1247,1248,1249,1250,1251,1252,1253,1254,1255,1256,1257,1258,1259,1260,1261,1262,1263,1264,1265,1266,1267,1268,1269,1270,1271,1272,1273,1274,1275,1276,1277,1278,1279,1280,1281,1282,1283,1284,1285,1286,1287,1288,1289,1290,1291,1292,1293,1294,1295,1296,1297,1298,1299,1300,1301,1302,1303,1304,1305,1306,1307,1308,1309,1310,1311,1312,1313,1314,1315,1316,1317,1318,1319,1320,1321,1322,1323,1324,1325,1326,1327,1328,1329,1330,1331,1332,1333,1334,1335,1336,1337,1338,1339,1340,1341,1342,1343,1344,1345,1346,1347,1348,1349,1350,1351,1352,1353,1354,1355,1356,1357,1358,1359,1360,1361,1362,1363,1364,1365,1366,1367,1368,1369,1370,1371,1372,1373,1374,1375,1376,1377,1378,1379,1380,1381,1382,1383,1384,1385,1386,1387,1388,1389,1390,1391,1392,1393,1394,1395,1396,1397,1398,1399,1400,1401,1402,1403,1404,1405,1406,1407,1408,1409,1410,1411,1412,1413,1414,1415,1416,1417,1418,1419,1420,1421,1422,1423,1424,1425,1426,1427,1428,1429,1430,1431,1432,1433,1434,1435,1436,1437,1438,1439,1440,1441,1442,1443,1444,1445,1446,1447,1448,1449,1450,1451,1452,1453,1454,1455,1456,1457,1458,1459,1460,1461,1462,1463,1464,1465,1466,1467,1468,1469,1470,1471,1472,1473,1474,1475,1476,1477,1478,1479,1480,1481,1482,1483,1484,1485,1486,1487,1488,1489,1490,1491,1492,1493,1494,1495,1496,1497,1498,1499,1500,1501,1502,1503,1504,1505,1506,1507,1508,1509,1510,1511,1512,1513,1514,1515,1516,1517,1518,1519,1520,1521,1522,1523,1524,1525,1526,1527,1528,1529,1530,1531,1532,1533,1534,1535,1536,1537,1538,1539,1540,1541,1542,1543,1544,1545,1546,1547,1548,1549,1550,1551,1552,1553,1554,1555,1556,1557,1558,1559,1560,1561,1562,1563,1564,1565,1566,1567,1568,1569,1570,1571,1572,1573,1574,1575,1576,1577,1578,1579,1580,1581,1582,1583,1584,1585,1586,1587,1588,1589,1590,1591,1592,1593,1594,1595,1596,1597,1598,1599,1600,1601,1602,1603,1604,1605,1606,1607,1608,1609,1610,1611,1612,1613,1614,1615,1616,1617,1618,1619,1620,1621,1622,1623,1624,1625,1626,1627,1628,1629,1630,1631,1632,1633,1634,1635,1636,1637,1638,1639,1640,1641,1642,1643,1644,1645,1646,1647,1648,1649,1650,1651,1652,1653,1654,1655,1656,1657,1658,1659,1660,1661,1662,1663,1664,1665,1666,1667,1668,1669,1670,1671,1672,1673,1674,1675,1676,1677,1678,1679,1680,1681,1682,1683,1684,1685,1686,1687,1688,1689,1690,1691,1692,1693,1694,1695,1696,1697,1698,1699,1700,1701,1702,1703,1704,1705,1706,1707,1708,1709,1710,1711,1712,1713,1714,1715,1716,1717,1718,1719,1720,1721,1722,1723,1724,1725,1726,1727,1728,1729,1730,1731,1732,1733,1734,1735,1736,1737,1738,1739,1740,1741,1742,1743,1744,1745,1746,1747,1748,1749,1750,1751,1752,1753,1754,1755,1756,1757,1758,1759,1760,1761,1762,1763,1764,1765,1766,1767,1768,1769,1770,1771,1772,1773,1774,1775,1776,1777,1778,1779,1780,1781,1782,1783,1784,1785,1786,1787,1788,1789,1790,1791,1792,1793,1794,1795,1796,1797,1798,1799,1800,1801,1802,1803,1804,1805,1806,1807,1808,1809,1810,1811,1812,1813,1814,1815,1816,1817,1818,1819,1820,1821,1822,1823,1824,1825,1826,1827,1828,1829,1830,1831,1832,1833,1834,1835,1836,1837,1838,1839,1840,1841,1842,1843,1844,1845,1846,1847,1848,1849,1850,1851,1852,1853,1854,1855,1856,1857,1858,1859,1860,1861,1862,1863,1864,1865,1866,1867,1868,1869,1870,1871,1872,1873,1874,1875,1876,1877,1878,1879,1880,1881,1882,1883,1884,1885,1886,1887,1888,1889,1890,1891,1892,1893,1894,1895,1896,1897,1898,1899,1900,1901,1902,1903,1904,1905,1906,1907,1908,1909,1910,1911,1912,1913,1914,1915,1916,1917,1918,1919,1920,1921,1922,1923,1924,1925,1926,1927,1928,1929,1930,1931,1932,1933,1934,1935,1936,1937,1938,1939,1940,1941,1942,1943,1944,1945,1946,1947,1948,1949,1950,1951,1952,1953,1954,1955,1956,1957,1958,1959,1960,1961,1962,1963,1964,1965,1966,1967,1968,1969,1970,1971,1972,1973,1974,1975,1976,1977,1978,1979,1980,1981,1982,1983,1984,1985,1986,1987,1988,1989,1990,1991,1992,1993,1994,1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023,2024,2025,2026,2027,2028,2029,2030,2031,2032,2033,2034,2035,2036,2037,2038,2039,2040,2041,2042,2043,2044,2045,2046,2047,2048,2049,2050,2051,2052,2053,2054,2055,2056,2057,2058,2059,2060,2061,2062,2063,2064,2065,2066,2067,2068,2069,2070,2071,2072,2073,2074,2075,2076,2077,2078,2079,2080,2081,2082,2083,2084,2085,2086,2087,2088,2089,2090,2091,2092,2093,2094,2095,2096,2097,2098,2099,2100,2101,2102,2103,2104,2105,2106,2107,2108,2109,2110,2111,2112,2113,2114,2115,2116,2117,2118,2119,2120,2121,2122,2123,2124,2125,2126,2127,2128,2129,2130,2131,2132,2133,2134,2135,2136,2137,2138,2139,2140,2141,2142,2143,2144,2145,2146,2147,2148,2149,2150,2151,2152,2153,2154,2155,2156,2157,2158,2159,2160,2161,2162,2163,2164,2165,2166,2167,2168,2169,2170,2171,2172,2173,2174,2175,2176,2177,2178,2179,2180,2181,2182,2183,2184,2185,2186,2187,2188,2189,2190,2191,2192,2193,2194,2195,2196,2197,2198,2199,2200,2201,2202,2203,2204,2205,2206,2207,2208,2209,2210,2211,2212,2213,2214,2215,2216,2217,2218,2219,2220,2221,2222,2223,2224,2225,2226,2227,2228,2229,2230,2231,2232,2233,2234,2235,2236,2237,2238,2239,2240,2241,2242,2243,2244,2245,2246,2247,2248,2249,2250,2251,2252,2253,2254,2255,2256,2257,2258,2259,2260,2261,2262,2263,2264,2265,2266,2267,2268,2269,2270,2271,2272,2273,2274,2275,2276,2277,2278,2279,2280,2281,2282,2283,2284,2285,2286,2287,2288,2289,2290,2291,2292,2293,2294,2295,2296,2297,2298,2299,2300,2301,2302,2303,2304,2305,2306,2307,2308,2309,2310,2311,2312,2313,2314,2315,2316,2317,2318,2319,2320,2321,2322,2323,2324,2325,2326,2327,2328,2329,2330,2331,2332,2333,2334,2335,2336,2337,2338,2339,2340,2341,2342,2343,2344,2345,2346,2347,2348,2349,2350,2351,2352,2353,2354,2355,2356,2357,2358,2359,2360,2361,2362,2363,2364,2365,2366,2367,2368,2369,2370,2371,2372,2373,2374,2375,2376,2377,2378,2379,2380,2381,2382,2383,2384,2385,2386,2387,2388,2389,2390,2391,2392,2393,2394,2395,2396,2397,2398,2399,2400,2401,2402,2403,2404,2405,2406,2407,2408,2409,2410,2411,2412,2413,2414,2415,2416,2417,2418,2419,2420,2421,2422,2423,2424,2425,2426,2427,2428,2429,2430,2431,2432,2433,2434,2435,2436,2437,2438,2439,2440,2441,2442,2443,2444,2445,2446,2447,2448,2449,2450,2451,2452,2453,2454,2455,2456,2457,2458,2459,2460,2461,2462,2463,2464,2465,2466,2467,2468,2469,2470,2471,2472,2473,2474,2475,2476,2477,2478,2479,2480,2481,2482,2483,2484,2485,2486,2487,2488,2489,2490,2491,2492,2493,2494,2495,2496,2497,2498,2499,2500,2501,2502,2503,2504,2505,2506,2507,2508,2509,2510,2511,2512,2513,2514,2515,2516,2517,2518,2519,2520,2521,2522,2523,2524,2525,2526,2527,2528,2529,2530,2531,2532,2533,2534,2535,2536,2537,2538,2539,2540,2541,2542,2543,2544,2545,2546,2547,2548,2549,2550,2551,2552,2553,2554,2555,2556,2557,2558,2559,2560,2561,2562,2563,2564,2565,2566,2567,2568,2569,2570,2571,2572,2573,2574,2575,2576,2577,2578,2579,2580,2581,2582,2583,2584,2585,2586,2587,2588,2589,2590,2591,2592,2593,2594,2595,2596,2597,2598,2599,2600,2601,2602,2603,2604,2605,2606,2607,2608,2609,2610,2611,2612,2613,2614,2615,2616,2617,2618,2619,2620,2621,2622,2623,2624,2625,2626,2627,2628
